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Summary 
Blood vessel diameter and blood flow are tightly controlled by electrical signals and calcium 
ion (Ca2+) signals in smooth muscle cells (SMCs) and endothelial cells (ECs) in which selective 
and non-selective ion channels play a crucial role. In this doctoral thesis we characterized the 
targets of cannabinoid- and calcitonin gene related peptide (CGRP)-triggered vasodilation 
and the role of connexin channels in the modulation of blood vessel tone. Additionally, we 
investigated connexin channels as a putative target to protect blood vessels against cell 
death associated with stressful conditions like cryopreservation. 
Blood vessel tonus can be modulated by several factors, such as endothelial factors or 
factors released from perivascular nerves, thereby promoting vasodilation or 
vasoconstriction. Cannabinoids have been used for centuries for their psychoactive 
properties, but they have also a profound influence on the cardiovascular system, leading to 
vasodilation. Vasorelaxation by cannabinoids can be mediated by stimulation of cannabinoid 
receptors. Others pointed a role for vanilloid receptors on perivascular nerves and a 
subsequent release of the neuropeptide CGRP. This peptide is one of the most potent 
vasodilatory substances and can act via an endothelium-dependent or -independent 
process. In order to find out if a direct effect of the cannabinoid methanandamide was 
present in small mesenteric rat arteries, we performed experiments on acutely isolated 
SMCs. Our findings show that the cannabinoid methanandamide fails to increase the 
membrane potassium (K+) currents and fails to hyperpolarize the membrane potential. 
Moreover, the neuropeptide CGRP is acting specifically and directly on these cells by 
increasing the large-conductance calcium-dependent potassium (BKCa) channel activity in a 
receptor-, cyclic adenosine monophosphate- (cAMP), and protein kinase A- (PKA) dependent 
way and hyperpolarizes the membrane potential of these cells. This is consistent with earlier 
reports suggesting that methanandamide relaxes and hyperpolarizes intact rat mesenteric 
arteries by releasing the neuropeptide CGRP from perivascular nerves. 
 
Next to electrical changes, vessel diameter and blood flow are also controlled by Ca2+ signals 
and communicative pathways between vascular cells in which gap junctions (GJs) play a 
crucial role. GJs are dodecameric channels composed of connexin proteins that directly 
connect the cytoplasm of cells. These intercellular channels are composed of two hexameric 
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hemichannels (HCs) that may also be junctional as non-junctional HCs. Non-junctional 
(unapposed) HCs are present in the plasma membrane normally closed but may open by 
various messengers and conditions thereby forming a pore that allows passage of ions and 
messengers like ATP or other substances with a molecular weight below 1.5 kDa. HC opening 
allows Ca2+ entry into the cells but opening is also controlled by the intracellular 
(cytoplasmic) Ca2+ concentration ([Ca2+]i). Therefore, these channels are likely to contribute 
to Ca2+ oscillations which are repetitive [Ca2+]i changes. We investigated the role of HCs in 
Ca2+ oscillations by interfering with HC function via the application of peptides that are 
identical to connexin sequences on the connexin protein. We found that in small mesenteric 
artery fragments isolated from rat, norepinephrine-induced Ca2+ oscillations in SMCs were 
inhibited by the connexin mimetic peptide Gap27, by the TAT-L2 peptide and by the TAT-CT9 
peptide. Gap27 inhibits HCs first and with some delay also GJs; it targets multiple connexins 
because it mimics well-conserved extracellular domains of the connexin protein. By contrast, 
TAT-L2 peptide has specificity at two levels: it only inhibits HCs but not GJs and it has 
specificity for Cx43 and not for other connexins. The latter is related to the fact that this 
peptide is identical to a part of the intracellularly located non-conserved domain. TAT-CT9 
also has specificity for Cx43 but this peptide prevents the closure of HCs at high micromolar 
[Ca2+]i. In addition to allowing Ca
2+ entry, open HCs can also allow the escape of ATP from 
the cell. We found that interfering with purinergic signaling, by promoting the degradation 
of ATP or by inhibiting purinergic receptors, norepinephrine-induced Ca2+ oscillations were 
also inhibited. Taken together, these findings suggest that ATP released by SMCs via 
connexin hemichannels (CxHCs) with subsequent activation of purinergic communication is 
involved in controlling vessel responses to norepinephrine. Tension measurements further 
confirmed the role of CxHCs in vascular smooth muscle tension since the contractility was 
also inhibited by Gap27, by TAT-L2 and by purinergic receptor antagonists. These data 
indicate that interfering with CxHCs offers a novel approach towards modulating blood 
vessel reactivity. 
 
GJs and CxHCs are important for vascular function, but they also play a role in cell death 
processes. GJs allow the passage of cell death messengers thereby contributing to the 
propagation of cell death known as bystander cell death. Unapposed CxHCs may promote 
cell death by uncontrolled opening and thereby contribute to the entrance or escape from 
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the cell of ions and small metabolites. Inhibiting connexin channels may thus lead to 
improved cell viability after exposure to stressful conditions like exposure to freezing 
conditions in the context of cryopreservation of cells and tissues. Cryopreserved blood 
vessels are being increasingly employed as grafts in vascular reconstruction procedures. 
However, the massive cell death provoked by the methods of cryopreservation used at most 
vascular banks is one of the main factors leading to the failure of grafting procedures 
performed using cryopreserved vascular allografts. We investigated whether blocking 
connexin channels could prevent cell death after cryopreservation. We report that Gap27 
significantly reduced cell death in human femoral arteries and saphenous veins when 
present during cryopreservation/thawing. Veins had a better conserved intimal layer 
compared to arteries and had less endothelial cell death. This implies that veins are better 
suited for vessel replacement in patients with vascular diseases and a high risk of thrombosis 
because of the anti-thrombogenic effect of an intact endothelium. Most notably, blocking 
GJs and HCs with connexin mimetic peptides like Gap27 appears to be very efficient to 
prevent cell death in complex tissues like blood vessels undergoing cryopreservation. It is 
important to note here that blocking GJs and HCs is (in most cases) are not indicated in vivo 
because GJs are necessary for normal physiological function. However, inhibition of GJs and 
HCs is perfectly possible in tissues and organs isolated ex vivo for subsequent cold or cryo 
storage. Such procedure may well be indicated in the context of heart, lung and kidney 
transplantation and cryopreservation/vitrification of various cells and tissues.  
In conclusion, this work has improved our understanding of the vascular action of 
cannabinoids and CGRP, and has brought up connexins and their channels as interesting new 
targets to modulate blood vessel function and to protect vascular cell viability after 
cryopreservation.  
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Samenvatting 
De diameter van een bloedvat en de bloeddoorstroming zijn strikt gereguleerd door 
elekrische signalen en calcium ion (Ca2+) signalen in gladde spiercellen en endotheelcellen 
waarin selectieve en niet-selectieve ionkanalen een cruciale rol spelen. In deze 
doctoraatsthesis karakteriseren we de doelwitten van cannabinoïde- en calcitonine gene 
related peptide (CGRP)-getriggerde vasodilatatie en de rol van connexine kanalen in de 
modulatie van de contractiegraad van een bloedvat. Bijkomend onderzochten we Cx kanalen 
als een mogelijks doelwit om bloedvaten te beschermen tegen celdood die geassocieerd 
wordt met stressvolle omstandigheden zoals cryopreservatie. 
De contractiegraad van een bloedvat kan gewijzigd worden door verschillende factoren die 
aanwezig zijn in het endotheel of factoren die vrijgesteld worden uit zenuwen gelegen rond 
een bloedvat (perivasculaire zenuwen). Cannabinoïden worden al eeuwen gebruikt omwille 
van hun psychoactieve eigenschappen, maar ze hebben ook een grote invloed op het 
cardiovasculair systeem en leiden tot een vasodilatatie. Deze vasodilatatie door 
cannabinoïden kan gemedieerd worden door een stimulatie van cannabinoïd receptoren. 
Daarnaast kunnen ook vanilloïde receptoren die gelegen zijn op de perivasculaire zenuwen 
een vasodilatie bewerkstelligen en via deze weg vasodilaterende substanties vrijstellen zoals 
het neuropeptide CGRP. Dit peptide staat bekend als één van de meest potente 
vasodilatoren en kan inwerken via het endotheel of rechtstreeks op de gladde spiercel. Om 
een direct effect van het cannabinoïd methanandamide na te gaan, gebruiken we acuut 
geïsoleerde kleine mesenterische gladde spiercellen van de rat. We vonden geen 
rechtstreeks effect van het cannabinoïd methanandamide op de kalium (K+) stromen of de 
membraanpotentiaal; wat doet vermoeden dat het effect van methanandamide 
onrechtstreeks gebeurt, via de vrijstelling van CGRP op perivasculaire zenuwen. Inderdaad, 
CGRP werkt rechtstreeks op de gladde spiercellen in en dit vertaalt zich door een stijging van 
de K+ stromen en een hyperpolarizatie van de membraanpotentiaal. De calciumafhankelijke 
K+ kanalen (BKCa) worden geactiveerd via een receptor-, cAMP- en PKA-afhankelijke weg. We 
kunnen dus besluiten dat methanandamide kleine mesenterische bloedvaten relaxeert door 
CGRP vrij te stellen uit de perivasculaire zenuwen. 
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Naast elektrische veranderingen, worden de bloeddoorstroming en de bloedvat diameter 
ook gereguleerd door Ca2+ signalen en signaaltransductiewegen tussen vasculaire cellen 
waarin gap juncties een belangrijke rol spelen. Gap juncties zijn kanalen die bestaan uit 12 
connexine eiwitten die een directe verbinding maken met het cytoplasma van cellen. Deze 
intercellulaire kanalen zijn gevormd uit twee hexamere hemikanalen. Niet-geconnecteerde 
hemikanalen zijn aanwezig in de celmembraan in een gesloten status maar kunnen openen 
door verschillende stimuli en condities en kunnen de passage toelaten van ionen en 
boodschapperstoffen zoals ATP en andere moleculen met een moleculair gewicht kleiner 
dan 1.5 kDa. Door het openen van hemikanalen kan Ca2+ de cel binnenkomen maar het 
openen is ook gereguleerd door de intracellulaire calciumconcentratie ([Ca2+]i). Deze kanalen 
zijn daardoor ook mogelijks betrokken bij Ca2+ oscillaties; dit zijn repetitieve [Ca2+]i 
veranderingen. We onderzochten de rol van hemikanalen in Ca2+ oscillaties door te 
interfereren met de hemikanaal functies via de toediening van peptiden die identiek zijn aan 
connexine sequenties op het connexine eiwit. We vonden dat in gladde spiercellen van 
kleine mesenterische rat arteriën norepinefrine-geïnduceerde Ca2+ oscillaties geïnhibeerd 
werden door het connexine mimetische peptide Gap27, door het TAT-L2 peptide en door het 
TAT-CT9 peptide. Gap27 inhibeert eerst hemikanalen en in een latere fase gap juncties; het 
is een doelwit voor verschillende connexines omdat het een goed bewaard extracellulair 
domein van het connexine eiwit nabootst. Het TAT-L2 peptide daarentegen, heeft een 
specificiteit op twee niveaus: het inhibeert enkel hemikanalen en het heeft een specificiteit 
voor Cx43 en niet voor andere connexines. Dit komt omdat het peptide identiek is aan een 
deel van het niet-geconserveerd intracellulair domein. TAT-CT9 is ook specifiek voor Cx43 
maar dit peptide verhindert het sluiten van de hemikanalen bij een hoge micromolaire 
[Ca2+]i. Naast het binnenkomen van Ca
2+, kunnen hemikanalen ook de loslating van ATP naar 
buiten toelaten. We vonden dat door het interfereren met purinerge 
signaaltransductiewegen via een degradatie van ATP of via het inhiberen van purinerge 
receptoren, ook de norepinefrine-geïnduceerde Ca2+ oscillaties geïnhibeerd werden. Tot slot, 
suggereren deze bevindingen dat ATP dat vrijgesteld wordt uit gladde spiercellen via 
connexine hemikanalen en de activatie van het purinerge systeem een rol speelt in de 
controle van de norepinefrine-getriggerde bloedvatrespons. Tensiemetingen bevestigden 
verder de rol van hemikanalen in vasculaire gladde spier tonus gezien de contractiliteit 
geïnhibeerd werd door Gap27, TAT-L2 en purinerge receptor antagonisten. Deze data tonen 
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aan dat het interfereren met connexine hemikanalen een nieuwe mogelijkheid biedt om de 
reactiviteit van een bloedvat te wijzigen. 
 
Gap juncties en connexine hemikanalen zijn niet alleen belangrijk voor de vasculaire functie, 
maar dragen ook bij tot celdoodprocessen. Gap juncties laten de passage van celdood 
boodschappers door, wat bijdraagt tot de verspreiding van celdood. Connexine hemikanalen 
die niet als gap juncties zijn geconnecteerd, zullen bij ongecontroleerd opengaan celdood 
promoten en zo ionen en kleine metabolieten zowel in als uit de cel doorlaten. Het 
blokkeren van connexine kanalen kan dus leiden tot een verbeterde celviabiliteit na 
blootstelling aan stresvolle omstandigheden zoals het invriezen van cellen en weefsels. 
Ingevroren bloedvaten worden gebruikt om een aangetast bloedvat te vervangen bij een 
patiënt. Echter, de methodes om bloedvaten in te vriezen en te ontdooien zijn niet optimaal 
gezien de grote celdood in de bloedvaten na preservatie, en dit leidt tot het falen van de 
vasculaire greffe. We onderzochten het effect van Gap27, dat tijdens het invriezen en 
ontdooien werd toegevoegd aan het preservatiemedium en vonden een significante 
reductie in celdood in zowel humane dijbeenslagaders (arteria femoralis) als stamaders 
(vena saphena). Aderen of venen hadden een beter bewaard endotheel en minder celdood 
in die laag in vergelijking met slagaderen. Dit betekent dat gezien de antitrombotische 
eigenschappen van het endotheel, dat bij patiënten met vaatziektes die een groter risico 
hebben op een trombose, een vene met intact endotheel de voorkeur geniet bij 
transplantatie. Het blokkeren van gap juncties en hemikanalen met connexine mimetische 
peptiden zoals Gap27 blijkt heel efficiënt te zijn in de preventie van celdood in complexe 
weefsels zoals ingevroren bloedvaten. Het is belangrijk te vermelden dat het blokkeren van 
gap juncties en hemikanalen in de meeste situaties niet aangewezen is in vivo omdat gap 
juncties belangrijk zijn voor een normale fysiologische functie. Maar inhibitie van gap 
juncties en hemikanalen is perfect mogelijk in geïsoleerde weefsels en organen die koel 
worden bewaard of ingevroren. Zo een procedure kan aangewezen zijn bij een hart-, long- 
en levertransplantatie of bij het invriezen van verschillende cellen en weefsels. 
Tot slot heeft dit werk onze kennis verruimd over de vasculaire actie van cannabinoïden en 
CGRP, en heeft het connexines en zijn kanalen naar voor gebracht als mogelijke nieuwe 
doelwitten om de bloedvat functie te moduleren en de celviabiliteit te beschermen na 
invriezen. 
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Preface 
Vascular tone plays an important role in the regulation of blood pressure and the 
distribution of blood flow between and within tissues and organs of the body. Blood flow is 
dependent on small blood vessel diameter. Regulation of the contractile activity of vascular 
smooth muscle cells (VSMCs) in the systemic circulation is dependent on a complex interplay 
of vasodilator and vasoconstrictor stimuli from circulating hormones, neurotransmitters, 
endothelium-derived factors and blood pressure. Like all muscle cells, vascular smooth 
muscle uses Ca2+ as a trigger for contraction. Ca2+ entry through plasma membrane channels 
and Ca2+ release from intracellular stores are the major sources of Ca2+ leading to blood 
vessel contraction (Berridge 2008). In addition, the movement of ions through ion channels 
determines, to a large extent, the membrane potential. The membrane potential, along with 
the cytosolic Ca2+ concentration, regulates and modulates the influx and release of Ca2+ 
through ion channels and the sensitivity of the contractile machinery to Ca2+ (Thorneloe and 
Nelson 2005). K+ channels are the predominant ion conductive pathways in VSMCs. As such, 
their activity importantly contributes to determine and regulate the membrane potential 
and vascular tone (Ko et al. 2008). The electrochemical gradient for K+ ions is such that 
opening of K+ channels results in diffusion of this cation out of the cells thereby 
hyperpolarizing the membrane. A hyperpolarization of the membrane potential closes 
voltage-gated Ca2+ channels and leads to vasodilation, whereas depolarization opens them, 
with a vasoconstriction as result. Thus, by their predominant role in setting the membrane 
potential, K+ channels play a central role in the regulation of vascular tone. Other channels 
that may influence the membrane potential and [Ca2+]i are the connexin channel family, 
consisting of GJs and HCs. GJ channels connect SMCs among each other and SMCs with ECs. 
These channels allow the passage of ions and metabolites with a molecular weight below 1.5 
kDa. Apart from this, unapposed non-junctional HCs in the plasma membrane connect 
between the cytoplasma and the extracellular space. Uncontrolled opening of CxHCs can 
lead to an ionic imbalance and this might contribute to cell death and cell survival 
mechanisms. 
In this doctoral thesis, we investigated the role of cannabinoids and CGRP on SMC K+ 
channels and determined the role of CxHCs on [Ca2+]i dynamics and contraction. While GJs 
and HCs play a role in vessel physiology SMCs, they may also contribute to cell death under 
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stressful conditions. We further determined whether inhibition of connexin channels, i.e. GJs 
and HCs, could protect blood vessels against cryoinjury. In the following 3 chapters we 
introduce each of these topics. In chapter IV we discuss our aims and in chapter V to VII our 
results. The general discussion and future perspectives will be discussed in Chapter VIII. 
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1. Cannabinoids 
1.1. Introduction 
Plant-derived cannabinoids such as Δ9-tetrahydrocannabinol (THC), the active ingredient of 
the hemp plant, have been used for centuries for their psychoactive properties (Hiley and 
Ford 2004). In the early 1990s, endogenous cannabinoids were described. The first of these 
endocannabinoids identified was N-arachidonoyl ethanolamide (anandamide) and had 
pharmacological and behavioural effects similar to THC (Devane et al. 1992). Since their 
discovery, the effects of both synthetic and endogenous cannabinoids have been extensively 
examined. In addition to their neurobehavioural effects, they have a profound influence on 
the cardiovascular system (Hillard 2000, Hiley and Ford 2004) and gastrointestinal function 
(Germano et al. 2001). Reported effects include vasodilation in a number of vascular beds, 
hypotension, bradycardia, inhibition of gastrointestinal motility and of gastric acid secretion 
and a reduction of stress-induced gastric ulcers (Kunos et al. 2000, Germano et al. 2001, 
Pertwee 2001, Hiley 2009).  
 
Endocannabinoids are synthesized in several cell types to regulate the cardiovascular 
system: in vascular SMCs, endothelial cells, nerve cells within the blood vessel walls (i.e. 
perivascular nerves) and circulating cells of the blood (Ishioka and Bukoski 1999, Hogestatt 
and Zygmunt 2002, Hiley and Ford 2004, Mach and Steffens 2008). The endocannabinoid 
anandamide (Figure 1) has been identified as an endogenous counterpart of THC, the 
psychoactive component of marijuana. The endocannabinoid is synthesized by cleavage of 
the lipid precursor arachidonyl phosphatidylethanolamine, and is metabolized relatively 
quickly to arachidonic acid and ethanolamine. Low levels of anandamide have been detected 
in rat blood and human serum (Giuffrida and Piomelli 1998, Wang et al. 2001). Another 
interesting source of anandamide in the cardiovascular system is circulating macrophages 
(monocytes), which can produce anandamide in vitro and in pathological conditions such as 
haemorrhagic and endotoxic shock, and advanced liver cirrhosis (Varga et al. 1998, Batkai et 
al. 2001, Wang et al. 2001). Substantial levels of anandamide have been detected in various 
animal tissues including skin and brain (Calignano et al. 1998, Bisogno et al. 1999). Tissue 
macrophages within and surrounding the vascular wall may produce anandamide locally and 
could be an important source of anandamide in atherosclerosis and inflammation.  
Chapter I: Cannabinoids and calcitonin gene related peptide modulating the vessel wall reactivity 
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Figure 1. Structures of the endocannabinoid anandamide and its stable analogue methanandamide. (Vanheel 
and Van de Voorde 2001) 
 
 
1.2. Receptors 
a) Cannabinoid (CB) receptors 
The classical receptors for cannabinoids are the type 1 cannabinoid (CB1) and type 2 
cannabinoid (CB2) receptors and both receptor subtypes are coupled through G-proteins to 
adenylyl cyclase and mitogen-activated protein kinase (MAPK). Cannabinoid CB1 receptors 
are mainly localized on neurons but are also present in some peripheral tissues including 
heart, lung and gastrointestinal tissues and in vasculature (Howlett et al. 2010). In several 
arteries, the vasorelaxant effect of cannabinoids is mediated by stimulation of CB1 
receptors. Indeed, SR141716A, a CB1 receptor antagonist, inhibits relaxations by 
anandamide in rat mesenteric arteries, coronary arteries and kidney arterioles (Randall et al. 
1996, Deutsch et al. 1997, White et al. 2001, O'Sullivan et al. 2004) and in cat cerebral 
arteries (Gebremedhin et al. 1999). Additionally, the hypotensive action of anandamide has 
been shown to be absent in mice lacking CB1 receptors (Ledent et al. 1999). Stimulation of 
the CB1 receptor modulates the activity of several types of ion channels via G-proteins. For 
example, it has been shown that (endo)cannabinoids block voltage-gated N-, L-, T and P/Q-
type Ca2+ channels (Mackie and Hille 1992, Twitchell et al. 1997, Gebremedhin et al. 1999) 
and stimulate inwardly rectifying K+ channels (Henry and Chavkin 1995, Mackie et al. 1995). 
Moreover, endocannabinoids can directly target and inhibit voltage-gated Ca2+ channels (Oz 
et al. 2000, Chemin et al. 2001), Na+ channels (Nicholson et al. 2003) and various types of K+ 
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channels (Poling et al. 1996, Van den Bossche and Vanheel 2000, Maingret et al. 2001), 
although usually at higher concentrations.  
 
CB2 receptors are primarily expressed in immune and hematopoietic cells (Munro et al. 
1993), although there is some evidence that these receptors are also expressed by neuronal 
tissue (Howlett et al. 2010) and recent evidence indicates a relatively widespread yet sparse 
distribution in the brain (Onaivi et al. 2006). There is little evidence of an involvement of CB2 
receptors in cannabinoid modulation of perivascular neurotransmission, although CB2 
activation has been reported to inhibit murine mesenteric afferent nerve activity (Hillsley et 
al. 2007). Recent evidence suggests that, at least in some vessels, the vasodilator response 
of cannabinoids is caused by stimulation of an endothelial non-CB1/CB2 receptor (CBx) (Jarai 
et al. 1999, Ford et al. 2002, Herradon et al. 2007)(Figure 2).  
 
b) TRPV receptors 
The vasorelaxant influence of cannabinoids has also been reported to be due to stimulation 
of type 1 vanilloid (TRPV1) receptors on primary afferent perivascular nerves and the 
subsequent release of sensory neuropeptides such as the powerful vasodilator CGRP (Figure 
2). In rat hepatic and small mesenteric arteries, the vasorelaxant influence of the 
cannabinoid anandamide was antagonized by the TRPV1 receptor antagonist capsazepine 
and the CGRP receptor antagonist CGRP(8-37), but not by the CB1 receptor antagonist 
SR141716A (Zygmunt et al. 2002), pointing to a role for the TRPV1 receptor in vasodilation 
by anandamide. The vanilloid TRPV1 receptor is a non-selective cation channel that displays 
a high permeability for Ca2+, and acts as a polymodal nociceptor, being activated by a variety 
of noxious stimuli including capsaicin, heat (> 42 °C), protons (pH < 6.5) and endogenous 
cannabinoids such as anandamide and N-arachidonoyl-dopamine (Caterina et al. 1997, 
Szallasi and Blumberg 1999). The receptor was originally identified as the recognition site for 
capsaicin, the pungent ingredient in hot chilli peppers. Although low levels of expression 
have been detected in certain brain areas, the vanilloid receptor is expressed predominantly 
on a population of capsaicin-sensitive primary afferent nerve fibers, namely thin, 
unmyelinated C-fibres and large diameter myelinated Aδ fibres, which are activated by a 
variety of noxious stimuli such as thermal, chemical and mechanical stress. These nerve 
fibres also participate in visceral reflexes and in local responses to tissue injury. Sensory 
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neurons from TRPV1 gene knockout mice have an impaired response to heat, protons and 
capsaicin, and initial studies have demonstrated that these animals fail to develop 
inflammation-induced thermal hyperalgesia (Holzer 1992, Szallasi and Blumberg 1999). 
Much interest has been focused on the role of the vanilloid receptor in pain signaling and 
inflammation, in which vasodilation is an important component (Hogestatt and Zygmunt 
2002). 
 
The picture is further complicated by more recent studies that identified endocannabinoids 
as potential activators of the type 4 vanilloid (TRPV4) receptor (Watanabe et al. 2003)(Figure 
2). The receptor is highly expressed on endothelial cells and its stimulation enhances Ca2+ 
influx, an essential trigger to release various vasoactive factors including nitric oxide (NO), 
prostaglandins, and to activate the endothelial derived hyperpolarizing factor (EDHF) 
mechanism (Yao and Garland 2005). Moreover, TRPV4 was also found in myocytes of 
cerebral arteries, and its activation was shown to cause SMC hyperpolarization via BKCa 
channel activation (Earley et al. 2005). 
 
 
            
Figure 2. Schematic presentation of the possible mechanisms of action of (endo)cannabinoids in the blood 
vessel wall. NO = nitric oxide; PGI2 = prostacyclin; GJ = gap junction; EDHF = endothelial derived hyperpolarizing 
factor; CGRP = calcitonin gene related peptide; CB1 = type 1 cannabinoid receptor; CB2 = type 2 cannabinoid 
receptor; CBx = non CB1/CB2 cannabinoid receptor; TRPV1 = type 1 vanilloid receptor; TRPV4 = type 4 vanilloid 
receptor. 
 
Chapter I: Cannabinoids and calcitonin gene related peptide modulating the vessel wall reactivity 
25 
 
c) Other receptors 
Several cannabinoid receptor ligands also bind to the orphan G-protein-coupled receptor 
GPR55 suggesting that this might represent an additional receptor subtype (Ryberg et al. 
2007, Lauckner et al. 2008). Activation by THC or methanandamide, a stable analogue of 
anandamide, increases the [Ca2+]i in neurons expressing this GPR55 receptor (Lauckner et al. 
2008). It has become evident that some cannabinoids, in addition to their effects on G 
protein-coupled receptors and TRP ion channels, can activate members of the nuclear 
peroxisome proliferator activated receptor (PPAR) family (O'Sullivan et al. 2005, Sun and 
Bennett 2007). THC was shown to be a PPARϒ ligand and PPARϒ agonists are used in the 
management of type 2 diabetes to improve insulin sensitivity and further stimulate 
vasorelaxation, increased availability of NO, anti-inflammatory actions, attenuation of 
atherosclerosis and vascular remodelling (O'Sullivan et al. 2005). Furthermore, an action on 
other receptors was suggested. Anandamide has been demonstrated to bind to serotonin (5-
HT)-3 receptors (Fan 1995), thereby contributing to the effects of cannabinoids, such as 
antiemesis and analgesia, and modulate the activity of the N-methyl-D-aspartate (NMDA) 
receptor (Hampson et al. 1998). Other potential receptors for anandamide are the 
muscarinic and nicotinic acetylcholine receptor, the glycine receptor, Ca2+, K+ and Na+ 
channels (Di Marzo et al. 2002). 
In table 1 an overview is shown of the receptors and their location for 
anandamide/methanandamide. 
 
Table 1. Overview of the receptors and their location for anandamide/methanandamide. 
Receptor Location 
CB1 (Howlett et al. 2010) Neurons, heart, lung, gastrointestinal tissues, vasculature 
CB2 (Munro et al. 1993) Immune and hematopoietic cells, neuronal tissue, brain 
Non-CB1/CB2 (CBx) (Jarai et al. 1999, Ford 
et al. 2002, Herradon et al. 2007, 
McCollum et al. 2007, Baranowska-
Kuczko et al. 2012) 
Endothelial cells 
TRPV1 (Zygmunt et al. 1999) Perivascular nerves, brain, spinal cord, bladder 
TRPV4 (Earley et al. 2005, Yao and 
Garland 2005) 
Endothelial cells, myocytes of cerebral arteries 
TRPM8 (De Petrocellis et al. 2007, De 
Petrocellis et al. 2008) 
Neurons, prostate, lungs, bladder 
TRPA1 (De Petrocellis and Di Marzo 2009) Neuronal tissue, pancreatic cells, endothelial cells, 
perivascular nerves 
GPR55 (Lauckner et al. 2008) Brain, vascular endothelium, vascular smooth muscle, 
immune system 
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PPARα (Bouaboula et al. 2005, Sun and 
Bennett 2007) 
Liver, heart, muscle, kidney and monocyte-derived 
macrophages, smooth muscle cells and endothelial cells 
of the arterial wall 
PPARγ (Sun and Bennett 2007) Adipose tissues, colonic epithelia, endothelial cells, 
macrophages 
Serotonin (5-HT)-3 receptor (Fan 1995) Peripheral and central nervous system 
NMDA receptor (Hampson et al. 1998) Central nervous system, heart, stomach, pancreas, kidney, 
lung, thymus and stomach 
Muscarinic acetylcholine receptor 
(Lagalwar et al. 1999) 
central and peripheral nervous system, heart, vascular 
smooth muscle, lungs 
Nicotinic acetylcholine receptor (Oz et al. 
2003) 
Neurons, endothelial cells, smooth muscle cells, 
neuromuscular junction  
Glycine receptor (Hejazi et al. 2006) Central nervous system, smooth muscle cells, endothelial 
cells 
Calcium channels (VDCC) (Chemin et al. 
2001) 
Muscle cells, glial cells, neurons 
Potassium channels (KATP, KV) (Poling et 
al. 1996, Oz et al. 2007, Barana et al. 
2010) 
All animal cells 
Sodium channels (NaV) (Nicholson et al. 
2003, Kim et al. 2005) 
Neurons, myocytes, astrocytes, endothelial cells 
 
 
1.3. Vasodilatory actions of (meth)anandamide 
The potent vasodilatory influence of anandamide has been shown in a variety of isolated 
vascular preparations. Its mechanism of action, however, is complex and seems to vary with 
species, vessel type, and even vessel size (Vanheel and Van de Voorde 2001, O'Sullivan et al. 
2004). Moreover, also methanandamide, is a powerful vasodilator of these vessels (Ralevic 
et al. 2000). In rabbit pial arterioles, rat aorta, rat pulmonary, bovine coronary and rabbit 
mesenteric arteries, (meth)anandamide produces endothelium-dependent vasodilation via 
cyclooxygenase. In rat mesenteric arteries, however, the vasorelaxing influence of 
anandamide is unaffected by cyclooxygenase inhibition (Tamaki et al. 2012). Additionally, 
anandamide-induced vasodilation has been reported to be mediated by the release of NO 
from perfused renal arterial segments (Deutsch et al. 1997). Furthermore, others 
hypothesized that anandamide is produced by ECs and acts as an endothelium-derived 
hyperpolarizing factor (Randall et al. 1997, Randall and Kendall 1998).  
Most studies, however, have shown that the vasorelaxations caused by (meth)anandamide 
are completely (White and Hiley 1998, Breyne et al. 2006) or partly (Chaytor et al. 1999, 
O'Sullivan et al. 2004) endothelium-independent. This endothelium-independency rules out 
the possible role of endothelium-derived relaxing factors that have been suggested to be 
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involved in the cannabinoid-induced relaxations in some isolated vascular preparations (Ellis 
et al. 1995, O'Sullivan et al. 2004). The endothelium-independent pathway by which 
cannabinoids induce vasodilation is still elusive. Some studies report that cannabinoids 
directly stimulate cannabinoid receptors on the VSMCs (White and Hiley 1998). More recent 
studies propose that in some vessels, the vasodilator response to cannabinoids is mediated 
by stimulation of a novel, yet non-identified, non-CB1/CB2 receptor located on the 
endothelium (Jarai et al. 1999, Ford et al. 2002, O'Sullivan et al. 2004, McCollum et al. 2007, 
Baranowska-Kuczko et al. 2012).  
Since the original observation that vasorelaxation by cannabinoids can be mediated by 
stimulation of TRPV1 receptors on CGRP-containing perivascular nerves (Zygmunt et al. 
1999, Ahluwalia et al. 2003, Breyne and Vanheel 2006), several studies have documented 
TRPV1 stimulation by anandamide or by methanandamide and stressed that anandamide 
should be considered both an endocannabinoid and an endovanilloid (Ralevic et al. 2002, 
Ahluwalia et al. 2003). Previously, Breyne et al. found that in gastric arteries a vasorelaxation 
produced by low concentrations (<1 µM) of methanandamide was completely inhibited after 
depletion of the perivascular nerves by pre-exposure to capsaicin, a TRPV1 agonist. 
Moreover, relaxations tended to decrease in the presence of the TRPV1 antagonist 
capsazepine. These findings suggest that at least at the lower concentrations 
methanandamide act on capsaicin-sensitive TRPV1 receptors on perivascular nerves and 
stimulate the release of CGRP. Conversely, relaxations to high concentrations of 
methanandamide (10 µM) were completely unaffected by 30 mM K+ and 
tetraethylammonium (TEA) or glibenclamide, pointing to a mechanism that does not require 
SMC hyperpolarization, but methanandamide might induce relaxation by reducing calcium 
entry into the SMCs (Breyne et al. 2006). Recently Tamaki et al. demonstrated in the rat 
superior mesenteric artery that anandamide caused a concentration-dependent vascular 
response by measuring the perfusion pressure: at low concentrations (0.1-1 nM) a 
vasodilation appeared, while at higher concentrations (10 nM-1 µM) anandamide elicited an 
initial transient and sharp endothelium-dependent vasoconstriction, which is mediated by 
CB1 receptors on the vascular endothelium and vasoconstrictor prostanoids, followed by a 
long-lasting vasodilation mainly mediated by perivascular capsaicin-sensitive CGRPergic 
nerves (Tamaki et al. 2012).  
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2. Calcitonin Gene Related Peptide 
2.1. Introduction 
In rat hepatic and small mesenteric arteries, the vasorelaxant influence of anandamide was 
antagonized by the TRPV1 receptor antagonist capsazepine and the CGRP receptor 
antagonist CGRP(8-37) but not by the classical CB1 receptor antagonist SR141716A (Zygmunt 
et al. 1999). It was proposed, therefore, that cannabinoids exert their relaxing influence by 
stimulating the release of CGRP from perivascular nerves  (Zygmunt et al. 1999, Ahluwalia et 
al. 2003). Figure 3 shows the presence of CGRP in perivascular nerves. 
 
 
 
Figure 3. Perivascular nerves containing 
CGRP. Confocal laser photomicrographic 
image showing calcitonin gene related 
peptide (CGRP) in 2nd and 3rd order 
branches of rat mesenteric arteries. Most 
blood vessels are surrounded by a dense 
perivascular CGRP-ergic neural network, 
which is found at the junction of the 
adventitia and the media, passing into 
the muscle layer. (Kawasaki et al. 2011) 
 
CGRP is a 37 amino acid peptide that is generated by alternative splicing of the calcitonin 
gene transcripts. Studies using CGRP-knockout mice have shown that these animals are 
hypertensive and endowed with an overactivity of the sympathetic nervous system (Oh-
hashi et al. 2001, Kurihara et al. 2003). CGRP is a microvascular vasodilator and is known to 
play an important role in neurogenic vasodilation in the skin and to increase blood flow in 
response to injury and noxious stimuli in a variety of pathological and physiological 
processes including cardioprotection, gastric ulcer protection (Evangelista 2009), migraine, 
neurogenic inflammation and pain perception (Smillie and Brain 2011). CGRP is widely 
distributed in the nervous and cardiovascular system and often coexists with substance P. In 
the peripheral nervous system, the prominent site of CGRP synthesis is the dorsal root 
ganglion (DRG), which contains the cell bodies of capsaicin-sensitive sensory neurons (Figure 
4). The peripheral processes of the sensory neurons terminate on blood vessels and 
transport CGRP to the nerve endings. CGRP is released from these perivascular nerve 
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endings in order to promote vasodilation. Their central processes terminate in laminae I and 
II of the dorsal horn and also synapse with the intermediolateral nucleus of the spinal cord, 
which contains the sympathetic pre-ganglionic neurons. This connection could influence the 
activity of the sympathetic nervous system, and thus vascular tone and blood pressure (Deng 
and Li 2005). Receptors for CGRP have been identified both in the media and intima of 
resistance vessels (Bell and McDermott 1996).  
 
 
 
Figure 4. Schematic illustration of the functional anatomy of the capsacin-sensitive sensory neurons, indicating 
the pathway of CGRP synthesis, release and action. (Figure adapted from Deng et al. 2005)  
 
 
2.2. CGRP receptors 
CGRP receptors have originally been classified into two subtypes termed CGRP1 and CGRP2, 
based on their affinity for CGRP(8-37), a truncated peptide of CGRP. CGRP(8-37) shows a 
high affinity for the CGRP1 receptor but not for the CGRP2 receptor. The CGRP1 receptor is 
now considered to be the primary and predominant cardiovascular receptor (Brain and Cox 
2006). It is now also apparent that the CGRP2 receptor phenotype is the result of CGRP 
acting at receptors for amylin and adrenomedulin. Accordingly, the term ”CGRP2” receptor 
should no longer be used, and the “CGRP1” receptor should be converted to “CGRP” 
receptor (Hay et al. 2008, Walker et al. 2010). The CGRP receptor belongs to the family of G-
protein coupled receptors. In 1998 McLatchie et al. demonstrated that the calcitonin 
receptor required co-binding of receptor activity modifying proteins (RAMP) with the 
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calcitonin like receptor (CLR) in order to form a functional receptor on the cell surface 
(Figure 5) (McLatchie et al. 1998, Conner et al. 2007). For functionality an additional protein 
called receptor component protein (RCP) is required which is essential for effective Gαs 
coupling (Walker et al. 2010). RAMPs are single transmembrane proteins, forming three 
distinct types, RAMP1, RAMP2 and RAMP3. Of these, CLR linked with RAMP1 leads to a high 
affinity CGRP receptor (Hay et al. 2002). The association of CLR with RAMP2 produces an 
adrenomedullin 1 receptor, with RAMP3 an adrenomedullin 2 receptor (Brain and Grant 
2004, Walker et al. 2010) (Figure 5). 
 
              
Figure 5. The CGRP/adrenomedullin (AM) receptor. The calcitonin receptor-like receptor (CL) component is 
common to all three receptors and is a G protein-coupled 7-transmembrane receptor. The three RAMP 
components are single transmembrane domain proteins. The active receptor is a functional heterodimer of one 
CL complexed with a RAMP, at the cell membrane. The interaction of RAMP1 with CL produces a CGRP 
receptor, RAMP2 with CL an AM receptor, and RAMP3 with CL a CGRP/AM receptor. The proposed receptor 
component protein (RCP), which is suggested to allow coupling to intracellular signaling pathways, is also 
included. (Brain et al. 2004) 
 
 
2.3. Vasodilatory actions of CGRP 
The mechanism involved in vasorelaxation to CGRP seems to vary among species and vessel 
types. CGRP mediates endothelium-dependent and -independent relaxation. Vasodilation 
through an endothelium-dependent pathway is possible through activation of endothelial 
nitric oxide synthase (eNOS) (release of NO) and soluble guanylate cyclase (sGC) to increase 
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cyclic guanosine monophosphate (cGMP) (Yoshimoto et al. 1998, Hosaka et al. 2006)(Figure 
6). CGRP–induced vasodilation through an endothelium-dependent pathway involving NO 
release has been described in rat aorta, mouse pial arteries, rat cremaster venules, rat 
mesenteric arteries, human mammary arteries and human forearm arteries (Yoshimoto et 
al. 1998, de Hoon et al. 2003, Hosaka et al. 2006). CGRP-mediated release of NO is very 
different from that mediated by acetylcholine. Acetylcholine induces synthesis of NO by an 
increase of endothelial synthesis of IP3 and intracellular Ca
2+. CGRP enhances endothelial 
production of PKA or protein kinase B (PKB) resulting in an increase in synthesis of NO 
independent of the increases in intracellular calcium. In rat aorta (Gray and Marshall 1992) 
and pulmonary arteries (Wisskirchen et al. 1998), human omental and bovine retinal arteries 
(Boussery et al. 2005), CGRP interacts with endothelial receptors stimulating the release of 
endothelium-derived relaxing factors, as both endothelium removal and blocking NO 
synthesis significantly reduced vasorelaxation.  
 
 
Figure 6. The cellular mechanisms of vasodilation to CGRP. Left: endothelium-independent vasodilation to 
CGRP. Activation of CGRP receptors on smooth muscle cells is coupled to production of cAMP by adenylate 
cyclase. The increase in intracellular cAMP concentration ([cAMP]i) then stimulates protein kinase A (PKA), 
which opens K
+ 
channels and activates Ca
2+ 
sequestration mechanisms to cause smooth muscle relaxation. 
Right: endothelium-dependent vasodilation to CGRP. CGRP interacts with receptors on endothelial cells and 
stimulates production of nitric oxide (NO). This is mediated via cAMP accumulation, although a direct effect of 
PKA on endothelial NO synthase (eNOS) is yet to be fully characterized. Diffusion of NO into adjacent smooth 
muscle cells, activating guanylate cyclase, then leads to relaxation. (Brain et al. 2004.) 
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Vasodilation through an endothelium-independent process happens through activation of 
adenylate cyclase to increase cAMP (Figure 6) in the majority of the vessels (rat mesenteric, 
gastric, splenic and renal arteries, rabbit jejunal, rat and rabbit hepatic artery, porcine 
coronary arteries, skin and skeletal muscle microcirculations, cat cerebral, dog lingual and 
human uterine arteries) (Foulkes et al. 1991, Nilsson et al. 1992, Ishikawa et al. 1993, 
Kageyama et al. 1993, Hill and Gould 1997, Yoshimoto et al. 1998, Hosaka et al. 2006). The 
resultant activation of PKA and PKA-dependent phosphorylation has been shown to open 
ATP-sensitive K+ (KATP)
 channels (Table 2) (Nelson et al. 1990, Quayle et al. 1994, Wellman et 
al. 1998) hyperpolarizing and relaxing the tissue (Wellman et al. 1998). Exogenous CGRP 
produced a hyperpolarization of the SMCs of comparable time course and magnitude to 
those obtained with methanandamide, and both methanandamide- and CGRP-induced 
membrane potential changes were sensitive to the KATP channel inhibitor glibenclamide 
(Dunn et al. 2003, Breyne and Vanheel 2006). However, studies on several vascular beds 
(Table 2) have not been able to demonstrate a possible involvement of KATP channel opening 
in CGRP induced vasorelaxation (Prieto et al. 1991, Kageyama et al. 1993). CGRP might also 
mediate relaxation by activation of BKCa channels (Table 2), by inhibition of voltage gated 
Ca2+ channels (Breyne et al. 2006), and by decreasing the Ca2+ sensitivity of the contractile 
apparatus (Sheykhzade and Nyborg 2001). In rat gastric arteries, Breyne et al. have found 
that the vasorelaxation to CGRP was partly sensitive to TEA, suggesting the involvement of 
BKCa channel activation (Breyne et al. 2006). In a number of vascular preparations, PKA-
dependent vasodilators have been shown to activate smooth muscle BKCa channels 
(Schubert and Nelson 2001). 
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Table 2. K+ channel involvement of CGRP-mediated vasodilatory actions in different vascular 
beds. 
Author tissue technique K+ channel 
involved 
Nelson M et al., 
1990 
Rabbit mesenteric arteries Isometric tension 
measurements 
KATP 
Miyoshi H and 
Nakaya Y, 1995 
Porcine coronary artery Electrophysiology KCa, KATP 
Quayle J et al., 1994 Rabbit mesenteric arteries Electrophysiology KATP 
Hill CE and Gould DJ, 
1997 
Rat irideal arterioles  Electrophysiology and 
arteriolar diameter 
measurements 
KATP 
Hong K et al., 1996 Rat pial arterioles Arterial diameter 
measurements 
BKCa, KATP 
Wellman GC et al., 
1998 
Porcine coronary artery Electrophysiology KATP 
Herzog M et al., 
2002 
Gerbil spiral modiolar artery Vascular diameter and 
[Ca2+]i measurements 
BKCa, KATP 
Sheykhzade M et al., 
2001 
 
Rat coronary artery 
(precontracted) 
Rat coronary artery (resting)  
Isometric tension and 
[Ca2+]i measurements  
BKCa,  
 
KATP 
Dunn W et al., 2003 Rat mesenteric arteries Electrophysiology KATP 
Dong Y et al., 2004 Umbilical artery/vein, 
chorionic artery/vein, stem 
villous vessels 
Isometric tension 
measurements 
KATP 
Breyne J et al., 2006 Rat gastric arteries Isometric tension 
measurements 
BKCa 
Gozalov A et al., 
2007 
Rat cerebral artery Isometric tension and 
arterial diameter 
measurements 
BKCa  
Breyne J and 
Vanheel B, 2006 
Rat gastric and mesenteric 
arteries 
Electrophysiology KATP 
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1. Connexins: overview  
1.1. The connexin family 
Connexins are four-pass transmembrane proteins, with two extracellular loops stabilized by 
intramolecular disulfide bridges, an intracellular loop, and N- and C-terminal cytoplasmic 
regions (Saez et al. 2003, Evans et al. 2006). The N-terminus, the two extracellular loops and 
the four transmembrane domains are highly conserved among different isoforms. In 
contrast, the cytoplasmic loop and the C-terminus domain are divergent and variable in 
length and sequence, allowing for the functional differences among the different connexins 
(Dbouk et al. 2009). After two decades of cloning and characterization of the genes encoding 
connexins, the connexin roster is now likely to be complete with over 20 genes in humans 
and rodents (Sohl and Willecke 2003). At the onset of connexin biology the nomenclature of 
connexin proteins was based on the predicted molecular weight of each family member (e.g. 
Cx43 is ~43kD in size) and this nomenclature continues to be widely used. Another 
nomenclature proposed a division into subclasses α, β, γ and δ and was based on sequence 
similarity and length of cytoplasmic domains, using the prefix GJ for gap junction, and a 
number referring to the order of their discovery. Cx43 is called GJA1 (human) or Gja1 
(mouse) (Sohl and Willecke 2003). It is rare for any cell type to express only one member of 
the connexin family and the coexpression of two or more connexins is the standard. 
Connexons are formed by six connexin proteins, which assemble into a channel that is often 
called a hemichannel (HC), with either identical connexin subunits (homomeric) or different 
connexins (heteromeric) (Figure 1). When two hemichannels from neighboring cells dock, 
they form GJ channels (Goodenough and Paul 2003). GJ channels may be homotypic, when 
two identical connexons (or hemichannels) assemble, or heterotypic, when two dissimilar 
connexons assemble between the two interacting cells (Dbouk et al. 2009). 
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Figure 1. The connexin family. Connexin proteins oligomerize into hexameric connexons or hemichannels and 
the intercellular joining of two connexons form a dodecameric intercellular channel (gap junction channel). 
(Figure adapted from Goodenough et al. 2003) 
 
 
1.2. The life cycle of connexins  
Connexins are co-translationally inserted into the endoplasmic reticulum (ER) and then 
trafficked through the Golgi apparatus (Figure 2) (Laird 2006). Misfolded connexins will be 
directed to the ER-associated degradation pathway (ERAD). At some point during the 
secretory pathway, connexins oligomerize into hexameric connexons. Depending on the 
connexin isoform, oligomerization has been observed in various locations ranging from the 
ER, the ER-Golgi intermediate compartment, to the trans-Golgi network (Diez et al. 1999, 
Koval 2006, Das et al. 2009). These connexons, that comprise one-half of the complete GJ 
channel, are transported to the plasma membrane to form GJs and large accretions of GJs, 
known as GJ plaques. Recently, undocked connexons at the plasma membrane have been 
demonstrated to have channel activity, i.e. display channel opening events, as well.  
From the plasma membrane, connexins are internalized as double membrane annular GJs, or 
connexosomes, or possibly, as undocked individual connexons and then degraded (Laird 
2006). It is clear that connexins undergo degradation through both the lysosomal and 
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proteasomal degradation pathways (Laing et al. 1998, Leithe and Rivedal 2004, VanSlyke and 
Musil 2005) and an additional pathway of autophagy was recently revealed (Hesketh et al. 
2010, Lichtenstein et al. 2011). However, the precise mechanisms that regulate connexin 
trafficking to and from the plasma membrane and subsequently through to degradation are 
still being studied and debated. Posttranslational modifications of connexins are thought to 
contribute to the regulation of connexin function and trafficking. Connexin phosphorylation, 
which is known to regulate GJ channel closure and connexon membrane stability, has been 
studied intensively (Solan and Lampe 2009). More recently, other modifications have been 
identified such as hydroxylation, methylation, nitrosylation and acetylation, the last of which 
has been reported to affect connexin 43 localization in the heart (Locke and Harris 2009, 
Colussi et al. 2011).  
 
                                
Figure 2. The lifecycle of connexins. Connexins are synthesized in the endoplasmic reticulum (ER) and 
oligomerize into connexons/hemichannels while trafficking through the ER, the ER-Golgi intermediate 
compartment, to the trans-Golgi network. Undocked connexons/hemichannels can open under certain 
conditions, allowing the exchange of small molecules between the intracellular and extracellular milieu. 
Connexons/hemichannels can also dock with neighboring hemichannels to form GJs. GJs internalize into 
annular junctions before degradation via the lysosomal or proteasomal pathway. ERAD = ER-associated 
degradation; TGN = trans-Golgi network; the question marks represent events that have not yet been clearly 
demonstrated. (Laird 2006) 
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1.3. Gap junctions 
GJs are intercellular membrane channels that typically gather in groups of 10 to 10.000, 
socalled plaques, at the membrane surface. They arise from interaction of two opposing 
HCs, in turn consisting of six connexin proteins (Sohl and Willecke 2003). In vertebrates, only 
a few cell types do not form GJs in their fully differentiated state, including blood cells, 
spermatozoa, and skeletal muscle. Nevertheless, the progenitors of these cells do express 
GJs (Saez et al. 2003). GJs were originally identified in transmission electron micrographs 
(EM) as pentalaminar structures at points of close membrane apposition (Figueroa et al. 
2004)(Figure 3). In the endothelium, long sections of well-defined GJs are commonly 
observed and form plaques of a few tents of a micrometer in diameter. GJs between 
endothelial cells and SMCs are called myoendothelial GJs (MEJ) (Figure 3) and have been 
extensively investigated as a direct route for communication between both cell types 
possibly influencing the contraction status of SMCs. In contrast to endothelium, gap 
junctional plaques in arterial smooth muscle have proven more difficult to visualize at the 
EM level, and often the junctional membranes are relatively widely separated even though 
the cells are dye coupled and electrically coupled. This had led to the suggestion that in 
vascular smooth muscle, individual gap junctional channels rather that GJ plaques are 
responsible for cell-cell communication (Figueroa et al. 2004).  
 
 
Figure 3. Gap junctions in the vascular wall. A. Transmission electron micrograph of the capillary endothelium.  
Inset: pentalaminar GJ at high magnification. B. Electron micrograph of an arteriolar myoendothelial gap 
junction (MEJ). (Figure adapted from Figueroa et al. 2004.) 
 
 
GJs form the most direct cell-cell communication pathway, connecting the cytoplasm of 
adjacent cells. They have a central role in blood vessel physiology, helping in coordinating 
Smooth muscle cell
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MEJ
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the contraction of SMCs (Figueroa and Duling 2009), communicating electrical and Ca2+ 
signals in upstream direction via the endothelial layer (Dora and Duling 1997, Dora 2010) 
and contributing to fine tuning of EC-SMC communication. GJs coordinate several other 
crucial events such as the synchronized contraction of the cardiac muscle for the rhythmic 
pumping of the heart (Dhein et al. 2010), embryonic growth (Houghton 2005), bone 
remodeling (Jiang et al. 2007), tissue differentiation (Cronier et al. 2003), cell death and cell 
growth (Decrock et al. 2009).  
The flux of molecules through these channels, called gap junctional intercellular 
communication (GJIC), includes the passive diffusion of small (< 1-1.5 kDa) and hydrophilic 
molecules, such as ATP, glucose, IP3, glutamate, cAMP, gluthatione, H2O2, prostaglandins and 
ions (Ca2+, K+, Na+) (Alexander and Goldberg 2003, Saez et al. 2003). GJ channels, depending 
on cellular needs and conditions, alternate between “closed” and “open” conformations. 
These changes are dependent on and are regulated by various mechanisms including 
calcium concentration, pH (Wang et al. 1996), transjunctional potential (Valiunas et al. 
1997), and protein phosphorylation (Peracchia 2004, de Vuyst et al. 2007). Increases in 
[Ca2+]i inhibit GJIC, albeit that the actual levels of [Ca
2+]i elevation necessary to suppress GJs 
is rather variable (from nanomolar to micromolar) and seems to depend on connexin and 
cell type (Spray et al. 1982, Lazrak and Peracchia 1993). The open probability of GJs 
furthermore depends on the transjunctional voltage (i.e. over the GJ), with large potential 
differences between cells resulting in closure of GJs. In addition, changes in connexin 
phosphorylation also affect GJIC (Kwak and Jongsma 1996, Lampe and Lau 2004, Moreno 
and Lau 2007).  
 
 
1.4. Connexin hemichannels 
In addition to forming GJs, CxHCs may also reside in the plasma membrane as unapposed 
free HCs not incorporated into GJs. Unapposed free CxHCs, are normally closed but they may 
open under certain conditions, often conditions regarded as stressful to cells. Several studies 
have shown that CxHCs, when open, may mediate the release of ATP, prostaglandins, 
glutamate, and gluthatione (Evans et al. 2006). ATP release via CxHCs has been studied 
extensively since its release activates purinergic receptors on neighboring cells and forms 
the basis of cell to cell Ca2+ signal propagation under the form of intercellular Ca2+ waves 
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(Burnstock 2006, Leybaert and Sanderson 2012). Although GJs and CxHCs allow 
molecules/ions up to 1.5 kDa to pass across, they have been shown to exhibit distinct 
sensitivities to increases of intracellular Ca2+ ([Ca2+]i). GJs close at 500-2000 nM [Ca
2+]i while 
CxHCs open between 200-500 nM and close again with higher [Ca2+]i (de Vuyst et al. 2006, 
De Vuyst et al. 2009, Wang et al. 2012). In addition to moderate elevation of [Ca2+]i , CxHCs 
also open in response to a reduction of the extracellular Ca2+ concentration ([Ca2+]e) (Thimm 
et al. 2005, de Vuyst et al. 2006, De Vuyst et al. 2009). Other signals or conditions that 
control the functional state of CxHCs include metabolic inhibition (Contreras et al. 2002, 
Contreras et al. 2004), osmotic changes (Quist et al. 2000), membrane depolarization 
(Retamal et al. 2007), mechanical stimulation (Gomes et al. 2005) and oxidative 
(Ramachandran et al. 2007) and ischemic stress (Shintani-Ishida et al. 2007). CxHCs not only 
respond to cytoplasmic Ca2+, but also determine cytoplasmic Ca2+, as a Ca2+ entry pathway, 
suggesting a possible contribution to the cellular Ca2+ homeostasis and signaling. 
Furthermore, HCs, together with GJs, play a role in cell survival and cell death (see further in 
section ‘connexin hemichannels and cell death’). The separate role of CxHCs and GJ channels 
in physiology and pathology can be determined by the use of synthetic peptides that mimic 
short sequences in the connexin subunit (see section ‘connexin mimetic peptides’) (Evans et 
al. 2006).  
 
 
1.5. Channel independent functions of connexin proteins 
In addition to their multiple roles via exchange of molecules, whether through GJs or HCs, 
connexins by themselves also play various roles independent of their channel-forming 
properties. Such connexin functions are mediated through their multiple interacting partners 
and subsequently lead to the modulation of gene expression resulting in a wide range of 
effects (Jiang and Gu 2005). 
Tumor suppressive properties of connexins has been shown for various connexins (e.g. Cx26 
and Cx32), which suppressed growth, invasion, and metastasis of renal cell carcinoma cell 
lines, and this effect was mediated through various modulators including Src, tight junction 
proteins, VEGF and others (Sato et al. 2007). In addition, controlled expression of Cx43 
prevented cell growth via the association of its C-terminal domain with proteins such as ZO-1 
and c-Src (Moorby and Patel 2001). Multiple studies have shown that alterations of connexin 
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expression, whether through over-expression or deletion, lead to changes in gene 
expression in multiple pathways and cellular functions, including transcription, metabolism, 
cell/cell and cell/extracellular matrix adhesion, cellular signaling, transport, and cell cycle 
and division (Iacobas et al. 2004).  
 
 
1.6. Connexin mimetic peptides 
Peptides that correspond to specific short connexin sequences that block the operation of 
GJs and CxHCs, called connexin mimetic peptides, have been applied to study the structure 
and function of both channels (Locke and Harris 2009). The development and application of 
short peptides mimicking sequences in various protein domains of connexins, especially 
Cx43, initially focused on the two extracellular loops; recently peptides corresponding to 
sequences on the intracellular loop and carboxyl tail have been demonstrated to influence 
CxHC function. Warner et al. (1995) pinpointed motifs that included short sequence motifs, 
SHVR in extracellular loop 1 and SRPTEK in extracellular loop 2, as likely potent peptides for 
use in disrupting cell communication (Warner et al. 1995). These motifs form the basis of 
Gap26 (sequence: VCYDKSFPISHVR) and Gap27 (sequence: SRPTEKTIFII) mimetic peptides 
and their close homologues (Figure 4). The primary action of Gap26 and Gap27 was likely to 
be on CxHCs prior to blockage of GJs. Gap27 has been demonstrated to inhibit CxHC-
mediated ATP release and dye uptake upon short (minutes) exposure (Braet et al. 2003), 
while longer exposures (hours) are generally needed to additionally inhibit GJs (Braet et al. 
2003, Decrock et al. 2009). This was further illustrated by a voltage-clamp approach in 
nonconfluent and confluent HeLa cells expressing Cx43. Gap26 inhibited macroscopic 
currents through CxHCs in 2-3 min. In contrast electrical coupling in cell pairs was delayed 
and completely inhibited after 30 min or more (Desplantez et al. 2012). The extended time 
course of action on gap junctional electrical coupling suggests that longer diffusion pathways 
into plasma membrane junctional domains lead ultimately to blockage of gap junctional 
coupling. A complementary study by Wang et al. examined the mechanism of action of 
Gap26 and Gap27 in HeLa cells transfected with Cx43 and in pig ventricular myocytes 
endogenously expressing Cx43 using a voltage-clamp approach (Wang et al. 2012). Both 
mimetic peptides inhibited Cx43HC unitary currents within minutes. The precise protein 
domains to which Gap26 and Gap27 attach and any conformational changes induced in 
Chapter II: Connexins, blood vessel function and cell death 
 
44 
 
connexin channels remain to be determined. HC dye uptake and dye release in Cx37 and 
Cx43 expressing rat brain endothelial cells exposed to bradykinin was rapidly (within 
minutes) inhibited by Gap27 (De Bock et al. 2011). A growing number of mimetic peptides 
derived from the cytoplasmic loop and C-terminus that act on CxHCs and GJs arise. Many of 
these peptides are not able to cross the plasma membrane and need to be attached first to 
“Trojan” cell-penetrating peptides that contain a membrane-translocation motif (Jarver and 
Langel 2006). Two of those ‘newer’ peptides are TAT-CT9 (sequence: 
YGRKKRRQRRRSRPRPDDLEI), which corresponds to the last 9 amino acids of Cx43 and TAT-L2 
(sequence: YGRKKRRQRRRDGANVDMHLKQIEIKKFKYGIEEHGK), which correspond to the 
cytoplasmic loop (Figure 4). TAT-CT9 prevented inhibition of Cx43-hemichannel activity by 
high micromolar [Ca2+]i. This peptide prevented bradykinin-induced [Ca
2+]i oscillations in 
MDCK cells expressing Cx43 and other connexins (De Bock et al. 2012). TAT-L2 inhibited 
Cx43-hemichannel responses likely by binding to the last 9 or 10 amino acids of the C-
terminal (CT) tail , thereby disrupting the intramolecular interaction between the CT tail and 
the endogenous L2 region (Ponsaerts et al. 2010). Other CT tail interaction sites may be 
involved as well. TAT-L2 had no inhibitory effect on GJs, it even favored the open state of 
Cx43 GJ channels and prevented closure of GJs (Delmar et al. 2004, Seki et al. 2004). The 
effects of connexin mimetic peptides on vascular tone will be discussed in section 3.4. 
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Figure 4. Connexin mimetic peptides for Cx43. The figure represents the peptides which mimic sequences of 
the extracellular loops (Gap26 and Gap27), cytoplasmic loop (L2) or carboxyl tail (CT9). (Figure adapted from 
Lampe et al. 2004)  
 
 
1.7. Pannexins 
Besides connexins, a new family of GJ-related channels has been identified, the pannexins 
(Panx) (Baranova et al. 2004, Scemes et al. 2009). Three pannexin isoforms have been 
described in rodents and human: Panx1, Panx2 and Panx3. They share a similar topology 
with connexins but have a different sequence homology. These channels primarily act as 
ATP-permeable HCs rather than GJs (Dahl and Locovei 2006). Among the pannexins, Panx1 
has been best documented in terms of its HC function as a passageway for ions, metabolites 
and signaling molecules with a MW below 1 kDa, for example, ATP (D'Hondt et al. 2011). 
Panx1-mediated ATP release (Bao et al. 2004) has been shown to serve as a key physiological 
signal for intercellular signaling as well as a signal to promote cell death (D'Hondt et al. 
2011). Pannexins have been recently identified as the channel mediating the “find me” signal 
released by apoptotic cells to recruit phagocytes in order to clear the dying cells (Chekeni et 
al. 2010). In the vasculature, a recent study reported a role of Panx1 in the contraction of 
resistance arteries where phenylepinephrine activates the release of vasoactive purines, 
such as ATP, through Panx1 channels (Billaud et al. 2011). Panx1 channel opening can also be 
detrimental, contributing to cell death and seizures under ischemic or epileptic conditions 
Chapter II: Connexins, blood vessel function and cell death 
 
46 
 
(Thompson et al. 2008, Santiago et al. 2011), and even facilitating HIV-1 viral infection (Seror 
et al. 2011). Panx2 has been shown to be involved in differentiation of neurons (Swayne et 
al. 2010) and its channel function can contribute to ischemic brain damage (Bargiotas et al. 
2011). Panx3 has been reported to play a role in differentiation of chondrocytes (Iwamoto et 
al. 2010) and osteoblasts (Ishikawa et al. 2011) while playing a key role in the maturation 
and transport of sperm (Turmel et al. 2011). Panx1 can be opened by mechanical stress (Bao 
et al. 2004), membrane depolarization (Bruzzone et al. 2005), increases in [Ca2+]i (Locovei et 
al. 2006), and activation of purinergic receptors, ATP and agonists (Locovei et al. 2006, 
D'Hondt et al. 2009). Pannexins are blocked by pannexin mimetic peptides and certain 
connexin-based channel inhibitors such as carbenoxolone, flufenamic acid and mefloquine 
(Bruzzone et al. 2005, Pelegrin and Surprenant 2006, D'Hondt et al. 2009).  
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2. Connexins in the cardiovascular system 
In the vasculature Cx37, Cx40, Cx43 and Cx45 are present (Spray et al. 2011). The expression 
of connexins in the vessel wall is not uniform and seems to vary with vessel size, vascular 
territory and species. In most cases Cx45 is observed only in SMCs. Cx37 is typically confined 
to ECs, although it has also been detected in SMCs. In contrast, Cx40 and Cx43 may be 
expressed in both cell types, but Cx40 is predominantly located in endothelial cells and Cx43 
is the most prominent connexin type found in SMCs (Figueroa and Duling 2009). The 
importance of connexins in the vasculature is highlighted by the fact that knock-out of 
several connexins disturbs vascular tone and development. Knockout of Cx40 is associated 
with irregular arteriolar vasomotion, impaired conduction of dilatory signals and 
hypertension (Kirchhoff et al. 1998, Simon et al. 1998, de Wit et al. 2000, de Wit et al. 2003). 
In Cx37 knockout mice K+-induced conducted vasoconstriction was significantly attenuated 
(McKinnon et al. 2006). The loss of Cx37 was not lethal (Simon and McWhorter 2002) and 
did not affect the conduction of vasodilation by acetylcholine in arterioles or gave rise to a 
cardiovascular phenotype (Schmidt et al. 2008). Research demonstrated an association of a 
polymorphism in the Cx37 gene, a protein normally expressed in endothelial cells but also 
found in monocytes and macrophages, with arterial stenosis and myocardial infarction in 
humans (Boerma et al. 1999, Yeh et al. 2003, Listi et al. 2005, Wong et al. 2006). Cx43 
deletions modify the expression of many genes in the differentiation and function of 
vascular cells, with alterations in the coronary artery development (Walker et al. 2005). Cx43 
plays a role in the looping of the ascending limb of the heart tube and the development of 
the right ventricle and the outflow tract, and Cx43-knockout mice die at birth of severe 
cardiac malformations (Reaume et al. 1995). Loss of Cx43 specifically confined to the 
endothelium was found to cause hypotension and bradycardia (Liao et al. 2001). In another 
study, lack of Cx43 in the endothelium had no effect on the blood pressure (Theis et al. 
2001). Cx45 is expressed in the smooth muscle layer of vessels and, to a lesser extent, also in 
the endothelium at least at early stages of development (Kruger et al. 2000). Knock-out of 
Cx45 blocks vascular development after the normal initiation of vessel formation, and 
impairs the differentiation of SMCs. Cx45-deficient mice die during embryonic development 
exhibiting striking abnormalities of vascular development (Kruger et al. 2000). Figure 5 
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shows a schematic illustration of the distribution pattern of connexin expression in the 
cardiovascular system. 
 
Figure 5. Schematic diagram illustrating general pattern of distribution and relative abundance of connexin 
types expressed in different regions of the mammalian heart and vessel wall. (Figure adapted from Spray et al. 
2011) 
 
 
The expression of connexins has been reported to be altered in several pathologies 
associated with vascular complications, such as hypertension (Rummery and Hill 2004, 
Figueroa et al. 2006), atherosclerosis (Kwak et al. 2002, Chadjichristos and Kwak 2007) and 
diabetes (Inoguchi et al. 1995, Zhang and Hill 2005). For example, endothelial Cx43 was 
upregulated in the initial phase of atherosclerosis (Gabriels and Paul 1998) and further 
progression of the disease downregulated endothelial Cx37 and upregulated Cx37 in 
macrophages recruited to the lesions (Kwak et al. 2002). Recently a link has been found 
between NO signaling and connexins and it is clear that in vascular diseases, such as 
atherosclerosis, hypertension and diabetes both NO signaling and connexin expression 
and/or function are altered (Looft-Wilson et al. 2011). NO affects vascular GJIC in vitro and in 
vivo, with both enhancement and inhibition of communication reported depending on the 
connexins involved and the cellular location within the vessel (McKinnon et al. 2009, Looft-
Wilson et al. 2011, Straub et al. 2011). There is new evidence that not only nitric oxide 
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interacts with connexins, but the enzyme endothelial NO synthase (eNOS) does as well. In 
endothelial cells, eNOS can exist as a complex with at least two connexins (Cx40 and Cx37) 
and this interaction affects eNOS function and expression at the membrane (Alonso et al. 
2010). It is also known that loss of eNOS affects gap junctional communication in arteries 
(Rodenwaldt et al. 2007).  
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3. Connexins and calcium signaling 
3.1. Introduction 
Many cellular functions are regulated by changes in [Ca2+]i. This generates Ca
2+ signals that 
are highly organized in both time and space. It is well accepted that modulation of [Ca2+]i is a 
critical determinant of vascular smooth muscle tone. Several Ca2+ signals in vascular 
preparations are described based on their spatio-temporal organization. Ca2+ sparks are 
highly localized, transient increases in [Ca2+]i, which occur in both isolated SMCs and intact 
arteries and are only observed at rest, or at very low level of stimulation (Dupont et al. 
2007). At higher stimulation levels, Ca2+ oscillations appear, i.e. transient rises in [Ca2+]i, that 
start from a specific region of the cell and are propagated along its length in a wave-like 
manner. Ca2+ oscillations may allow Ca2+ to function as a messenger while limiting the toxic 
effects of a sustained elevation in [Ca2+]i (Savineau and Marthan 2000). Two main types of 
Ca2+ oscillations have been reported: asynchronous Ca2+ oscillations, underlying tonic 
contractions of arteries and veins, and synchronous Ca2+ oscillations signaling vasomotion, 
which are spontaneous, rhythmical contractions, in some resistance arteries (Dai et al. 
2010). Asynchronous Ca2+ oscillations are caused by regenerative Ca2+ release from the 
sarcoplasmic reticulum (SR) and maintained by refilling of the SR by several channels and 
exchange pumps in the plasma membrane (see further). Synchronized Ca2+ oscillations are 
also paced by periodic Ca2+ release from the SR, which however, does not directly activate 
myofilaments, but serves to activate Ca2+ dependent Cl− channels, which depolarize the 
plasma membrane and activate L-type Ca2+ channels in electrically coupled SMCs (Jacobsen 
et al. 2007). 
 
 
3.2. Asynchronous Ca2+ oscillations 
In 1994, asynchronous Ca2+ oscillations were first described by Iino et al. (Iino et al. 1994); 
Ca2+ oscillations in individual SMCs of rat tail arteries were induced by norepinephrine. These 
oscillations occurred in the form of repetitive intracellular Ca2+ waves that propagated along 
the longitudinal axis of the ribbon-shaped SMCs. The Ca2+ waves did not spread 
intercellularly and were not synchronized between neighbouring SMCs. Since then similar 
asynchronous Ca2+ oscillations were found in a large set of other vessel types in response to 
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a variety of agonists such as phenylephrine, norepinephrine, angiotensin II, UTP or high K+ 
solutions (Ruehlmann et al. 2000, Lee et al. 2001, Mauban et al. 2001, Peng et al. 2001). The 
concentration of the agonist is the main factor that modulates the pattern of Ca2+ 
oscillations in SMCs (Ruehlmann et al. 2000). But in some cells, the oscillation pattern seems 
to be independent of the agonist concentration, but the percentage of cells oscillating in 
response to agonist stimulation does depend on the agonist concentration (Savineau and 
Marthan 2000).  
 
Calcium oscillations are initiated by binding of the extracellular agonist to its receptor and 
this leads, via a G-protein activation cascade, to phospholipase C (PLC) activation. PLC 
catalyzes the cleavage of phosphatidylinositol-4,5-bisphosphate (PIP2) into diacylglycerol 
(DAG) and inositol trisphosphate (IP3). IP3 binds to receptors located on the SR surface 
(Figure 6). The Ca2+ release initiated by this binding can trigger successive cycles of 
activation/inhibition of the IP3 receptor resulting in sustained Ca
2+ oscillations.  
A bimodal regulation of IP3-induced Ca
2+ release is mostly accepted as the basis of Ca2+ 
oscillations (Iino 2000). The IP3 receptor channel is highly regulated by the cytoplasmic Ca
2+ 
concentration. Indeed, up to a certain level [Ca2+]i promotes Ca
2+-induced Ca2+ release (CICR) 
whereas [Ca2+]i exceeding this threshold provides a negative feedback on IP3-induced Ca
2+ 
release (IICR), initiating the declining phase of the Ca2+ spike (Ilyin and Parker 1994). The 
declining phase of the wave can be seen as a combination of a decrease of the Ca2+ release 
and the active removal of Ca2+ from the cytosol depends on the sarco-endoplasmic reticulum 
Ca2+-ATPase (SERCA) (Mumtaz et al. 2011), that pumps some of the Ca2+ back into the ER, 
and the plasma membrane Ca2+-ATPase (PMCA) or Na+/Ca2+ exchanger (Dora 2001, Lee et al. 
2001), that pumps Ca2+ out of the cell (Berridge 2008). In such a manner, Ca2+ release can 
trigger successive cycles of IP3 receptor activation-inhibition resulting in Ca
2+ oscillations. To 
entrain this mechanism, Ca2+ entry via several ways (Figure 6) such as L-type voltage-
operated Ca2+ channels (VDCCs), TRP channels, ATP sensitive P2X receptors and the Na+/Ca2+ 
exchanger in the reverse mode, is needed (Guibert et al. 1997, Hyvelin et al. 1998, Lee et al. 
2001, Syyong et al. 2009). 
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Figure 6. Schematic diagram of Ca
2+
 signaling in vascular smooth muscle cells. Ca
2+
 oscillations are initiated by 
agonist binding to its receptor. This leads to the formation of IP3. IP3 binds to its receptor and a subsequent 
release of Ca
2+
 can trigger successive cycles of activation/inhibition of IP3 receptor resulting in Ca
2+
 oscillations. 
To entrain this mechanism, Ca
2+
 entry via voltage-dependent Ca
2+
 channels (VDCC), Na
+
–Ca
2+
 exchanger in 
reverse mode (NCX), hemichannels (HC), transient receptor potential ion channels (TRP) and ATP-sensitive P2X 
receptors (P2X) is needed. This Ca
2+
 entry promotes Ca
2+
-induced Ca
2+
 release (CICR) via IP3R or RyR up to a 
certain [Ca
2+
]i level.When [Ca
2+
]i exceeds this threshold a negative feedback mechanism initiates the declining 
phase of the Ca
2+
 wave by a decrease in Ca
2+
 release and active removal of Ca
2+
 from the cytosol. Removal of 
Ca
2+
 from the cytosol depends on the sarco-endoplasmic reticulum Ca
2+
-ATPase (SERCA) that pumps Ca
2+
 into 
the sarcoplasmic reticulum (SR) and the plasma membrane Ca
2+
-ATPase (PMCA) or NCX exchanger to pump 
Ca
2+
 outside the cell. Ca
2+
 oscillations can trigger cGMP-dependent Cl
−
 channels to open and this leads to a 
depolarization of the membrane potential (Em). This depolarizing current can pass through gap junctions (GJ) 
and this will start the vasomotion mechanism.  
 
 
GJs are known to influence the frequency of the Ca2+ oscillations, the number of cells 
displaying Ca2+ oscillations and the synchronization of the Ca2+ oscillations (Clair et al. 2001, 
Fanchaouy et al. 2005). Recently, the picture is further complicated by the possible 
contribution of CxHCs in the process of Ca2+ oscillations (Figure 7). Release of Ca2+ via the IP3 
receptor can influence the opening of CxHCs and this is followed by HC-mediated Ca2+ entry. 
Opening of CxHCs can also lead to the release of ATP. Ca2+-triggered ATP release via HCs 
followed by autocrine action of ATP on cell-surface receptors and subsequent regeneration 
of the cytoplasmic Ca2+ signal constitutes a putative signaling loop necessary for these 
oscillations (Kawano et al. 2006, Verma et al. 2009). De Bock et al. demonstrated recently 
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that bradykinin, a peptide that activates the PLC-IP3-pathway, triggers Ca
2+ oscillations 
involving CxHCs (De Bock et al. 2011).  
 
 
 
Figure 7. Diagram of basic mechanisms involved in generating an oscillatory Ca
2+
 spike and the contribution of 
connexin hemichannels in IP3-based Ca
2+
 oscillations. Ligand binding of a G protein coupled receptor (GPCR) 
generates IP3 which leads to IP3-induced Ca
2+
 release (IICR) that is further amplified by CICR (positive feedback) 
and Ca
2+ 
activation of PLC, producing the rising phase of the Ca
2+
 spike. Elevated [Ca
2+
]i will inactivate IICR 
(negative feedback) and stimulate Ca
2+
 sequestration and extrusion. Metabolic conversion of IP3 to IP2 and IP4 
will lower the IP3 concentration. Ca
2+
, together with diacylglycerol (DAG), will also activate protein kinase C 
(PKC) (dotted line) suppressing GPCRs and PLC activity. Once all OFF mechanisms have restored [Ca
2+
]i to the 
resting level, the cycle is ready for a next Ca
2+
 spike. 
Moreover, connexin hemichannel opening by moderate [Ca
2+
]i elevation results in Ca
2+
 entry, accompanied by 
ATP release. ATP acts on GPCRs at the cell surface thereby enhancing IP3 production, while Ca
2+
 entry via 
hemichannels contributes to the rising phase of the Ca
2+
 spike. When [Ca
2+
]i rises above 500 nM, connexin 
hemichannels close and this contributes to the restoration of resting [Ca
2+
]i. (De Bock et al. 2012) 
 
 
Asynchronous Ca2+ oscillations induced by extracellular agonists are always mediated by IP3 
(Aalkjaer and Nilsson 2005); however, other messengers may also be involved: cyclic ADP 
ribose (cADPR) that activates the ryanodine receptor (RyR) channel and nicotinic acid 
adenine dinucleotide phosphate (NAADP) that activates two-pore channels (TPC). The 
periodic release of Ca2+ from the ER (via IP3R, RyR, or TPC) is important to induce 
synchronized Ca2+ oscillations and subsequent vasomotion.  
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3.3. Vasomotion / Synchronous Ca2+ oscillations 
In some blood vessels, a specific tone is maintained by the spatial averaging of asynchronous 
Ca2+ oscillations. However, in some vessels Ca2+ oscillations in groups of cells are 
synchronized and this results in the pulsatile contractions known as vasomotion (Haddock 
and Hill 2005). Rhythmical contractions are generated in many different types of smooth 
muscle, from the gastro-intestinal tract, urinary tract and lymphatic vessels through to 
arteries and veins. In blood vessels, this activity known as vasomotion occurs in small 
resistance vessels of the microcirculation, as well as in larger arteries both in vivo and in 
vitro. Rhythmicity in vascular smooth muscle is apparently synchronous over considerable 
lengths of arteries. Vasomotion is thus expected to increase flow as its amplitude increases, 
in turn resulting in a decrease in vascular resistance. In this case vasomotion may be seen to 
be beneficial and its up-regulation during pathological conditions, such as hypertension, may 
be considered to be protective (Haddock and Hill 2005, Chen et al. 2010). Studies on both 
animals and humans indicate a tight coupling between blood pressure level and the ability of 
vessels to oscillate (Hollenberg and Sandor 1984, Chen et al. 2010). Pathologies such as 
diabetes and ischemia are associated with altered prevalence of vasomotion, and there is 
evidence that vasomotion has a protective role during ischemia. The latter suggestion is 
strongly supported by the findings that vasomotion enhances dialysis of the extravascular 
fluid (Lefrandt et al. 2003, Sakurai and Terui 2006). This might relate to the observation that 
impaired vasomotion favors the development of skin lesions and hypertension in patients 
with type 2-diabetes (Broegger et al. 2011). 
Vasomotion requires both a mechanism which can initiate the oscillation and a mechanism 
for the synchronization of the SMCs in the vascular wall. It has been proposed that 
oscillatory release of Ca2+ from the SR, induced or modulated by neurotransmitters or 
hormones, is responsible for initiating the oscillation. This hypothesis is supported by several 
studies showing that vasomotion could be abolished by inhibiting the release of Ca2+ from 
SR. Those periodic releases of Ca2+ cause a membrane depolarization of the cell. This 
depolarization can spread to neighboring cells by current flow through the GJs to provide a 
synchronization mechanism (Nilsson et al. 2003, Berridge 2008). The membrane 
depolarization will activate voltage-dependent Ca2+ channels in neighboring cells to provide 
a Ca2+ pulse that will help to iniate their Ca2+ transients thus bringing them into phase with 
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each other. Figure 8 shows the model for the generation of vasomotion in rat mesenteric 
small arteries. 
 
 
Figure 8. Model for the generation of vasomotion in rat small mesenteric arteries. 1. The basic oscillator is the 
sarcoplasmic reticulum (SR), which releases Ca
2+
 leading to regenerative Ca
2+
 waves traversing the cell. 2. In the 
presence of cGMP, this Ca
2+
 is able to activate a chloride channel (Cl
-
) in the plasma membrane. 3. If this 
current is activated in a sufficient number of cells at the same time, cells will depolarize. 4. This depolarization 
can spread to neighboring cells via GJs. 5. Depolarization will cause Ca
2+
 influx through L-type Ca
2+
 channels and 
contraction. 6. This Ca
2+
 influx will also release Ca
2+
 in quiescent cells and thus resetting their intracellular 
oscillators. 
  
 
Other types of oscillations, either based solely on interactions of ion currents in the 
sarcolemma or based on oscillations of the glycolytic pathway and consequently the Na-K-
pump, have also been suggested and could play a role under some conditions, although 
these pathways are probably less frequent (Aalkjaer and Nilsson 2005). 
 
Vasomotion has been shown in many studies of isolated arteries to be endothelium 
dependent and several reports support that endothelial removal prevents vasomotion (Peng 
et al. 2001, Sell et al. 2002, Rahman et al. 2005, Boedtkjer et al. 2008)). In rat mesenteric 
arteries, removal of the endothelium desynchronizes [Ca2+]i oscillations and abolishes 
vasomotion (Peng et al. 2001) and this has been proposed to be due to a loss of NO and the 
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subsequent activation of a cGMP-dependent depolarizing current in the SMCs. Addition of 
cell-permeable cGMP analogues was shown to restore vasomotion in endothelium-denuded 
tissues (Jackson et al. 1991, Gustafsson 1993). The synchronizing effect of NO is complex. NO 
can activate directly or through sGC/cGMP depolarizing and hyperpolarizing currents that 
can affect synchronization (Kapela et al. 2012). However, in the same artery, and in other 
vessels, NO has been reported to have an inhibitory effect on vasomotion and under these 
conditions it is unlikely to be responsible for initiating vasomotion (Omote et al. 1992, Hill et 
al. 1999, Sell et al. 2002, Mauban and Wier 2004). Seppey et al. showed that it is possible to 
obtain vasomotion in rat small mesenteric strips in the presence and in the absence of an 
intact endothelium. The range of agonist concentrations leading to vasomotion seems to 
greatly differ between these two cases. Three times more phenylephrine was needed to 
induce vasomotion in arterial strips with an intact endothelium to compensate the 
decreasing contractility by the endothelium-derived factors (Seppey et al. 2008). Next to NO, 
EDHF has been suggested to initiate vasomotion (Okazaki et al. 2003, Mauban and Wier 
2004). Vasomotion is abolished and only asynchronous [Ca2+]i oscillations can be detected in 
SMCs following inhibition of EDHF with the KCa channel blockers apamin and charybdotoxin 
(Mauban and Wier 2004). Since Ca2+ and IP3 can move through MEJ from SMCs into ECs 
(Schuster et al. 2001, Lamboley et al. 2005, Isakson et al. 2007), it has been proposed that 
these molecules could activate KCa channels in the endothelium. The resulting 
hyperpolarization would be electrotonically propagated back into the SMCs.  
 
 
3.4. Interfering with connexin channels modulates the vascular tone 
A number of studies have demonstrated that GJ uncouplers such as heptanol, 18α-
glycyrrhetinic acid, carbenoxolone and connexin mimetic peptides abolish synchronized 
contractions (Jackson et al. 1991, Chaytor et al. 1997, Hill et al. 1999, Matchkov et al. 2006), 
synchronized waves (Sell et al. 2002, Martin et al. 2005, Matchkov et al. 2006) and 
oscillations in membrane potential (Hill et al. 1999). However, a growing body of evidence 
suggests that many of these compounds have additional non-specific effects on targets 
other than GJs (Spray and Burt 1990, Chaytor et al. 1997, Tare et al. 2002, Matchkov et al. 
2004) and so the results of these studies must be interpreted with caution.  
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Connexin mimetic peptides, i.e. peptides that are identical with a short amino acid sequence 
on the connexin subunit, were initially designed to produce connexin-selective blockage of 
GJs, but have recently emerged as a tool to block CxHCs with little or no immediate effects 
on GJs (Evans et al. 2012). In most cases, a time window can be defined where HCs are 
inhibited (1 h exposure time for instance) without concurrent effects on GJs (Wang et al. 
2012). Gap26 and gap27 peptides appear to act in a connexin-specific manner and have 
been widely applied to block GJs in the past. These peptides inhibit gap junctional transfer of 
fluorescent dyes (Chaytor et al. 1999), electrical coupling (Dora et al. 1999) and synchronized 
Ca2+ oscillations (Isakson and Duling 2005, Martin et al. 2005, Matchkov et al. 2006) in SMCs. 
The peptides also inhibit several cellular integrative processes mediated by Cxs and/or GJs, 
such as synchronized rhythmic activity of arteries (Chaytor et al. 1997, Griffith et al. 2004, 
Figueroa et al. 2006, Matchkov et al. 2006) and endothelial smooth-muscle interactions 
governing relaxation of blood vessels (Chaytor et al. 1999, Dora et al. 1999, De Vriese et al. 
2002, Matchkov et al. 2006, Tang and Vanhoutte 2008, Lopez et al. 2009). The authors 
suggested a role for (myo)endothelial GJs in the regulation of vascular tone. Matchkov and 
others suggested that a peptide combination of 43gap26, 40gap27 and 37,43gap27 suppressed 
vasomotion in rat mesenteric small arteries (Matchkov et al. 2006); an effect that was 
attributed to an interruption of intercellular communication via GJs.  
Braet et al. were the first to report that connexin mimetic peptides also inhibit CxHCs (Braet 
et al. 2003, Braet et al. 2003). This observation was somehow expected, given the fact that 
the extracellular-loop sequences, with which the peptides are likely to interact, are freely 
available in the CxHC form. Both gap26 and gap27 blocked uptake of the reporter dye 
propidium iodide and ATP release in Cx43-expressing cells, and the effect became apparent 
after short incubations, typically in the order of 10-30 min. Moreover, Wang et al. showed in 
HeLa cell lines and pig ventricular cardiomyocytes that unitary HC currents were strongly 
inhibited by both peptides within minutes (Wang et al. 2012). For comparison, the effects of 
connexin mimetic peptides on GJs typically require longer incubations of the order of about 
1 hour or more (Evans et al. 2006, Evans and Leybaert 2007). 
Recently new connexin mimetic peptides were discovered by the hostlab in collaborative 
research work with the group of Geert Bultynck (KULeuven). These block Cx43 HCs, without 
interfering with gap junctional communication (Ponsaerts et al. 2010, Wang et al. 2013). 
Two peptides corresponding to the cytoplasmic loop of Cx43 (L2 peptide and Gap19, part of 
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the L2 sequence) were shown to inhibit CxHC mediated responses (Ca2+ waves and ATP 
release) (Ponsaerts et al. 2010) and HC unitary currents (Wang et al. 2013)  
Lately pannexins were shown to be involved in the control of vasoconstriction. This was due 
to the release of purines through Panx1 channels on VSMCs triggered by phenylephrine 
stimulation and participates in the control of vascular tone by purinergic receptors (Billaud, 
Lohman et al. 2011).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter II: Connexins, blood vessel function and cell death 
59 
 
4. Connexins and cell death  
4.1. Introduction 
In multicellular organisms, the maintenance of tissue homeostasis ultimately relies on the 
critical balance between cell growth and cell death. Abnormalities in the control of cell death 
contribute to a variety of cardiovascular diseases; for example, regulated cell death is 
involved in vessel remodeling during development or following injury, but deregulated death 
is implicated in pathologies such as atherosclerosis, aneurysm formation, restenosis after 
angioplasty/stenting, vascular graft infection, ischemic and dilated cardiomyopathies and 
infarction (Clarke et al. 2007). Cell death is characterized by a number of distinct 
mechanisms, including apoptosis, autophagy and necrosis. Apoptosis, necrosis and 
autophagy are defined on the basis of morphology, tissue location and the dependence of 
lysosomes.  
 
a) Apoptosis 
Apoptosis is an energy-dependent process characterized by rounding-up of the cell, 
reduction of cellular volume (pyknosis), minor changes in cytoplasmic chromatin 
condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing (but 
maintenance of its integrity until the final stages of the process) and lysosomal degradation 
of apoptotic bodies by phagocytes (Elmore 2007, Kroemer et al. 2009, Orrenius et al. 2011). 
The efficient recognition of apoptotic cells by phagocytes requires rearrangement of the 
infrastructure and molecular composition of the plasma membrane in the dying cell. For 
example, alteration of the distribution of carbohydrates on the cell surface promotes 
preferential binding of macrophages to apoptotic cells. The loss of phospholipid asymmetry, 
resulting in the externalization of phosphatidylserine (PS), further facilitates the recognition 
of dying cells by macrophages. In fact, PS exposure on the apoptotic cell surface appears to 
be the most important “eat me” signal, although its binding to macrophages is usually not 
direct but mediated by a number of bridging molecules (Hanayama et al. 2004). However, it 
should be noted that under in vitro conditions, where phagocytic cells are normally absent, 
apoptotic cells and their fragments lyse in a process similar to necrosis. This is termed 
secondary necrosis (Orrenius et al. 2011). In vivo secondary necrosis occurs when massive 
apoptosis overwhelms the available scavenging capacity, or when the scavenger mechanism 
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is directly impaired, and may result in leakage of the cell contents with induction of tissue 
injury and inflammatory and autoimmune responses (Silva et al. 2008) 
 
Two major apoptotic pathways can be distinguished, the mitochondria-mediated intrinsic 
cascade and the death receptor-mediated extrinsic pathway (Figure 9). Both rely on the 
proteolytic activity of an evolutionary conserved family of cysteine proteases – the caspases 
– which form the biochemical basis of the apoptotic phenotype (Earnshaw et al. 1999). They 
are responsible for the cleavage of a large number of cellular proteins including major 
cytoplasmic and nuclear elements. The extrinsic signaling pathway is triggered by the 
binding of an extracellular death ligand, such as Fas ligand, tumor necrosis factor α (TNFα) or 
TNF-related apoptosis-inducing ligand (TRAIL) to their corresponding receptors at the plasma 
membrane (Figure 9). This is followed by the formation of the death-inducing signaling 
complex (DISC) and resulted in the activation of pro-caspase-8 (Gump and Thorburn 2011). 
In type I cells, caspase-8 activates procaspase-3, which cleaves target proteins, leading to 
apoptosis. In type II cells, caspase-8 cleaves the pro-apoptotic B-cell lymphoma-2 (Bcl-2) 
protein Bid, which, in turn, induces the translocation, oligomerization, and insertion of the 
Bcl-2-associated X protein (Bax) and/or Bcl-2 antagonist/killer (Bak) into the mitochondrial 
outer membrane. This is followed by the release of several proteins from the mitochondrial 
intermembrane space, including cytochrome C (CytC), which forms a cytosolic apoptosome 
complex with Apaf-1 (apoptosis activating factor-1) and procaspase-9 in the presence of 
dATP. This results in the activation of procaspase-9, which triggers the caspase cascade by 
activation of procaspase-3 (Orrenius et al. 2011). 
 
In contrast, the intrinsic signaling pathway is mediated by mitochondria and involves a 
diverse array of non-receptor-mediated stimuli that produce intracellular signals directly 
acting on targets within the cell (Figure 9). It is regulated by the Bcl-2 family of pro- and anti-
apoptotic proteins, inhibitor of apoptosis proteins (IAPs) (inhibition of caspases), second 
mitochondrial activator of caspases (Smac), and Omi (negative regulation of IAPs). The 
intrinsic pathway may also operate via caspase-independent mechanisms, which involve the 
release from mitochondria and translocation to the nucleus of at least two proteins, 
apoptosis inducing factor (AIF) and endonuclease G (EndoG) (Orrenius et al. 2011).  
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Figure 9. The extrinsic and intrinsic apoptotic pathways. The extrinsic pathway is triggered by ligands binding to 
receptors on the cell surface, resulting in their oligomerization, formation of death-inducing signaling complex 
(DISC), and caspase-8 activation. In type I cells, caspase-8 activates caspase-3, which results in the cleavage of a 
host of target proteins and apoptosis. In type II cells, caspase-8 cleaves Bid, resulting in the engagement of the 
mitochondrial pathway. The intrinsic pathway involves the release of proapoptotic proteins (cytochrome c, 
Smac, Omi, AIF, and EndoG) from the mitochondrial intermembrane space into the cytosol via Bax/Bak-
mediated pores in the outer membrane. Here, cytochrome c, Smac and Omi participate in the activation of the 
caspase cascade, whereas AIF and EndoG are further translocated to the nucleus, where they participate in 
chromatin condensation and large-scale DNA fragmentation. X-Inhibitor of Apoptosis Protein (XIAP) is a 
cytosolic IAP, whose activity is blocked by Smac and Omi. Bcl-2 and Bcl-XL inhibit apoptosis. (Orrenius et al 
2011) 
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b) Necrosis 
In contrast to apoptosis and autophagy, the swelling of organelles and rupture of the plasma 
membrane during necrosis result in the release of many inflammatory molecules, leading to 
an inflammatory respons. Necrosis is prominent in ischemia, trauma and some forms of 
neurodegeneration (Golstein and Kroemer 2007, Vanlangenakker et al. 2008). For a long 
time, necrosis has been considered merely as an accidental uncontrolled form of cell death, 
but evidence is accumulating that the execution of necrotic cell death may be finely 
regulated by a set of signal transduction pathways and catabolic mechanisms (Kroemer et al. 
2009). Some authors therefore have proposed the term ‘necroptosis’ to indicate regulated – 
as opposed to accidental – necrosis (Vanden Berghe et al. 2010). Necroptosis is 
biochemically defined as a form of cell death that is activated by the receptor-interacting 
protein kinase 1 (RIPK1) and RIPK3, a metabolic burst associated with overproduction of 
reactive oxygen species (ROS), as well as mitochondrial and lysosomal membrane 
permeabilization, ATP depletion, failure of Ca2+ homeostasis and perinuclear clustering of 
organelles (Golstein and Kroemer 2007, Vanlangenakker et al. 2008, Vandenabeele et al. 
2010). 
 
c) Autophagy 
In contrast, autophagy is not associated with phagocytosis, and is characterized by the 
presence of autophagic vacuoles that fuse with lysosomes to form autophagolysosomes 
within the dying cells that are responsible for self-degradation (Orrenius et al. 2011). It is an 
evolutionary conserved mechanism that, in addition to its role in the normal turnover of 
proteins and organelles, is involved in the cell’s response to stress and starvation (Gump and 
Thorburn 2011). Although the classification into different modes of cell death is useful, there 
is considerable overlap between the different mechanisms, particularly in vivo (Gump and 
Thorburn 2011, Orrenius et al. 2011). There is accumulating evidence that the inhibition of 
autophagy is oncogenic. Loss of only one allele from either one of the two autophagy genes, 
beclin-1 or UVRAG (UV radiation resistance-associated gene), is sufficient to promote 
carcinogenesis. For example, mutation in beclin-1 is common in human cancer (Koneri et al. 
2007). Multiple oncogenes, such as Bcl-2 and Akt, inhibit autophagy, supporting the 
hypothesis that autophagy contributes to tumor suppression (Sridharan 2011). Active 
autophagy can prevent tumor development by at least two mechanisms. It may switch the 
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balance between protein synthesis and degradation towards degradation to reduce cell 
growth. Alternatively, it may act to remove defective mitochondria and other intracellular 
organelles that are potential sources of ROS, which can induce DNA damage and genome 
instability and thereby promote carcinogenesis (Orrenius et al. 2011). 
 
 
4.2. Gap junctions and cell death 
A body of evidence shows that GJIC is associated with apoptotic activity. Communication via 
GJs frequently underlies the propagation of cell death between a dying cell and its healthy 
neighbor; this phenomenon of ‘bystander death’ (‘the kiss of death’) has gained a lot of 
attention in the context of ischemia-related cell injury, such as in the case of cerebral 
infarction (Lin et al. 1998, Contreras et al. 2004, Nakase et al. 2004) and to amplify the 
potency of cancer treatment (Krutovskikh et al. 2002). Recently, Feine et al. showed that a 
localized oxidative insult of endothelial cells propagates through GJIC while stimulating de-
novo generation of reactive oxygen and nitrogen species, thereby driving the insult’s 
expansion (Feine et al. 2012). Previous work from our group as well as others demonstrated 
that CytC-induced apoptosis propagates from dying to healthy neighboring cells through GJs 
(Cusato et al. 2003, Frank et al. 2005, Udawatte and Ripps 2005, Cusato et al. 2006, Decrock 
et al. 2009, Peixoto et al. 2009). The modulation of IP3 receptors by Bcl-2 family proteins 
(Distelhorst and Bootman 2011) will determine the Ca2+ load of mitochondria and will thus 
be expected to be decisive in initiating apoptosis through mitochondrial CytC release. The 
biochemical nature of the signals that propagate the cell death message are largely 
unknown. Ca2+ has been proposed as the ‘killing messenger’, thus spreading the death wave 
from cell to cell. The onset of apoptosis is indeed frequently accompanied by drastic 
alterations in cytoplasmic Ca2+ concentrations, and several crucial apoptotic effectors are 
known to depend on Ca2+ (Krutovskikh et al. 2002, Contreras et al. 2004, Krysko et al. 2005, 
Cusato et al. 2006, Decrock et al. 2009). However, Ca2+ may be limited by its interactions 
with more slowly mobile Ca2+-binding proteins. IP3, produced by PLC activation and 
triggering Ca2+ release from the ER, is probably a better candidate as it can pass through GJs 
(Boitano et al. 1992, Decrock et al. 2012). Its ER IP3-receptor is modulated by pro- and anti-
apoptotic proteins such as Bcl-2 (Chen et al. 2004, Rong et al. 2008), and the Ca2+ changes 
may trigger CytC release from mitochondria (Orrenius et al. 2003). Recently Decrock et al. 
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stated that the transfer of IP3 through GJs is critical, but was not sufficient for the spread of 
apoptosis (Decrock et al. 2012). Other proposed candidate killer messengers that can pass 
through GJs include cAMP and cGMP (Seul et al. 2004, Krysko et al. 2005). Potential rescue 
messengers on the other hand include glucose and ATP or the free radical scavenger 
ascorbic acid and reduced glutathione that are all able to pass through GJs and favor cell 
survival (Contreras et al. 2004). Likewise, GJs can promote cell survival by limiting the flux of 
toxic metabolites, such as nitric oxide and superoxide ions (Nakase et al. 2003, Contreras et 
al. 2004, Nakase and Naus 2004). Thus, there seems to be a clear two-way traffic between 
(early) apoptotic and non-apoptotic cells, and depending on the balance, two opposite 
biological outcomes can be achieved, namely cell death or cell survival (Vinken et al. 2006). 
 
 
4.3. Connexin hemichannels and cell death 
As mentioned in section 1.4. Connexin hemichannels, CxHCs may open under conditions 
often regarded as stressful to cells and HC opening may lead to cell death, caused by the 
excessive entry of Na+ and Ca2+ ions and the loss of extracellular ATP or other crucial 
molecules (Kalvelyte et al. 2003, Saez et al. 2003, Contreras et al. 2004). Recent evidence 
from Decrock et al. showed that Cx43 HCs contribute to the propagation of apoptotic cell 
death in a rat C6 glioma cell model (Decrock et al. 2009). In ischemia-related cell injury, the 
involvement of HCs as ‘toxic pores’, has been demonstrated. Indeed, metabolic inhibition of 
astrocytes was found to accelerate cell death, which was directly associated with Cx43 HC 
opening (Contreras et al. 2004, Retamal et al. 2007). The releasing molecules themselves 
(e.g. ATP, glutamate or prostaglandins), can also enroll as paracrine communication 
components and ligand-receptor binding of these messengers is often accompanied by a rise 
in cytosolic Ca2+ (and trigger a new cycle of HC responses)(Orrenius et al. 2003). Increased 
cytosolic Ca2+ concentration may exert toxic effects on neighboring cells. On the other hand, 
HCs might favor cell survival. A well-known example includes their involvement in the anti-
apoptotic actions of bisphosphonates. Alendronate inhibits apoptosis in osteoblasts and 
osteocytes, by a mechanism that involves the activation of ERK/MAP kinases and Src kinase. 
It is thought that alendronate induces opening of the Cx43-based HCs. The subsequent 
conformational change probably causes activation of the Cx43-associated Src kinase. The 
latter then triggers ERK/MAP kinases, which in turn results in cell survival and thereby the 
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prevention of osteoporosis (Goodenough and Paul 2003, Plotkin et al. 2005). Another 
possible link between HCs and cell survival/death relates to modifications in the subcellular 
localization of HCs. For example, upon ischemic preconditioning which is a form of 
cardioprotection, Cx43 translocates from the plasma membrane to the inner mitochondrial 
membrane through a heat-shock protein 90-dependent pathway (Boengler et al. 2005, 
Rodriguez-Sinovas et al. 2006). Cx43 redistribution to mitochondria was also shown in 
endothelial cells and could have a role in endothelial dysfunction. Li et al. showed that 
homocysteine-exposed human umbilical vein endothelial cells (HUVEC) overexpress Cx43 
and homocysteine induced a Cx43 shift from intercellular plaques to intracellular 
compartments (Li et al. 2002). Homocysteine decreased EDHF-mediated relaxations in rat 
interlobar arteries, suggesting that Cx43 redistribution to mitochondria could have a role in 
endothelial dysfunction (Li et al. 2002). Mitochondrial Cx43 was also found to be a major 
regulator of cardiomyocyte apoptosis (Goubaeva et al. 2007).  
 
 
4.4. Connexin proteins and cell death 
Connexin proteins as such can influence tissue homeostasis by actions that are not related to 
their channel-forming capabilities. Connexin proteins can directly or indirectly affect the 
production of cell growth and cell death regulators or can act as a cellular signaling reservoir 
by reversibly interacting with these substances (Vinken et al. 2012). It has been suggested 
that connexins participate in cell death pathways through direct interaction with apoptotic 
factors. The cytoplasmic co-localization of Cx26 and Cx43 with the Bcl-2 proteins Bak, Bcl-XL 
and Bax, in human breast cancer cells and human colorectal cancer cells, respectively, could 
be in favor of this idea (Kanczuga-Koda et al. 2005, Kanczuga-Koda et al. 2005). Connexins 
may also be involved in the control of cell death-related gene expression. A number of 
papers have reported changes in the expression of individual subsets of apoptotic factors 
while interfering with connexin expression. For example, in heart tissue of Cx43 knockout 
mice, an altered expression of the apoptotic genes Bok, Bax, Bid, Diablo, caspase 6 and 
caspase 9 was shown (Walker et al. 2005). The exact nature of the link between connexins 
and apoptosis-related gene expression is still a matter of debate. One hypothesis is that 
connexins are directly involved in transcriptional control and modulate gene expression for 
instance in rat osteocytes (Stains and Civitelli 2005). Connexin proteins can also interact with 
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cell growth and cell death regulators, such as the adherens junction protein β-catenin and 
the tight junction building blocks ZO-1/2 and ZO-1 associated nucleic acid binding protein 
(Jiang and Gu 2005). 
 
Figure 10 summarizes the role of connexins/pannexins and their channels in cell death 
signaling. 
 
 
Figure 10. Overview of connexin- and pannexin-related signaling in cell death. Connexins can affect the cell 
death process through GJs (1), HCs (2) or connexin proteins (6,7). GJ channels can support direct exchange of 
cell death and cell survival signals between cells (1). HCs may contribute to cell death by four different 
mechanisms: by the entry of cell death or the loss of cell survival signals (2), through paracrine signaling of 
death or survival messengers (3) by HC-mediated transmembrane signal transduction (4) or by affecting 
mitochondrial functioning (5). Cx proteins as such can associate with cell death regulators (6) or influence the 
expression of these molecules (7). HCs composed of pannexins may act as a permeabilization pore by itself or 
as a part of the P2X7R death complex (8), allowing ATP to leave the cell or bacterial molecules to make their way 
into the cell.  (ASK1, apoptosis signal-regulating kinase 1; ATP, adenosine triphosphate; cAMP, cyclic adenosine 
monophosphate; cGMP, cyclic guanosine monophosphate; ERK, extracellular signal-regulated kinase; GCV, 
ganciclovir; IP3, inositol trisphosphate; pBad, phosphorylated Bad; pC/EBP , phosphorylated CCAAT/enhancer-
binding protein ; ROS, reactive oxygen species) (Decrock et al. 2009) 
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1. Introducing vascular grafts  
Vascular grafts have been widely used for myocardial reperfusion following coronary artery 
occlusion or for major peripheral vascular diseases. The superiority of autogenous veins in 
reconstructive procedures is well recognized (Rashid et al. 2004). This is primarily due to the 
fact that the risk of rejection associated with antigen-antibody mismatch may be eliminated. 
Also the process of harvesting and transplanting the vessel is almost instantaneous, reducing 
the concentration of damage associated with storage of tissue in cold ischemia. However, an 
inadequate supply of these vessels in patients has resulted in surgeons having to use 
alternative techniques (Thakrar et al. 2006). Prosthetic vessels are an option but they are 
insufficient to match the functional properties of autogenous vessels, especially relating to 
the biomechanical properties (Hoenig et al. 2005). Expanded polytetrafluoroethylene 
(ePTFE) is one of the most frequently used prostheses in human clinical practice. This 
biomaterial had several advantages over other prosthetic materials, including high 
electronegativity and a hydrophobic surface that reduces platelet adhesion. Although this 
material boasts a good blood/biomaterial interface and shows excellent biotolerance on the 
part of the recipient, many polymeric materials are to some extent thrombogenic. Attempts 
to resolve this problem include establishing a cell lining on the luminal surface of the graft 
using autologous endothelial cells from the patient. Coating the luminal surface in this way 
substantially improves clinical results after grafting, increasing the biocompatibility, and 
viability of the prostheses (Deutsch et al. 1997, Laube et al. 2000). However, prosthetic 
material is also susceptible to infection, a devastating complication that often requires its 
withdrawal and replacement (Pascual et al. 2004). To reduce such risks, it has been 
proposed to replace the infected graft by human vessels collected from clinically dead 
patients. This alternative source of blood vessels, named allografts, has the advantage that 
they are relatively more abundant than autografts and more likely to possess adequate 
biomechanical properties to function efficiently in the recipient. Conversely, there are 
common problems associated with the use of this technique, primarily being an increased 
risk of disease transmission between individuals. Further, rejection is a common occurrence 
in patients and occlusion of a graft is the most serious postoperative complication. Many 
factors have been considered responsible for the early occlusion of grafts. Atherogenic 
factors such as smoking, diabetes, dyslipidaemias and high blood pressure cause significant 
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changes in the vascular wall that lead to a reduction in viability when those vessels are used 
as grafts (Kanellaki-Kyparissi et al. 2005). Vein and artery bypass grafting is an integral 
component of cardiovascular surgical practice for both arterial and venous diseases. 
However, many of these grafts will eventually fail due to either intrinsic or extrinsic causes 
such as intimal hyperplasia, accelerated atherosclerosis, thromboembolism and graft sepsis 
(Davies and Hagen 2011). Veins are the most commonly used source of vessel and the 
general consensus is that arteries are more antigenic (Elmore et al. 1991, Fujitani et al. 
1992). Venous grafts (saphenous veins) are mostly used for femorodistal bypasses on crural 
or pedal vessels in the absence of a suitable autologous saphenous vein. These grafts are 
resistant to infection when performed for revascularization in patients with an infected ulcer 
(Randon et al. 2010). Arterial grafts (femoral arteries) are suited for aorta-iliacal bypasses 
after infection. Infection is the principal indication for using an arterial allograft and this may 
be a primary arterial infection in which haematogenous spread of bacteria or fungi cause an 
infective arteritis or due to trauma or iatrogenic injury such as during angiographic 
procedures; or a secondary infection to previous arterial reconstructive surgery (Dodd 2010). 
Although long term follow-up of bypass patients showed that the patency of arterial grafts 
was greater than that of venous grafts and for that reason the use of the internal thoracic 
artery has been steadily gaining ground in recent years (Kanellaki-Kyparissi et al. 2005). 
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2. Preservation of vascular grafts 
To date, three current approaches to vessel preservation exist. The first is storage of the 
vessels at hypothermic temperatures (4 °C, for approximate 1 month). A second 
preservation and the most used technique is cryopreservation, a process of long-term 
subzero preservation of blood vessels. Here, vessel segments are placed in 10-15 % 
cryoprotectants and cooled slowly in a freezer to –70 °C (yielding an average cooling rate of 
–1-2 °C/min). Then the vessels are placed in liquid nitrogen, cooled to –196 °C (Pegg 2002, 
Thakrar et al. 2006). Another subzero technique is vitrification; this process involves 
converting an aqueous solution by use of high concentrations of cryoprotectants into an 
amorphous solid at low temperatures, such that when the liquid is cooled down it may be 
taken below its melting point without producing ice crystal growth. Restriction of ice crystal 
growth results in reduced structural and molecular damage. However, the key problem 
associated with vitrification of tissues is that approximately half the water within the tissue 
must be replaced by the vitrification solute. The vessels are further rapidly cooled to –196 °C 
by placing the tube in liquid nitrogen (with an average cooling rate of –40 °C/min) (Thakrar 
et al. 2006). Fresh vascular grafts undergo rapid rejection and destruction. Preserved grafts 
were thought to be less so and arterial banks became standard in many vascular centers. 
Harvesting, sterilizing, and preserving grafts utilized formalin, alchohol, glycerine, ethylene 
oxide, betapriolactone, high voltage cathode ray irradiation, and freeze drying, each had its 
shortcomings (Callow 1996, Dodd 2010). However, recently long term-storage at 4 °C in 
tissue culture medium of vein homografts was successful for distal revascularization in 
critical ischemia, especially in infected fields (Galambos et al. 2009).  
 
Over the last years, cryopreserved vessels are being increasingly employed in vascular 
reconstruction procedures, given the developments made in minimizing tissue damage 
induced by low temperatures. It has been demonstrated that storage at -196 °C for an 
extended period of time yields a better preservation of vascular function than storage at -
70 °C (Rigol et al. 2000). However, other studies have found that storage of vessels at a 
temperature of -80 °C seemed to lead to better results than temperatures as low as -160 °C / 
-190 °C (Ku et al. 1994). Storage of allografts in liquid nitrogen up to 13 years did not 
significantly undergo loss of cell viability in cardiac valve allografts (Mirabet et al. 2008). 
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Further research pointed to an important role for the cooling rate and medium to improve 
vascular function of cryopreserved vessels. Cryopreservation with a cooling rate of 0.7 °C per 
minute seemed to be superior above the standard 1 °C per minute cooling in porcine 
femoral arteries (Rigol et al. 2000) and rabbit common carotid arteries (Song et al. 1995). In 
human internal mammary arteries the optimal freezing rate for preserving post-thaw 
contractile function is around 1 °C/min and for human saphenous veins 0.6 °C/min (Muller-
Schweinitzer 2009). An even more important factor in improving the vessel quality after 
cryopreservation is the thawing procedure. Rapid thawing was associated with more cell 
damage and fractures (see further) of the grafts. Slow, automated thawing at a warming rate 
of 1 °C per minute improved vessel quality and endothelial preservation (Pascual et al. 2004) 
especially in arteries (Muller-Schweinitzer 2009). Today, slow automated thawing is highly 
recommendable for arterial grafts, while venous grafts are less susceptible to rapid thawing 
(Ruddle et al. 2000). Further advances in the cryopreservation/thawing process (Bujan et al. 
2000, Bujan et al. 2001) including the introduction of cryoprotectants (Gournier et al. 1995, 
Alonso et al. 1999, Castier et al. 1999) have led to their current use in clinical practice. 
Glycerol was the first cryoprotectant agent to gain widespread use in cryobiology, for 
cryopreserving red blood cells and sperm. The value of dimethyl sulfoxide (DMSO) as a 
cryoprotectans was discovered not long thereafter. Other polyols, such as ethylene glycol 
(automobile anti-freeze) and propylene glycol (formerly used to reduce ice formation in ice 
cream) were later shown to be effective cryoprotectants (Pegg 2002). In the late seventies, 
cryopreservation of canine artery segments in liquid nitrogen and 15 % DMSO, an oxygen 
radical scavenger, was found as an excellent method for preserving and storing fresh 
allograft arteries (Boren et al. 1997). DMSO, the most commonly used cryoprotectant of 
vascular tissues (Muller-Schweinitzer 2009) rapidly diffuses through cell membranes and 
prevents the formation of intracellular ice crystals. Optimal protection against cryoinjury will 
be obtained by the combination of a permeating and non-permeating cryoprotecting agent 
(CPA). Glycerol and DMSO are permeating CPAs and examples of non-permeating CPAs are 
sucrose and glucose and are suggested to stabilize the cell volume by retaining more liquid 
water at low temperatures, thereby reducing the external electrolyte concentration (Muller-
Schweinitzer 2009). 
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Today, the performance of cryopreserved vascular substitutes is not ideal, mainly because of 
spontaneous fractures (Figure 1) appearing at the time of thawing or grafting (Lehalle et al. 
1997, Pegg et al. 1997, Bujan et al. 2000). Cryopreserved vessels suffer from macroscopic 
and microscopic fractures; a phenomenon that probably results from the thermal stresses 
created by rapid warming of the vitreous material that is produced by freeze-concentration 
of the aqueous phase. Relatively slow warming to -100 °C, at which temperature the vitreous 
material has softened, reduces these stresses and avoids fractures (Pegg et al. 1997). 
     
Figure 1. Spontaneous fractures in a blood vessel. a. a cryopreserved/rapidly thawed arterial segment. 
Note how the spontaneous fracture affects the entire wall (arrows) except the tunica adventitia (A). ×25. b. 
SEM of the fracture above, showing clean cutting of the muscle layer (M) and disorganized fibres in the 
adventitia (A). Also, on the luminal surface, a microfracture (arrows) may be seen to only involve the 
endothelium (E) and the internal elastic lamina. ×200. (Bujan et al. 2000) 
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3. Cell death in cryopreserved vascular grafts 
One of the main factors leading to failure of grafting procedures performed using 
cryopreserved vessel substitutes is, besides spontaneous fractures, the endothelial loss 
provoked by the methods of vascular cryopreservation used at most human vessel banks 
(Pascual et al. 2004). The loss of the endothelial layer could be the consequence of several 
factors: the freezing protocol used, the cryopreservation medium, the cold storage 
temperature or the thawing protocol (Pegg et al. 1997). The endothelium is the key 
regulator of vascular homeostasis. Endothelial cells continuously interact with blood 
components and with the structures of the vessel itself. Endothelial function is essential for 
maintaining vessel tone and antithrombotic properties. Hence, its adequate preservation 
plays a crucial role in the mid- and long-term viability of arterial grafts (Rigol et al. 2000). 
Besides maintaining a non-thrombogenic surface and regulating vessel tone, the main 
functions of the vascular endothelium are: controlling vascular cell growth (Jurado et al. 
2002), cytokine regulation, maintaining selective permeability, synthesizing extracellular 
matrix components, and the synthesis, secretion and metabolism of biologically active 
components. The partial absence of the endothelium means that the extracellular matrix 
makes contact with the circulating blood, which generally leads to several acute disease 
states such as thrombosis and chronic/progressive states such as hyperplasia (Bellon et al. 
1996) and atherosclerosis. Several factors are responsible for the cellular damage in 
cryopreserved vascular grafts. Toxicity of the preserving agents is one factor. Therefore a 
maximum concentration of 15 % DMSO is advised. DMSO as well as other cryoprotecting 
agents are important to prevent intracellular ice formation. Recently it has been shown that 
this ice formation is more lethal in cells in suspension than in monolayers. This was due to 
the presence of GJs in monolayers and the abililty of ice propagation between cells via GJs 
(Armitage and Juss 2003, Zhurova et al. 2010). MDCK cells expressing no GJs showed indeed 
no increased damage to intracellular freezing (Armitage and Juss 2003). In HepG2 cell pairs, 
the GJ blocker 18β glycyrrhetinic acid reduced the intercellular ice propagation rate 
compared to untreated controls (Irimia and Karlsson 2002). Thawing procedures are another 
important factor leading to impaired vessel viability. Rapidly thawed endothelial cells 
showed irreversible ultrastructural damage such as mitochondrial dilation and rupture, 
reticular fragmentation and peripheral nuclear condensation. In contrast, slow gradually 
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thawing showed a lower proportion of damaged cells. Gradual automated thawing seemed 
to be the best way of preserving the endothelial surface of the arterial cryograft (Pascual et 
al. 2004).  
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In this doctoral thesis, we investigated the role of cannabinoids and CGRP on K+ currents in 
acutely isolated small mesenteric rat artery SMCs and the role of CxHCs in [Ca2+]i dynamics 
and contraction in this blood vessel type. While GJs and CxHCs modulate vessel tone, they 
may also contribute to cell death processes in pathological conditions. We further 
determined whether inhibition of these connexin channels could protect vascular grafts 
against cryopreservation-induced cell death. 
 
Influence of methanandamide and CGRP on K+ currents in smooth muscle cells of small 
mesenteric arteries 
 
Cannabinoids have potent vasodilatory actions in a variety of vascular preparations. Their 
mechanism of action, however, is complex. Apart from acting on vascular smooth muscle or 
endothelial cannabinoid receptors, several studies point to the activation of TRPV1 receptors 
on primary afferent perivascular nerves, stimulating the release of CGRP. We explored 
possible direct actions of methanandamide and of CGRP on rat small mesenteric artery SMCs 
by comparing their effects on whole cell K+ currents in freshly isolated myocytes. We 
specifically addressed the question whether CGRP might activate BKCa currents in these cells. 
 
 
Connexin hemichannels contribute to Ca2+ dynamics and contractility of smooth muscle cells 
in small mesenteric arteries 
 
GJs are important for the communication between vascular cells and the synchronization of 
Ca2+ signals and control the vessel diameter and blood flow. Non-junctional CxHCs reside in 
the plasma membrane in a closed state. HCs can be opened by various messengers and 
conditions, including [Ca2+]i. HC opening may also influence [Ca
2+]i and recent evidence 
suggests this may play a role in Ca2+ oscillations. Previous reports pointed to an important 
role for GJs in vascular tone, however, unapposed HCs have never been investigated as a 
putative additional partner in controlling the vessel wall tone. The connexin mimetic peptide 
Gap27 inhibits Cx37 and Cx43 HCs after short incubation, and GJs with a time delay. The TAT-
L2 peptide and TAT-CT9 peptide have specificity for Cx43 and the first inhibits HC responses 
while the latter prevents closure of the HC at high micromolar [Ca2+]i. Here we determine 
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whether HCs can play a role in SMC [Ca2+]i dynamics and contraction. We used acutely 
isolated small mesenteric blood vessels to this purpose and investigated both [Ca2+]i 
dynamics and contractility of the vessels induced by exposure to norepinephrine. 
 
 
Inhibiting connexin channels protects against cryopreservation-induced cell death in human 
blood vessels 
 
Cryopreserved vascular grafts are widely used for cardiovascular interventions. However, the 
graft quality is suboptimal due to the cryopreservation protocol used in vascular banks. 
Grafts are preserved in cold storage at 4 °C as well as cryopreserved, but the procedure is 
still unsatisfactory and complication such as thrombosis and vasospasms occur and could 
lead to late graft failure. CxHCs and GJs play a role in cell – cell communication and cell death 
processes. GJs can pass messenger molecules and metabolites which can influence  
neighbouring cells. Under pathological conditions, this pathway could induce cell death of 
neighbouring cells or pass cell death messengers. HCs are normally closed but may open 
under stressful conditions and thereby promoting cell death. Uncontrolled opening of HCs 
can contribute to loss of ATP, entrance of Ca2+ and disturbing of ion gradients. All these 
items form an important factor that could lead to cell death. Blocking GJs and HCs by 
connexin mimetic peptides could prevent cell death after cryopreservation. An example of a 
connexin mimetic peptide with possible interesting effects on vascular cells is Gap27. This 
peptide has a peptide sequence identical to a short amino acid sequence on the second 
extracellular loop of Cx43 and Cx37. Short incubation of this peptide is sufficient to inhibit 
HC related responses, while long incubations are necessary to inhibit GJs. We hypothesized 
that during prelevation and preservation of blood vessels, inhibiting both GJs and HCs might 
reduce cell death in vascular grafts. We investigated the role of connexin mimetic peptides 
on cell viability in vascular grafts. 
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Influence of methanandamide and CGRP on K+ currents in smooth 
muscle cells of small mesenteric arteries 
Mélissa Bol, Luc Leybaert and Bert Vanheel 
Pflugers Arch - Eur J Physiol (2012) 463:669–677 
 
Abstract 
Cannabinoids have potent vasodilatory actions in a variety of vascular preparations. Their 
mechanism of action, however, is complex. Apart from acting on vascular smooth muscle or 
endothelial cannabinoid receptors, several studies point to the activation of type 1 vanilloid 
(TRPV1) receptors on primary afferent perivascular nerves, stimulating the release of 
calcitonin gene-related peptide (CGRP). In the present study, the direct influence of the 
cannabinoid methanandamide and the neuropeptide CGRP on the membrane potassium ion 
(K+) currents of rat mesenteric myocytes was explored. Methanandamide (10 µM) decreased 
outward K+ currents, an effect similar to that observed in smooth muscle cells from the rat 
aorta. Conversely, CGRP (10 nM) significantly increased whole cell K+ currents and this effect 
was abolished by pre-exposure to TEA (1 mM) or iberiotoxin (100 nM), inhibitors of large-
conductance calcium-dependent K (BKCa) channels but not by glibenclamide (10 µM), an 
inhibitor of ATP-dependent K (KATP) channels. In the presence of the CGRP-receptor 
antagonist CGRP8-37 (100 nM), the adenylyl cyclase inhibitor SQ22536 (100 µM), or the PKA 
inhibitor Rp-cAMPS (10 µM), CGRP had no effect. These findings show that methanandamide 
does not increase membrane K+ currents in smooth muscle cells of small mesenteric arteries, 
supporting an indirect mechanism for the reported hyperpolarizing influence in this vessel. 
Moreover, CGRP acts directly on these smooth muscle cells by increasing BKCa channel 
activity in a CGRP receptor and cyclic adenosine monophosphate (cAMP) dependent way. 
Collectively, these data indicate that methanandamide relaxes and hyperpolarizes intact 
mesenteric vessels by releasing CGRP from perivascular nerves. 
 
Keywords: cannabinoids, vasoactive agents, endothelial factors, vasorelaxation, vanilloid 
receptor, neuropeptides. 
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INTRODUCTION 
Anandamide has been identified as an endogenous counterpart of Δ9-tetrahydrocannabinol, 
the psychoactive component of marijuana. The endocannabinoid is synthesized by cleavage 
of the lipid precursor arachidonyl phosphatidylethanolamine, and is metabolized relatively 
quickly to arachidonic acid and ethanolamine. The potent vasodilatory influence of 
anandamide has been shown in a variety of isolated vascular preparations. Its mechanism of 
action, however, is complex and seems to vary with species, vessel type, and even vessel size 
(Vanheel and Van de Voorde 2000, O'Sullivan et al. 2004). In rabbit pial arterioles and 
mesenteric arteries, the anandamide induced vasodilation is mediated by the generation of 
vasodilator eicosanoids, since it is blocked by indomethacin and diclofenac (Ellis and 
Conanan 1995, Fleming et al. 1999). Similarly, in isolated bovine coronary arteries the 
vasorelaxant effect of anandamide has been suggested to be due to its hydrolysis to 
arachidonic acid and further conversion to vasodilatory eicosanoids (Pratt et al. 1998). In rat 
mesenteric arteries, however, the vasorelaxing influence of anandamide is unaffected by 
cyclooxygenase inhibition (White and Hiley 1998). Moreover, also the stable analogue of 
anandamide, methanadamide, is a powerfull vasodilator of these vessels (Ralevic et al. 
2000). 
Endogenous, plant derived and synthetic cannabinoids have been reported to target 
receptors different from the classical CB1 and CB2 receptors. In the rat mesenteric and 
coronary circulation, a novel non CB1/non CB2 receptor present on endothelial cells, has 
been shown to be involved in vasorelaxation (O'Sullivan et al. 2004). Furthermore, an action 
on other receptors and membrane proteins was described. Cannabinoids have been shown 
to activate endothelial TRPV4 receptors (Watanabe et al. 2003) and endothelial peroxisome 
proliferator-activated receptor gamma (O'Sullivan et al. 2005), and anandamide has been 
demonstrated to bind to serotonin (5-HT)-3 receptors (Fan 1995) and modulate the activity 
of the NMDA receptor (Hampson et al. 1998). Furthermore, stimulation of TRPV1 receptors 
on perivascular sensory nerves accounts for the vasorelaxing influence of anandamide 
(Zygmunt et al. 1999). Other studies showed that cannabinoids directly inhibit calcium 
channels (Gebremedhin et al. 1999, Breyne et al. 2006) and activate various K+ channels 
(Randall and Kendall 1997, White et al. 2001, Sade et al. 2006) an influence which might also 
account for its vasorelaxant action. By contrast, cannabinoids have direct inhibitory effects 
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on delayed rectifier K+ currents in freshly isolated rat aortic smooth muscle cells (Van den 
Bossche and Vanheel 2000). 
Calcitonin gene related peptide (CGRP) is a 37 amino acid peptide that is generated by 
alternative splicing of the calcitonin gene transcripts. As a neurotransmitter it is localized 
predominantly in sensory nerves, innervating various tissues and blood vessels. In rat 
hepatic and small mesenteric arteries, the vasorelaxant influence of anandamide was 
antagonized by the TRPV1 receptor antagonist capsazepine and the CGRP receptor 
antagonist CGRP(8-37) but not by the classical CB1 receptor antagonist SR141716A (Zygmunt 
et al. 1999). It was proposed, therefore, that cannabinoids exert their relaxing influence by 
stimulating the release of CGRP from perivascular nerves (Zygmunt et al. 1999). 
The mechanism involved in vasorelaxation to CGRP seems to vary among species and vessel 
types. In the rat aorta (Gray and Marshall 1992) and pulmonary arteries (Wisskirchen et al. 
1998), human omental and bovine retinal arteries (Boussery et al. 2005), CGRP interacts with 
endothelial receptors stimulating the release of endothelium derived relaxing factors, as 
both endothelium removal and blocking NO synthesis significantly reduced vasorelaxation. 
By contrast, in cat cerebral, pig coronary and rat mesenteric vessels, CGRP acts directly on 
the smooth muscle cells. A number of studies have shown that CGRP relaxes tension by 
increasing the cyclic AMP content in vascular smooth muscle (Ishikawa et al. 1993, 
Kageyama et al. 1993, Yoshimoto et al. 1998). The resultant activation of protein kinase A 
(PKA) and PKA dependent phosphorylation has been shown to open ATP-dependent K+ (KATP)
 
channels (Nelson et al. 1990, Quayle et al. 1994) hyperpolarizing and relaxing the tissue 
(Wellman et al. 1998). In line with this view, we have shown that the hyperpolarization of 
isolated rat gastric and small mesenteric arteries evoked by methanadamide was abolished 
by capsazepine (Breyne and Vanheel 2006). Exogenous CGRP produced a hyperpolarization 
of the smooth muscle cells of comparable time course and magnitude, and both 
methanandamide- and CGRP-induced membrane potential changes were sensitive to the 
KATP channel inhibitor glibenclamide. However, two studies on isolated rat and porcine 
coronary arteries have failed to demonstrate KATP
 channel opening in CGRP-induced 
vasorelaxation (Prieto et al. 1991, Kageyama et al. 1993). CGRP might also mediate 
relaxation by activation of BKCa channels, by inhibition of voltage gated calcium channels 
(Breyne et al. 2006) or by decreasing the Ca2+ sensitivity of the contractile apparatus 
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(Sheykhzade and Nyborg 2001). In rat gastric arteries, we found the vasorelaxation to CGRP 
to be partly sensitive to low concentrations of TEA, suggesting involvement of BKCa channel 
activation (Breyne et al. 2006). In a number of vascular preparations, PKA dependent 
vasodilators have been shown to activate smooth muscle BKCa channels (Schubert and 
Nelson 2001). 
In the present experiments, we explored possible direct actions of methanandamide and of 
CGRP on rat small mesenteric artery smooth muscle cells by comparing their effects on 
whole cell K+ currents in freshly isolated myocytes. We specifically addressed the question 
whether CGRP might activate BKCa currents in these cells. 
 
 
MATERIALS AND METHODS 
Cell Isolation 
Smooth muscle cells from rat small mesenteric arteries were dissociated on the day of the 
experiments. The animals were treated in accordance with the Guiding Principles for the 
Care and Use of Animals (published by National Academy Press, 2101 Constitution Ave, NW, 
Washington, DC 20055, USA, 1996) and the experiments were approved by the ethical 
committee on animal research of Ghent University. The animals were anesthetized by a 
lethal dose (200 mg kg-1) of pentobarbitone and killed by cervical dislocation. Third order 
branches of the superior mesenteric artery from 2-3-month-old female Wistar rats were 
excised and placed in a chilled solution containing (mM): NaCl, 135; KCl, 5; NaHCO3, 20; 
CaCl2, 2.5; MgSO4.7H2O, 1.3; KH2PO4, 1.2; EDTA, 0.026; glucose, 10, which was continuously 
bubbled with 95% O2 / 5% CO2. The vessels were carefully cleared of adherent fat and 
connective tissue, and cut into small pieces. The artery segments were subsequently 
transferred to cold (4 °C) low calcium dissociation medium (DM) containing (mM): NaCl, 110; 
KCl, 5; CaCl2, 0.16; MgCl2, 2; KH2PO4, 0.5; EDTA, 0.49; NaH2PO4, 0.5; Taurine, 10; HEPES, 10; 
glucose, 10, titrated to pH 7.0. The small pieces were allowed to rest in this medium for 30 
min. The tissue was then transferred to fresh DM supplemented with papain (17 U/ml) and 
bovine serum albumin (2 mg/ml) for 20 min, after which dithiothreitol was added from a 
concentrated stock solution to a final concentration of 6.7 mM and the mixture was warmed 
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to 37 °C for 20 min. The partially digested tissue was subsequently washed twice in cold DM. 
After this, collagenase (410 U/ml) and hyaluronidase (330 U/ml) were added and the mixture 
was warmed to 37 °C for 20 min. The digested tissue was washed three times in cold DM. 
After this, gentle trituration with a wide-bore Pasteur pipette yielded a suspension of single 
cells, which was kept at 4 °C in the low- Ca2+ medium. 
 
Electrophysiological recordings 
Electrophysiological recordings were performed as previously described (Van den Bossche 
and Vanheel 2000). Briefly, part of the cell suspension was pipetted into a perfusion 
chamber fixed to the stage of an inverted microscope (Nikon, Diaphot). After 10 min, 
allowing the cells to adhere to the glass bottom of the chamber, the cells were superfused 
with a normal calcium containing solution containing (mM): NaCl, 140; KCl, 5.4; CaCl2, 1.8; 
MgCl, 1; HEPES, 10; glucose, 10, pH = 7.4.  
Whole-cell membrane currents were recorded at room temperature using the conventional 
patch-clamp technique. Borosilicate glass capillaries were used. Pipettes were attached to 
the headstage of an EPC-9 patch clamp amplifier (HEKA, Lambrecht/Pfalz, Germany). Pipette 
resistance ranged 3-5 MΩ after fire-polishing. The composition of the pipette solution for 
conventional whole-cell recording was (in mM): KCl, 102; K+ (from KOH), 38; EGTA, 10; NaCl, 
10; CaCl2, 1; HEPES, 10; Na2GTP, 0.2; NaADP, 0.1; Na2ATP, 3; MgCl2, 3 (pH 7.2, free Ca
2+ = 
17.1 nM). Pipettes were coated with beeswax. After breaking in, the cell membrane 
capacitance was measured from the capacitive transient using the automatic compensation 
procedures of the EPC-9 amplifier. Series resistance was compensated by 2-30%. Membrane 
currents were evoked by stepping the membrane potential from a holding potential of -70 
mV for 200 ms to various test potentials between -110 and +60 mV, in 10 mV increments at 
3 sec intervals. Currents were filtered at 2.3 kHz and followed on computer monitor. 
Membrane currents were sampled at 5 kHz, recorded on hard disk and analysed using the 
Review program of the EPC-9 system. Current values given in the results represent the 
steady state current, measured as the average current during the terminal 50 ms portion of 
the voltage step. 
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In some experiments, measurements of the myocyte membrane potential were performed 
with the whole cell patch configuration in current clamp mode. 
 
Drugs 
Papain, BSA, dithiothreitol, collagenase (type VIII), hyaluronidase (type I-S), glibenclamide, 
iberiotoxin, tetraethyl ammonium chloride (TEA), 4-aminopyridine (4-AP), SQ22536, and 
adenosine 5’-triphosphate disodium salt (ATP) were obtained from Sigma Aldrich (St. Louis, 
MO). Calcitonin gene-related peptide (CGRP rat), CGRP8-37, Rp-cAMPS and R-(+)-
methanandamide were obtained from Tocris (Bristol, UK).  
The influence of a drug was investigated by adding the appropriate amount from a stock 
solution to a reservoir containing equilibrated superfusion solution a few seconds before 
use. Pre-exposure times to the various blockers were at least 10 minutes. During 
superfusion, membrane potential was stepped to 60 mV at 20 seconds interval, in order to 
observe the influence on the corresponding current and to verify that a steady state effect 
was reached before recordings of the current family were started. The influences of 
methanandamide and CGRP reached steady state 4 to 7 minutes after adding these 
substances to the superfusate.  
Stock solutions of methanandamide were made in anhydrous ethanol, while glibenclamide 
was dissolved in dimethyl sulfoxide. The final concentration of solvent never exceeded 0.1%. 
CGRP, iberiotoxin, TEA-Cl, 4-AP and Rp-cAMPS were dissolved in water. All concentrations 
are expressed as final molar concentrations in the superfusate. 
 
Statistics 
Results are presented as normalized (i.e. pA/pF) means + s.e.mean. Statistically significant 
differences are evaluated using Student’s t-test for paired or unpaired observations, as 
appropriate. A P value < 0.05 indicates a significant difference. n represents the number of 
cells. 
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RESULTS 
Freshly isolated smooth muscle cells from small mesenteric arteries were superfused at least 
10 minutes with the control solution before measurements were started.  
 
1. INFLUENCE OF METHANANDAMIDE AND CGRP ON MEMBRANE CURRENTS 
Cells were clamped at a holding potential of -70 mV. Depolarizing voltage steps of increasing 
amplitude resulted in the activation of a family of outward currents which displayed graded 
voltage-dependent activation kinetics and showed little inactivation during the 200 ms test 
pulse (Figure. 1 A).  
 
Influence of methanandamide 
The addition of methanandamide (10 µM) to the bath fluid decreased outward K+ currents of 
the smooth muscle cells (Figure 1A). The current block by methanandamide reached a 
steady state approximately 5 minutes after its addition to the superfusate. As we have 
described for smooth muscle cells from rat aorta (Van den Bossche and Vanheel 2000), the 
inhibitory influence of the cannabinoid was most pronounced on current inactivation during 
the 200 ms depolarizing step (Figure 1A). In four experiments, the mean current amplitude 
measured at the end of the voltage step to +60 mV decreased from 19.3 +2.6 pA/pF in 
control conditions to 10.5 +0.5 pA/pF in the presence of methanandamide. The I-V plot 
(Figure 1B) revealed a statistically significant inhibition (P<0.05) in the potential range of -20 
to +60 mV. The methanandamide sensitive (difference) current reversed at -72 mV (Figure 
1B inset), indicative for inhibition of a K+ current.  
In the continuous presence of iberiotoxin (100 nM), a selective BKCa channel inhibitor, 
inhibition of K+ currents by methanandamide was still present (Figure 2A). Moreover, after 
pre-exposure to both 1 mM TEA, at this concentration acting as an inhibitor of BKCa channels 
(Langton et al. 1991), combined with the KATP channel inhibitor glibenclamide (10 µM), 
methanandamide still significantly decreased K+ currents (Figure 2B). Conversely, after pre-
exposure to 4-AP (5 mM), the influence of methanandamide was totally abolished (Figure 
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2C). These experiments, therefore, point to an inhibition of delayed rectifier K+ (Kv) currents 
by methanandamide. In rat aortic smooth muscle cells, indeed, anandamide and 
methanandamide have been shown to directly affect Kv channels (Van den Bossche and 
Vanheel 2000). 
 
                              
Figure 1. Influence of methanandamide on IK. A. Representative current traces from a small mesenteric artery 
myocyte in control conditions (Co) and in the presence of methanandamide (Me, 10 μM). B. Mean normalized 
current (I)- voltage (V) plot showing the influence of methanandamide on the steady state current. Each point 
represents the mean + s.e.mean from four cells. * denotes statistically significant from control value at p < 
0.05. Inset shows the difference current (Co-Me) on an extended current axis. 
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Figure 2. Influence of methanandamide (Me, 10 μM) 
after blocking BKCa, KATP and Kv. A. Mean normalized 
current (I)-V plot showing the influence of the 
cannabinoid after pre-exposing the myocytes to 
iberiotoxin (Ibx, 100 nM). B. Mean normalized IV-plot 
showing the influence of methanandamide in the 
combined presence of TEA (1 mM) and glibenclamide 
(10 μM). Mean normalized IV-plot showing the 
influence of methanandamide after pre-exposure to 
4-AP (5 mM). Each point represents the mean + 
s.e.mean from 7 (A) or 5 (B, C) cells. * and ** denote 
statistically significant from control value at p < 0.05 
or p < 0.01, respectively. 
 
   
 
Influence of CGRP 
Application of the neuropeptide CGRP (10 nM) significantly increased whole cell currents in 
mesenteric artery smooth muscle cells. Typical traces, obtained after reaching a steady state 
(which lasted approximately 6 minutes after adding CGRP to the superfusate) are shown in 
Figure 3A. In eight cells, the mean current amplitude measured at the end of the voltage 
step to +60 mV was increased to 220% of control levels (Figure 3B). The I-V plot showed a 
statistically significant increase (P<0.05) in the potential range from +40 to +60 mV. The 
CGRP-induced (difference) current appeared on depolarization beyond +10 mV and showed 
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pronounced outward rectification. These features suggest the involvement of a voltage 
dependent potassium channel such as BKCa (Nelson et al. 1990). 
 
 
Figure 3. Influence of CGRP on IK. A. Representative current traces from a myocyte in control conditions (Co) 
and in the presence of CGRP (10 nM) B. Mean normalized current (I)-V plot showing the influence of CGRP (10 
nM). Each point represents the mean + s.e.mean from eight cells. * and ** denote statistically significant from 
control value at p < 0.05 and p < 0.02, respectively. 
 
 
In a next series of experiments, cells were pre-exposed to either 1 mM TEA or to the more 
selective BKCa channel blocker iberiotoxin (100 nM). Both substances significantly decreased 
BKCa current, as also reflected by the smoother (less noisy) appearance of the current traces 
in the presence of the inhibitors (Figure 4A and 4C ). In the presence of TEA, the mean IK at 
+60 mV decreased from 22.6 + 4.6 to 9.3 + 2.0 pA/pF. Application of iberiotoxin decreased 
the IK at +60 mV from 31.7 + 7.3 to 23.4 + 8.0 pA/pF. In the continuous presence of either 
TEA or iberiotoxin, the additional application of CGRP had no effect (Figure 4). 
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Figure 4. Influence of CGRP after 
inhibition of BKCa channels A. 
Representative current traces from a 
myocyte in control conditions (Co), in 
the presence of TEA (1 mM) and after 
extra addition of CGRP (10 nM). B. Mean 
normalized current (I)-V plot showing 
the effect of TEA and of additional 
exposure to CGRP. Each point represents 
the mean + s.e.mean from three cells. C. 
Representative current traces from a 
myocyte in control conditions (Co), in 
the presence of iberiotoxin (Ibx, 100 nM) 
and after extra addition of CGRP (10 
nM). D. Mean normalized current (I)-V 
plot showing the effect of iberiotoxin 
and of additional exposure to CGRP. 
Each point represents the mean + 
s.e.mean from five cells. * and ** denote 
statistically significant from control value 
at p < 0.05 and p < 0.02, respectively. 
 
In six cells, the influence of addition of CGRP was investigated in the presence of the 
inhibitor of KATP channels, glibenclamide (10 µM). Pre-exposure to glibenclamide did not 
influence control currents. In the presence of glibenclamide, CGRP increased the mean 
current at +60 mV from 15.8 + 3.2 to 25.3 + 6.4 pA/pF (Figure 5A), i.e. to 160 % of control.  
 
 
Figure 5. Influence of inhibition of KATP channels and the 
CGRP receptor. A. Mean normalized current (I)-V plot 
showing the effect of CGRP in the presence of glibenclamide 
(Glib, 10 :M). B. Mean normalized current (I)-V plot showing 
the lack of effect of CGRP in the presence of CGRP8-37. (100 
:M). Each point represents the mean + s.e.mean from four 
(A) or five (B) cells. * denotes statistically significant from 
control value at p < 0.05. 
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CGRP acts by stimulating the CGRP receptor and the adenylyl cyclase pathway  
In order to verify whether the effect of the neuropeptide is receptor-mediated, the CGRP 
receptor antagonist CGRP8-37 was applied. The mean I-V relationships obtained in five cells 
are shown in Figure 5B. Pre-exposure to 100 nM CGRP8-37 completely prevented the current 
potentiation by CGRP.  
In five cells, the influence of CGRP was tested after pre-exposure to 100 µM SQ22536, an 
adenylyl cyclase inhibitor. The compound significantly decreased outward K+ currents in the 
+40 to +60 mV range (Figure 6A). The mean IK at +60 mV decreased from 31.5 + 4.6 to 21.0 + 
2.9 pA/pF. A direct influence of SQ22536 on BKCa channels was excluded since pre-exposure 
to iberiotoxin did not block the effect of SQ22536 (Figure 6B). In the continuous presence of 
SQ22536, CGRP had no effect (Figure 6A). Currents in the combined presence of SQ22536 
and CGRP were not significantly different from currents in the presence of SQ22536 alone.  
In five cells, the influence of the protein kinase A (PKA) inhibitor Rp-cAMPS (10 µM) was 
tested. The compound significantly decreased control currents (Figure 6C). A direct influence 
of Rp-cAMPS on BKCa channels was excluded since pre-exposure to iberiotoxin did not block 
the influence of Rp-cAMPS (Figure 6D). Furthermore, after pre-exposure to Rp-cAMPS, CGRP 
failed to increase K+ currents (Figure 6C). Currents in the combined presence of Rp-cAMPS 
and CGRP were not significantly different from currents in the presence of Rp-cAMPS alone. 
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Figure 6. Influence of inhibition of adenylyl cyclase or PKA. A. Mean normalized current (I)-V plot showing the 
influence of CGRP (10 nM) after pre-exposure to SQ22536 (100 μM). B. Mean normalized I-V plot showing the 
influence of SQ22536 (100 μM) after inhibition of BKCa channels with iberiotoxin (Ibx, 100 nM). C. Mean 
normalized I-V plot showing the influence of CGRP (10 nM) after pre-exposure to Rp-cAMPS (10 μM). D. Mean 
normalized I-V plot showing the influence of Rp-cAMPS (10 μM) after inhibition of BKCa channels with 
iberiotoxin (Ibx, 100 nM). In A, B, C, and D, each point represents the mean + s.e.mean from 5 cells. * and ** 
denote current value statistically significant from the control value (A,C) or current in the presence of Ibx (B,D) 
at p < 0.05 or p < 0.01, respectively. 
 
 
2. INFLUENCE OF METHANANDAMIDE AND CGRP ON MEMBRANE POTENTIAL 
Some isolated resting myocytes were current clamped at 0 pA to measure membrane 
potential. Typical traces are shown in Figure 7. In three cells, the application of 
methanandamide (10 µM) failed to alter the membrane potential (-35.5 + 4.8 mV five min 
after addition of the cannabinoid, vs -35.2 + 4.3 mV in control conditions). Conversely, the 
addition of CGRP (10 nM) slowly hyperpolarized the membrane potential from -30.4 + 2.3 
mV to -37.2 + 3.2 mV as measured five min after application of the neuropeptide (cf. Figure 
7) . 
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Figure 7. Influence of methanandamide (Me, 10 μM) 
and CGRP (10 nM) on the membrane potential of 
isolated myocytes, as measured in current clamp 
mode. 
 
 
DISCUSSION 
The present findings show that the cannabinoid methanandamide fails to increase 
membrane K+ currents and fails to hyperpolarize the membrane potential of isolated smooth 
muscle cells of small mesenteric arteries. Moreover, they reveal that the neuropeptide CGRP 
is acting specifically and directly on these cells by increasing the BKCa channel activity in a 
receptor-, cAMP- and PKA-dependent way (Figure 8). This is consistent with earlier studies 
suggesting that methanandamide relaxes and hyperpolarizes intact rat mesenteric vessels by 
releasing the neuropeptide from perivascular nerves.  
In the present study, the stable cannabinoid derivative methanandamide was found to 
decrease K+ current in isolated smooth muscle cells from small mesenteric arteries. A similar 
influence has been described for smooth muscle cells isolated from the aorta of the rat (Van 
den Bossche and Vanheel 2000). In the cited study, detailed investigations using the blockers 
TEA and 4-aminopyridine have shown a direct influence of cannabinoids on the delayed 
rectifier K+ channels, independent from their possible interaction with cannabinoid 
receptors. In the present study, neither iberiotoxin nor the combined presence of TEA (1 
mM) and glibenclamide were able to affect the influence of methanandamide, while it was 
completely abrogated after pre-exposure to 4-AP. We propose, therefore, a similar inhibition 
of the delayed rectifier in mesenteric artery myocytes, although this was not further 
investigated. 
It has been shown that the mechanism of vasorelaxation to cannabinoids differs between 
conduit and resistance mesenteric arteries (O'Sullivan et al. 2004). Moreover, in a previous 
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study, we have shown that anandamide and methanandamide did not notably alter 
membrane potential of the smooth muscle of the main mesenteric artery, while the 
cannabinoids caused a substantial and endothelium-independent hyperpolarization in small 
mesenteric arteries (Vanheel and Van de Voorde 2001). The present findings, in which a 
similar inhibition of K+ current was found in smooth muscle cells from resistance arteries as 
was described for aortic smooth muscle cells, strongly argue against a direct hyperpolarizing 
influence of methanandamide on the smooth muscle cells from small mesenteric arteries. In 
the previous microelectrode study, the anandamide-induced hyperpolarization was 
insensitive to the classical CB1 receptor antagonist SR141716A, but fully blocked by 
capsazepine (Vanheel and Van de Voorde 2001), suggesting that the substance acts 
indirectly by stimulation of TRPV1 receptors on perivascular sensory nerves with the 
subsequent release of the vasodilator neurotransmitter CGRP (Zygmunt et al. 1999, Ralevic 
et al. 2000, Vanheel and Van de Voorde 2001). The present membrane potential 
measurements in isolated myocytes fully confirm such an indirect action.  
The application of exogenous CGRP substantially increased mesenteric smooth muscle cell IK. 
Moreover, the membrane potential of isolated myocytes substantially hyperpolarized after 
exposure to CGRP. These findings unequivocally show that the neuropeptide is acting 
directly on the smooth muscle cells and that at least part of the hyperpolarization we 
previously found in intact small mesenteric arteries (Breyne and Vanheel 2006) is 
endothelium-independent. This observation is also in line with literature data showing that 
CGRP-induced vasorelaxation of rat mesenteric arteries is endothelium-independent 
(Takenaga et al. 1995, Gao et al. 1996).  
A number of studies have shown that CGRP increases cAMP content in vascular smooth 
muscle (Kageyama et al. 1993, Yoshimoto et al. 1998). cAMP-dependent protein kinase may 
activate KATP channels, as in pig coronary arteries (Wellman et al. 1998) and rabbit 
mesenteric artery (Quayle et al. 1994), or BKCa channels, as in pig coronary arteries (Minami 
et al. 1993) and rat aorta (Sadoshima et al. 1988) and tail arteries (Schubert et al. 1996, 
Schubert and Nelson 2001). In some vessels, the CGRP-induced vasodilation was mediated 
by activation of both BKCa and KATP channels (Hong et al. 1996, Herzog et al. 2002). In 
preconstricted rat coronary arteries, charybdotoxin inhibited the CGRP-induced 
vasorelaxation, while in the resting arteries only the pretreatment with a combination of 
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glibenclamide and charybdotoxin attenuated the CGRP-induced decrease in [Ca2+]i and 
tension (Sheykhzade and Nyborg 2001). In the present experiments, we found low 
concentrations of TEA and the presence of the more selective inhibitor of BKCa channels, 
iberiotoxin, to fully block the influence of CGRP. It was also inhibited by the CGRP receptor 
antagonist CGRP8-37, as well as by the adenylyl cyclase inhibitor SQ22536 and the PKA 
inhibitor Rp-cAMPS. Moreover, the KATP channel inhibitor glibenclamide had no effect. This 
shows that in the present conditions CGRP induces BKCa channel activation of rat mesenteric 
artery smooth muscle cells in a receptor-, cAMP- and PKA-dependent way. 
 
               
 
Figure 8. Findings of the present study as related to possible mechanisms for cannabinoid induced 
vasorelaxation. Cannabinoids may activate classical CB1 or CB2 receptors of the vascular smooth muscle cells. 
Various cannabinoids have also been shown to activate non CB1/non CB2 (CBx) receptors and TRPV4 receptors 
of the endothelial cells, causing the release of the endothelial relaxing factors NO and PGI2 and activating the 
EDHF pathway. In addition, activation of TRPV1 receptors on perivascular nerves has been shown, stimulating 
the release of vasodilator neuropeptides such as CGRP. In the present study, it is concluded that the 
cannabinoid methanandamide decreases delayed rectifier (Kv) currents of small mesenteric artery smooth 
myocytes and that CGRP causes BKCa activation in a receptor-, cAMP- and PKA-dependent way. 
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CONCLUSION 
In summary, we have shown that exogenous CGRP potently activates BKCa currents in small 
mesenteric artery smooth muscle cells, and substantially hyperpolarizes the membrane 
potential of these cells. The influence on BKCa current is receptor-dependent and mediated 
by adenylyl cyclase and PKA. Moreover, methanandamide failes to hyperpolarize the 
membrane potential of these myocytes and decreases K+ currents in a way similar as has 
been described for smooth muscle cells of the aorta. The latter finding is fully consistent 
with studies reporting that the cannabinoid hyperpolarizes and relaxes intact mesenteric 
arteries indirectly, by releasing CGRP from perivascular sensory nerves.  
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Abstract 
Rationale: Gap junctions are important for coordinating vascular cell function and controlling 
vessel diameter and blood flow. Gap junctions are formed by the interaction of two 
connexin hemichannels from each of the connecting cells. Hemichannels may also reside as 
non-junctional closed hemichannels in the plasma membrane that can be opened by various 
stimuli leading to the entry/loss of ions and the escape of ATP. Interestingly, hemichannels 
form a Ca2+ entry pathway that is also controlled by the cytoplasmic Ca2+ concentration 
([Ca2+]i).  
Objective: We hypothesized that Ca2+-controlled Ca2+ entry and ATP release via 
hemichannels might contribute to smooth muscle cell (SMC) Ca2+ dynamics, thereby possibly 
influencing blood vessel contractility. We used various tools inhibiting or promoting 
connexin hemichannel opening to investigate their influence on SMC Ca2+ dynamics and 
blood vessel contractility. 
Methods and Results: Small mesenteric arteries from rat showed Cx37 and Cx43 expression 
in SMCs, without evidence for Panx1. Exposure of mesenteric arteries to norepinephrine 
induced Ca2+ oscillations in SMCs and vessel contraction that were inhibited by the connexin 
channel blockers carbenoxolone and connexin mimetic peptide Gap27, and suramin and 
PPADS as purinergic receptor antagonists. Ca2+ oscillations were also inhibited by TAT-L2 
peptide that blocks Ca2+-promoted opening of Cx43 hemichannels and by TAT-CT9 peptide 
that prevents closure of Cx43 hemichannels at micromolar [Ca2+]i. Most notably, TAT-L2 
strongly inhibited norepinephrine-induced contraction.  
Conclusions: These results indicate that Cx43 hemichannels play a role in SMC Ca2+ 
oscillations and contractility, and bring up a novel handle to exert control over vascular tone. 
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INTRODUCTION 
 
Vascular function is largely determined by the concentration of intracellular cytoplasmic Ca2+ 
([Ca2+]i) in the endothelial and smooth muscle cells (SMCs) of the blood vessel wall. The 
steady, baseline level of [Ca2+]i determines the contraction state of SMCs and superimposed 
on this are changes in [Ca2+]i that are organized in time (Ca
2+ oscillations) and space (Ca2+ 
waves) and play an essential role in determining vascular tone (Ruehlmann et al. 2000, 
Savineau and Marthan 2000).  
Gap junction channels composed of connexin proteins form a direct communication 
pathway between vascular cells that are crucial in coordinating [Ca2+]i signals and vessel 
function, setting the balance between vasodilation and vasoconstriction. For example, cyclic 
variations of the vascular diameter, called vasomotion, are induced by synchronous Ca2+ 
oscillations of SMCs in which gap junctions are involved (Koenigsberger et al. 2005). Before 
being incorporated into gap junctions, unapposed/non-junctional connexin hemichannels 
reside in the plasma membrane in a closed state. Recent evidence suggests that non-
junctional hemichannels can be opened by various messengers and conditions, thereby 
providing a conduit that allows the passage of ions and messengers like ATP or other 
substances with MW up to 1.5 kDa (Kang et al. 2008). Connexin hemichannels are Ca2+-
permeable channels that can mediate Ca2+ entry (Saez et al. 2010, Sanchez et al. 2010, 
Schalper et al. 2010, Fiori et al. 2012). Moreover, their opening is also influenced by [Ca2+]i in 
a biphasic manner (de Vuyst et al. 2006, De Vuyst et al. 2009, Ponsaerts et al. 2010, De Bock 
et al. 2012, Wang et al. 2012): once open, Ca2+ entry further elevates [Ca2+]i, favouring more 
hemichannel opening in a positive feedback loop. Once [Ca2+]i attains levels above ~500 nM, 
Ca2+ inhibits hemichannel opening, providing negative feedback with subsequent 
hemichannel closure and stop of this Ca2+ entry pathway. The biphasic Ca2+-dependence of 
hemichannels greatly resembles the Ca2+-dependence of inositol-trisphosphate receptor 
(IP3R) channels that are Ca
2+ release channels in the ER/SR that are central in generating Ca2+ 
oscillations in diverse cell types including SMCs (Morel et al. 2003, Dupont et al. 2007, Bai et 
al. 2009). Based on this similarity, we hypothesized that connexin hemichannels may 
contribute to Ca2+ oscillations.  
Vascular cells express several connexins, including Cx37, Cx40 and Cx43 in endothelial cells, 
and Cx43 and Cx37 in SMCs (Haefliger et al. 2004). Pannexins are related to the connexin 
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protein family: they have a similar topology but little sequence homology with connexins 
and form plasma membrane channels that, like connexin hemichannels, are Ca2+-permeable 
and may function as ATP release channels (D'Hondt et al. 2011). Recent work has 
demonstrated that Panx1, which is expressed in SMCs of resistance arteries in several 
vascular beds (Lohman et al. 2012), plays a role in the vasoconstriction induced by α1-
adrenergic stimulation of thoracodorsal arteries at least in mice (Billaud et al. 2011, Billaud 
et al. 2012).  
The purpose of the present work was to determine whether connexin hemichannels are 
involved in SMC Ca2+ oscillations and control of vascular tone. We investigated [Ca2+]i 
dynamics and vessel contractility in acutely isolated small mesenteric blood vessels of rats 
exposed to the vasoconstriction-inducing agent norepinephrine. Besides classical modulators 
such as carbenoxolone and Gap27, we applied several synthetic peptides to specifically 
interfere with Cx43 hemichannel function, either inhibiting or promoting their function. The 
synthetic L2 peptide consists of amino acid sequence 119 to 144 of the cytoplasmic loop of 
Cx43. This peptide prevents intramolecular interactions between the C-terminal tail (CT) and 
the cytoplasmic loop (CL) of Cx43, thereby inhibiting hemichannel ATP release (Ponsaerts et 
al. 2010, D'Hondt et al. 2013) while slightly favoring the open state of gap junctions (Seki et 
al. 2004). Another peptide, CT9, that corresponds to the last 9 amino acids of the Cx43 C-
terminal was used in this study. A similar 10 amino acid long peptide was found to stimulate 
hemichannel opening/ATP release by preventing hemichannel closure at high (1 µM) [Ca2+]i 
(Ponsaerts et al. 2010).  
 
 
METHODS 
Small mesenteric artery preparation 
Small mesenteric arteries from female Wistar rats (180-280 g) were used. The experiments 
were approved by the ethical committee on animal research of Ghent University and 
conform the directive 2010/63/EU of the European Parliament. The animals were 
anaesthetised by a lethal dose (200 mg/kg) of pentobarbitone and killed by cervical 
dislocation.  
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Polymerase chain reaction 
In these experiments, the endothelium was removed by bubbling the lumen of the vessels 
for 2 min with a 95% O2 – 5% CO2 gas mixture. Total RNA from small mesenteric artery 
smooth muscle was isolated using RNeasy Plus mini kit (Qiagen). Reverse transcription was 
performed by iScriptcDNA synthesis kit (BioRad) and cDNA was amplified using Taq DNA 
polymerase kit (Invitrogen). Primer sequences were: Cx37 forward 5’-
AGCTCTGCATCCAAGAAGCAGTA-3’ and reverse 5’-AGTTGTCTCTCAAGTGCCTTTGA-3’; Cx43 
forward 5’-GAGATGCACCTGAAGCAGATTGAA-3’ and reverse 5’-
GATGTTCAAAGCGAGAGACACCAA-3’; Panx1 forward 5’-TTCTTCCCCTACATCCTGCT-3’ and 
reverse 5’-GGTCCATCTCTCAGGTCCAA-3’; GAPDH (internal control) forward 5’-
ACCACAGTCCATGCCATCA-3’ and reverse 5’-TCCACCACCCTGTTGCTGTA-3’. The PCR protocol 
contained 35 cycles of 94 °C (45 sec), 50 °C (1 min) and 72 °C (1 min), preceded by 4 min 
94 °C and followed by 5 min 72 °C. As a negative control, a sample lacking reverse 
transcriptase (RT-) was used. The PCR end products were separated on a 2 % agarose gel and 
visualized with ethidium bromide (Invitrogen).  
 
Immunocytochemistry 
SMCs from small mesenteric arteries were dissociated as previously described (Van den 
Bossche and Vanheel 2000) and immunocytochemistry was performed with antibodies for 
Cx43 and Cx37.  
SMC isolation: artery segments were transferred to cold (4 °C) low calcium dissociation 
medium and were allowed to rest in this medium for 30 min. The small pieces were 
incubated with papain (17 U/ml), bovine serum albumin (1.98 mg/ml) and dithiothreitol (6.7 
mM) for 20 min and afterwards for another 10 min with hyaluronidase (330 U/ml) and 
collagenase (410 U/ml). Cells were triturated and were fixed with 4 % paraformaldehyde in 
phosphate buffered saline (PBSD) (10 min, room temperature) and subsequently 
permeabilized with 0.2 % Triton X-100 in PBSD (10 min, room temperature). Preincubation 
with 0.1 M glycine in PBSD for 1 h was done to prevent autofluorescence. Cells were 
incubated for 1 h with primary antibody (rabbit polyclonal anti-rat Cx43 (1/10000, Sigma, 
Belgium) or Cx37 (1/250, Zymed, Life Techologies, Belgium)) diluted in blocking solution 
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(0.4 % gelatine in PBSD), washed three times with PBSD and incubated for 1 h with the 
secondary antibody coupled to an Alexafluorophore 488 (goat anti-rabbit IgG antibody; 
Molecular Probes, 1/500). Cell nuclei were stained with DAPI (1µg/ml) and the preparations 
were then mounted in Vectashield (Vector Laboratories) to prevent photobleaching. Images 
were acquired on a Nikon TE300 inverted microscope with a x100 oil immersion objective 
(Fluor, NA 1.3, Nikon Benelux, Belgium). 
 
Immunohistochemistry 
Paraffin slices of small mesenteric arteries were deparaffined and an antigen retrieval 
solution was used (Lab Consult, Belgium). Preincubation with a blocking buffer (BSA, 50 mg; 
bovine skin gelatin, 500 µl; Triton X-100, 25 µl; PBS, 9 ml) for 30 min at room temperature 
was done. Preparations were incubated overnight at 4 °C with primary antibody anti-Cx43 
polyclonal AB (1/250, Sigma, Belgium) or anti-Cx37 (1/100, Zymed, Life Techologies, 
Belgium) or anti-Panx1 polyclonal (1/1000, Santa Cruz Biotechnology, Germany) diluted in 
blocking solution. After washing, secondary antibody conjugated to alexa-594 (1/500, 
Molecular Probes, Life Technologies, Belgium) was added. The preparations were mounted 
with Vectashield + DAPI (Vector Labs, Lab Consult, Belgium). Images were acquired on a 
Nikon TE300 inverted microscope with a x20 objective (Plan Apo, NA 0.75, Nikon Benelux, 
Belgium). 
 
Fluorescence recovery after photobleaching (FRAP) 
SMC isolation was as described for immunocytochemistry (see above) and was followed by 
gentle trituration with a wide-bore Pasteur pipette to obtain small cell groups, including cell 
pairs or cell triplets. Cells were then loaded with 5-CFDA-AM (10 µM) in HBSS-HEPES for 1 h 
at room temperature, followed by 30 min de-esterification. Cells were transferred to a 
custom developed real-time laser scanning microscope (Leybaert et al. 2005) built on a 
Nikon Eclipse TE300 (Analis, Ghent, Belgium) with a x40 oil immersion objective (CFI Plan 
Fluo, Nikon – 1.4 NA) and a 488 nm laser excitation source (Cyan CW Laser, 488 nm - 100 
mW, Newport Spectra-Physics, Utrecht, The Netherlands). After 1 min of recording, the cell 
in the middle of the field was photobleached by spot exposure (1 s) to increased power of 
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the 488 nm laser and fluorescence recovery, caused by dye inﬂux from neighbouring non-
bleached cells, was recorded over a 5 min period. The fluorescence recovery trace was then 
analyzed for the recovery of the signal expressed relative to the starting level before 
photobleaching. 
 
Ca2+ imaging 
Vessel segments were cannulated with a thin glass capillary (borosilicate glass, Hilgenberg, 
Malsfeld, Germany) with flame polished tip that was inserted into the lumen over the entire 
segment length. The diameter of the glass capillary was slightly (~15 %) larger than the 
vessel lumen diameter and cannulation was done to stabilize the preparation against 
possible smooth muscle contractions after challenging with norepinephrine. Visual 
inspection on the confocal microscope showed that by cannulating the vessel, most of the 
endothelium was removed since endothelial cells, visualised by the fluorescent Ca2+ 
indicator dye (see below) did not appear in most preparations.  
[Ca2+]i imaging was done with the fluorescent Ca
2+ probe fluo-3 in combination with laser 
scanning confocal microscopy (Leybaert et al. 2005) built on a Nikon Eclipse TE300 (Analis, 
Ghent, Belgium) with a x40 oil immersion objective (CFI Plan Fluo, Nikon – 1.4 NA) and a 488 
nm laser excitation source (Cyan CW Laser, 488 nm - 100 mW, Newport Spectra-Physics, 
Utrecht, The Netherlands). Excitation was done with 488 nm light (Cyan CW Laser, 488 nm - 
100 mW, Newport Spectra-Physics, Utrecht, The Netherlands); the dichroic mirror was a 
dual-wavelength type (490-550DBDR) and the emission light was bandpass filtered at 522 
nm (25 nm bandwidth – all filters from Omega Optical, Brattleboro, VT, USA – details can be 
found in Leybaert et al. (Leybaert et al. 2005)). Images of an optical section of the arterial 
wall (~123 µm x 93 µm and containing about 30-40 SMCs) were obtained at 2 frames per 
second and transferred directly to a PC equipped with an image acquisition and processing 
board (DT3155, Data translation, Marlboro, MA, USA). Off-line image analysis was done with 
custom-developed software (Fluoframes) written in Microsoft Visual C. 
These experiments were done at room temperature. Cannulated arterial segments were 
loaded with 20 µM fluo-3-AM by incubation for 2 h at room temperature in HBSS-HEPES 
containing 0.05 % pluronic. The arteries were then washed in HBSS-HEPES, placed on a glass 
coverslip and immobilized by covering with a fine nylon mesh attached to a ring. The 
Chapter VI: CxHCs contribute to Ca
2+
 dynamics and contractility of SMCs in small mesenteric arteries 
 
109 
 
coverslip with the cannulated vessel was transferred to the stage of the laser scanning 
inverted microscope and was continuously superfused with HBSS-HEPES at a rate of 1 
ml/min. Point measurements in individual cells showed repetitive Ca2+ spikes and these 
spikes were quantified for frequency and amplitude. Only [Ca2+]i peaks that were at least 
two standard deviations above the baseline noise were considered in the calculation of the 
spiking frequency and amplitude.  
 
Tension measurements 
Arterial segments (average diameter 311 ± 13 µm, n=86) were mounted into an organ bath 
of a small-vessel myograph, filled with 10 ml KRB solution for isometric tension 
measurements as described before (Van de Voorde and Vanheel 1997). In brief, two 
stainless steel wires (40 µm in diameter) were guided through the lumen of the segments. 
Each wire was fixed to a holder of the myograph: one holder was connected to a micrometer 
which was used to change the distance between the wires, the other holder was connected 
to a force-displacement transducer to measure the isometric tension changes. After 
mounting, the preparations were allowed to equilibrate for at least 30 min. The pretension 
settings were adjusted according to an optimal vessel lumen diameter that was calculated 
based on the relationship between passive wall tension and internal circumference (Mulvany 
and Halpern 1976). A first set of experiments was done at room temperature and with the 
endothelium removed by gas bubbling (as described under Polymerase chain reaction). In a 
subsequent set of experiments the endothelium was intact and the organ bath was heated 
to 37 °C. The presence of a functional endothelium was assessed by the ability of 10 µM 
acetylcholine to provoke more than 80 % relaxation of norepinephrine-induced tone. Control 
experiments showed that application of vehicle solutions had no effect on the 
norepinephrine-induced contractions. 
 
Pharmacological agents 
Norepinephrine bitartrate, carbenoxolone, suramin, pyridoxal-phosphate-6-azo(benzene-
2,4-disulfonic-acid)tetra-sodium-salt (PPADS) and apyrase were purchased from Sigma-
Aldrich (Bornem, Belgium). Fluo-3 acetoxymethyl ester (fluo-3-AM), 5-carboxyfluorescein-
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diacetate-acetoxy-methylester (5-CFDA-AM) and pluronic acid F-127 were obtained from 
Molecular Probes (Invitrogen, Merelbeke, Belgium). Xestospongin C was purchased from 
Tocris (Bristol, UK). 
Gap27 (SRPTEKTIFII) and scrambled Gap27 (TFEPIRISITK) were synthesized by Thermo Fisher 
Scientific (Ulm, Germany) at >80% purity. TAT-L2 
(YGRKKRRQRRRDGANVDMHLKQIEIKKFKYGIEEHGK), TAT-L2 mutant (TAT-L2H126K/I130N 
,YGRKKRRQRRRDGANVDMKLKQNEIKKFKYGIEEHGK), TAT-CT9 (YGRKKRRQRRRSRPRPDDLEI) 
and TAT-Cx43rev (YGRKKRRQRRRSIELDDPRPR) at >90% purity were synthesized by China 
Peptides (Shanghai, China). 10panx1 (WRQAAFVDSY) was obtained from Lifetein (Edison, 
New Jersey, USA) and purity was > 90%. 
 
Solutions and drugs 
The KRB solution had the following composition (in mM): NaCl, 135; KCl, 5; NaHCO3, 20; 
CaCl2, 2.5; MgSO4.7H2O, 1.3; KH2PO4, 1.2; EDTA, 0.026; glucose, 10. The solution was gassed 
with 95% O2 – 5% CO2 (pH 7.4). The low calcium dissociation medium contained (mM): NaCl, 
110; KCl, 5; CaCl2, 0.16; MgCl2, 2; KH2PO4, 0.5; EDTA, 0.49; NaH2PO4, 0.5; Taurine, 10; HEPES, 
10; glucose, 10, titrated to pH 7.0. HBSS-HEPES contained (in mM): NaCl, 137; KCl, 5.36; 
Na2HPO4.2H2O, 0.18; CaCl2.H2O, 0.95; MgSO4.7H2O, 0.81; KH2PO4, 0.44; HEPES, 25; glucose, 
5.55 (pH 7.4, adjusted with NaOH). Phosphate-buffered saline (PBSD) contained (in mM): 
NaCl, 137; KCl, 2.68; CaCl2, 0.90; MgCl2.6H2O, 0.334; KH2PO4, 1.47; Na2HPO4.2H2O, 6.46 (pH 
7.4).  
 
Statistics 
Results are expressed as means + SEM. Statistical evaluation was performed using Student’s 
t test or ANOVA, as appropriate. Values of P<0.05 were considered significantly different. 
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RESULTS 
 
Connexin expression in rat small mesenteric arteries  
PCR analysis demonstrated the presence of Cx37 and Cx43 in small mesenteric artery 
preparations (Figure 1A). Immunocytochemistry performed on isolated mesenteric artery 
SMCs (Figure 1B) or on slices of small mesenteric arteries (Figure 1C) confirmed the presence 
of Cx43 and Cx37. We found no evidence for Panx1 in SMCs of small mesenteric arteries, not 
at the mRNA level (Figure 1A) and not with immunohistochemistry (Figure 1C). 
 
 
Figure 1. Connexins in small mesenteric artery SMCs. A. RT-PCR analysis illustrating presence of Cx43 and Cx37 
mRNA transcripts and the absence of Panx1 mRNA transcripts in rat mesenteric SMCs. GAPDH was used as a 
control for cDNA synthesis. RT- is a reverse transcriptase negative control. B. Immunocytochemistry in isolated 
SMCs illustrating Cx43 and Cx37 expression (green); images overlayed on DAPI stainings (blue). C. 
Immunohistochemistry on vessel slices illustrating Cx43 and Cx37 expression (red) and absence of Panx1; 
images overlayed on DAPI staining (blue). 
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Norepinephrine triggers repetitive Ca2+ oscillations in rat mesenteric artery SMCs 
We used norepinephrine to trigger Ca2+ oscillations. Norepinephrine (3 µM) triggered 
repetitive intracellular Ca2+ waves in SMCs of cannulated mesenteric arteries imaged with 
real-time confocal microscopy. Point measurements in individual cells showed repetitive 
Ca2+ spikes, further called Ca2+ oscillations (Figure 2A). Ca2+ oscillations were not 
synchronized between cells and vasomotion was never observed. Ca2+ oscillations induced 
by norepinephrine-only were recorded over an 11 min time window and during this period, 
the spiking rate (frequency) and amplitude decreased spontaneously (Figure 2A), as reported 
by others and probably resulted from desensitization to the agonist by continued exposure. 
On average, the Ca2+ oscillation frequency attained 2.51 + 0.53 spikes per minute measured 
over the last 3 minutes of norepinephrine exposure (n=4, p<0.05 compared to exposure to 
solutions without norepinephrine where the frequency was zero). In the experiments that 
follow, we investigated the effect of several agents on the spiking frequency.  
 
 
Norepinephrine-triggered Ca2+ oscillations involve IP3R activation  
Ca2+ oscillations are based on an increase of IP3 in combination with positive and negative 
feedback of [Ca2+]i on the IP3R (Dupont et al. 2007). Xestospongin C (10 µM), a small-
molecular-weight membrane-permeable inhibitor of IP3Rs, had a drastic effect on the spiking 
activity as can be appreciated from the example trace in figure 2B. It significantly reduced 
the oscillation frequency of SMCs to 0.06 + 0.03 spikes/min measured over the last 3 
minutes (n = 8; p<0.001 compared to control frequency). Figure 3 summarizes average data 
on the spiking frequency expressed in a normalized manner, with the control response to 
norepinephrine set to 100 %. We next tested dantrolene (25 µM) to investigate the effect of 
ryanodine receptor (RyR) inhibition. These experiments showed no significant effects on 
oscillation frequency or amplitude (Figure 2C and Figure 3). 
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Interfering with connexin channel function inhibits norepinephrine-induced Ca2+ 
oscillations 
We tested several connexin-targeting substances to determine whether these could 
influence norepinephrine-induced SMC Ca2+ oscillations. Addition of the non-selective 
connexin channel blocker, carbenoxolone (50 µM) during norepinephrine-induced Ca2+ 
spiking reduced the oscillation frequency to 0.02 + 0.02 spikes/min (n = 4; p<0.001 
comparison of raw frequency data – comparisons on normalized data see figure 3) (Figure 
2D).  
 
Gap27 composed of a conserved sequence of 11 amino acids in the second extracellular loop 
of both Cx37 and Cx43 rapidly blocks hemichannels (Wang et al. 2012) and with some delay 
also gap junctions (de Vuyst et al. 2006, De Bock et al. 2011, De Bock et al. 2012). This 
peptide (200 µmM) reduced the Ca2+ oscillation frequency to 0.05 + 0.03 spikes/min (n = 6; 
p<0.001) (Figure 2E and Figure 3). Control experiments on freshly isolated SMC pairs 
demonstrated that Gap27 (200 µM) had no effect on gap junctional dye coupling (measured 
with fluorescence recovery after photobleaching, FRAP) when applied for 60 min 
(supplementary figure 1). Scrambled Gap27 (gap27scr) had no effect on the Ca2+ oscillation 
frequency (Figure 2F and Figure 3). 
 
                                      
Supplementary figure 1. Dye coupling in isolated SMC pairs was studied with fluorescence recovery after 
photobleaching (FRAP). Average FRAP experiments showed a limited fluorescence recovery that was 
significantly inhibited by carbenoxolone (cbx, 50 µM, 20 min) but not by Gap27 (200 µM, 60 min). In line with 
previously reported observations that Gap27 only inhibits GJs upon longer exposures (Braet et al. 2003, 
Decrock et al. 2009, De Bock et al. 2011). The number of experiments is given in the bars. * p<0.05  
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Previous work has demonstrated that hemichannels contribute to Ca2+ oscillations by acting 
as a [Ca2+]i-controlled Ca
2+ entry pathway (De Bock et al. 2012) We here used L2 and CT9 
peptides (linked to a TAT permeation sequence) to inhibit the positive and negative 
feedback of [Ca2+]i on hemichannel Ca
2+ entry respectively (Figure 4 depicts the biphasic 
effect of [Ca2+]i on hemichannel opening and the alterations induced by the synthetic 
peptides L2 and CT9), and tested their effect on norepinephrine-triggered Ca2+ oscillations in 
mesenteric artery SMCs. We applied peptides covalently linked to a TAT sequence to 
facilitate their plasma membrane passage and uptake into the cells. Addition of TAT-L2 (100 
µM) or TAT-CT9 (100 µM) attenuated the Ca2+ oscillation frequency to 0.87 + 0.27 
spikes/min (n = 7; p<0.001) and 0.69 + 0.22 spikes/min respectively (n = 5; p<0.001) (Figure 
2GI and Figure 3). By contrast, mutant TAT-L2 peptide (TAT-L2H126K/I130N) and reversed 
sequence TAT-CT9 (TAT-CT9rev) had no effect on the Ca2+ oscillations (Figure 2HI and Figure 
3). Figure 2I illustrates that TAT-CT9 not only inhibited the Ca2+ oscillations but also tended 
to increase baseline [Ca2+]i towards the end of the 8 min exposure. In fact, such effect is 
expected because CT9 prevents hemichannel closure at high [Ca2+]i and may thus effectively 
promote Ca2+ entry. We further analyzed baseline fluo-3 fluorescence over the last 4 min of 
the recordings (expressed relative to the fluorescence in the preceeding 4 min) and found 
that TAT-CT9 significantly increased the baseline signal as compared to control recordings, 
while TAT-CT9rev or TAT-L2 had no such effect (Table 1).  
 
Billaud et al. (Billaud et al. 2011) reported a role for Panx1 in α1-adrenergic receptor-
mediated vasoconstriction and we therefore tested 10panx1 (200 µmol/L), a pannexin1 
mimetic peptide that inhibits these channels (Wang et al. 2007). These experiments showed 
no significant effects on the oscillation frequency or amplitude (Figure 2K and 3). 
 
Table 1. TAT-CT9 increases SMC baseline [Ca2+]i 
 
Condition Fluo-3 fluorescence last 4 min divided by fluorescence during preceding 4 min of [Ca
2+
]i 
recording (%) 
Control 96.2 + 0.16 % (n=4) 
TAT-CT9 122.7 + 7.23 % (n=5)** 
TAT-CT9
rev
 97.6 + 0.68 % (n=5) 
TAT-L2 100.6 + 0.52 % (n=7) 
** p < 0.01 compared to all other conditions 
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Figure 2. Example traces of Ca
2+
 oscillations induced by norepinephrine (Nor) in an individual small mesenteric 
artery SMC and the effect of various inhibitory/modulatory substances used. The rectangle in dotted line 
indicates the last 3 min time window used for frequency analysis. Traces A-N are discussed and referred to in 
the text. 
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Figure 3. Average data of effects of various inhibitor/modulator substances on the oscillation frequency in the 
time window illustrated in figure 2 (control set to 100 %). The number of experiments is given in/above the 
bars. ** p<0.01 *** p<0.001. 
 
 
Figure 4. Ca
2+
 activation of hemichannels composed of Cx43 is characterized by a bell-shaped [Ca
2+
]i-
dependence (hemichannel ATP release and dye uptake studies, derived from data in De Vuyst et al. 2009). 
Gap27 and TAT-L2 peptide remove the inclining phase at low [Ca
2+
]i , TAT-CT9 peptide removes the declining 
phase at [Ca
2+
]i above 500 nM (Ponsaerts et al. 2010). Black dots: C6Cx43 ATP release; grey dots: C6Cx43 dye 
uptake; white dots: HeLaCx43 ATP release) 
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Purinergic receptor antagonists and ATP degrading enzymes inhibit norepinephrine-
induced Ca2+ oscillations 
Connexin hemichannel opening is associated with the release of messengers such as ATP. In 
order to test whether extracellular ATP plays a role in norepinephrine-induced Ca2+ spiking, 
we tested two purinergic receptor antagonists. Suramin (200 µM) and PPADS (75 µM), 
diminished the oscillation frequency to respectively 0.18 + 0.10 and 0.09 + 0.06 spikes/min 
(n = 3 and 4 respectively; p<0.001 for both) (Figure 2LM and Figure 3). We further applied 
enzymes known to degrade ATP. Apyrase V (5 U/ml) degrades ATP into ADP and apyrase VI 
(5 U/ml) further degrades ADP to AMP. In the presence of these two enzymes, the oscillation 
frequency was reduced to 0.50 + 0.19 spikes/min (n = 5; p<0.001 compared to control 
frequency) (Figure 2N and Figure 3).  
 
 
Carbenoxolone, Gap27, TAT-L2, PPADS and suramin also inhibit norepinephrine-induced 
contraction of rat small mesenteric arteries 
Ca2+ oscillations are known to control blood vessel tone. In the following experiments we 
tested the effect of some of the compounds that had profound effects on Ca2+ oscillations, 
on the contractility as determined in isometric tension measurements in small mesenteric 
arteries. As the [Ca2+]i measurements were performed on cannulated blood vessels, a 
procedure that largely removes the endothelium, we also removed the endothelium in the 
contraction experiments by bubbling the lumen of the vessels for 2 minutes with gas (95 % 
O2 and 5 % CO2). In a first series, measurements were performed at room temperature. 
 
Figure 5A illustrates a control tension measurement experiment with contraction induced by 
norepinephrine (3 µM). Preincubation with carbenoxolone (50 µM, 20 min) inhibited the 
norepinephrine-induced contractions (Figure 5A). The area under the contraction curve 
(AUC) was decreased to ~56 % (average data see Figure 6). We also verified the peak 
amplitude (peak force) and the force averaged over the last 3 min of norepinephrine 
exposure. The peak force was decreased to ~60 % and the force during the last 3 minutes 
attained 53 % of the control values, i.e. these contraction parameters were influenced to a 
comparable extent as the AUC. Gap27 (200 µM, 20 min) and TAT-L2 (100 µM, 20 min) 
inhibited the norepinephrine-induced contractions (Figure 5BC) and decreased the AUC to 
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~74 % and ~50 % of control, the peak force to ~81 % and ~51 % and the force during the last 
3 minutes of the recording to ~70 % and ~56 %. Surprisingly, TAT-CT9 had no effect on 
contractility while it inhibited Ca2+ oscillations (Figure 5D). Suramin (200 µM, 20 min) and 
PPADS (75 µmM, 20 min) inhibited the norepinephrine-induced contractions (Figure 5KL), 
reducing the AUC to 30 % and 67 % of control (Figure 6) while the peak force and the force 
during the last 3 minutes of the recording were reduced to ~26 % and ~70 %. 
 
We repeated the tension measurements on blood vessels with an intact endothelium and 
performed the experiments at 37 °C instead of room temperature. Under those conditions 
carbenoxolone, Gap27, TAT-L2, PPADS and suramin again significantly inhibited the 
norepinephrine-induced contractions (Figure 5G-L and Figure 6). Importantly, the effects of 
these compounds were comparable with the findings at room temperature/without 
endothelium, and none of the measured AUC values (except TAT-L2), was significantly 
different from its corresponding measurement at room temperature/without endothelium. 
Remarkably, TAT-L2 had a significantly stronger effect at 37 °C/intact endothelium as 
compared to room temperature/no endothelium, reducing the AUC to ~20 % of control 
(Figure 6).  
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Figure 5. Representative mesenteric artery tension traces illustrating the influence of the various substances 
used on the contractile response induced by norepinephrine (nor) at room temperature (RT) without 
endothelium (A-F) and at 37° C with intact endothelium (ET) (G-L).  
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Figure 6. Summary data of the area under the curve (AUC) of the contraction curve for the various substances 
applied. The number of experiments is given in the bars. * p<0.05 **p<0.01  ***p<0.001. 
 
 
 
DISCUSSION 
 
The most salient result of the present work is the fact that TAT-L2, a peptide containing the 
L2 sequence of the cytoplasmic loop of Cx43, strongly reduces vasoconstriction of small 
mesenteric arteries triggered by norepinephrine. TAT-L2, as well as other connexin-targeting 
peptides, also inhibited norepinephrine-triggered Ca2+ oscillations in SMCs of isolated 
mesenteric arteries. Work in MDCK cells has suggested that Ca2+ entry via connexin 
hemichannels may contribute to agonist-induced Ca2+ oscillations (De Bock et al. 2012). 
Hemichannels are [Ca2+]i-controlled channels (de Vuyst et al. 2006, De Vuyst et al. 2009, 
Wang et al. 2012) that provide positive feedback to Ca2+ entry leading to Ca2+-induced Ca2+-
entry. They also provide Ca2+-induced ATP release (Braet et al. 2003, de Vuyst et al. 2006, De 
Vuyst et al. 2009) that will subsequently trigger P2X and P2Y receptor-mediated responses. 
Thus, inhibition of SMC Ca2+ oscillations by TAT-L2 is likely to be caused by blockage of 
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hemichannels, thereby disrupting Ca2+ entry and ATP release/purinergic signaling that may 
be crucial to support the Ca2+ oscillations (Figure 7) (Berridge 2007). 
 
 
Figure 7. Schematic diagram illustrating the Ca2+ signaling aspects of this study. Norepinephrine 
(NOR) activates metabotropic α1-adrenergic receptors (α1R) on the SMC plasma membrane (PM), 
resulting in IP3 formation. IP3 activates IP3R opening with Ca
2+ release from the endoplasmic 
reticulum (ER). Moderate [Ca2+]i elevation promotes ER Ca
2+ release (red arrow to IP3R) while higher 
[Ca2+]i levels inhibit Ca
2+ release (blue arrow to IP3R) and this is a basic mechanism leading to Ca
2+ 
oscillations. The inset below illustrates the rising and falling phase of each Ca2+ spike, resulting from 
positive (red) and negative (blue) Ca2+ feed-back on IP3Rs. Cx43 hemichannels (HC) are Ca
2+-
permeable channels that are modulated by [Ca2+]i in a similar manner as IP3Rs, resulting in Ca
2+-
induced Ca2+ entry at moderate [Ca2+]i (red arrow to HC) and stop of Ca
2+ entry at higher 
concentrations (blue arrow to HC). Hemichannel opening also triggers the release of ATP that 
activates P2X and P2Y receptors. SMC P2X1 receptors facilitate Ca2+ entry while P2Y receptors 
generate IP3, and both sustain the central IP3R-based oscillator (delineated by dotted grey line). 
Inhibition of positive and negative Ca2+ feed-back on Cx43 hemichannels with L2- and CT9-peptide 
respectively, inhibits the oscillations, suggesting a contribution of hemichannels in the oscillation 
mechanism; work with purinergic receptor antagonists and ATP-degrading enzymes supports the ATP 
signaling arm. 
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While moderate [Ca2+]i elevation stimulates hemichannel opening, larger [Ca
2+]i increases 
result in hemichannel closure (de Vuyst et al. 2006, De Vuyst et al. 2009, Wang et al. 2012). 
This provides negative feedback that will stop Ca2+-entry via hemichannels. CT9 peptide, 
identical to the last 9 amino acids of the C-terminal tail of Cx43, prevented high [Ca2+]i 
closure of Cx43 hemichannels. CT9 peptide is identical to the αCT1 peptide (O'Quinn et al. 
2011) that interferes with Cx43/ZO-1 interactions and thereby influences gap junction 
plaque size (Hunter et al. 2005). However, CT9 inhibition of high [Ca2+]i hemichannel closure 
is independent of Cx43/ZO-1 interactions (De Bock et al. 2012). TAT-CT9 inhibited SMC Ca2+ 
oscillations, but by preventing high [Ca2+]i –induced hemichannel closure, it also increased 
baseline [Ca2+]i. TAT-CT9 had no effect on norepinephrine-induced vasoconstriction, 
suggesting that the increased baseline Ca2+ signal might have compensated for the reduced 
spiking activity in driving SMC contraction. 
 
The effects of carbenoxolone and Gap27 on Ca2+ spiking and SMC contraction were very 
comparable to TAT-L2 (at room temperature/without endothelium). Carbenoxolone rapidly 
inhibits both hemichannels and gap junction channels, while Gap27 first blocks 
hemichannels and with some delay (variable between cell types) also gap junctions (Braet et 
al. 2003, Decrock et al. 2009, De Bock et al. 2011, Wang et al. 2012). L2 peptide inhibits 
hemichannels while it slightly promotes junctional coupling by decreased dwelling of gap 
junction channels in the subconductance state (Seki et al. 2004). Recent work with a 
biologically active subdomain peptide of L2, gap19, gave similar results: no effect on gap 
junctions the first 30 min and slightly stimulating them after 24 h (Wang et al. 2013). Thus, 
carbenoxolone, Gap27 and TAT-L2 have in common that they inhibit hemichannels while 
having very divergent effects on gap junctions. Gap27 has previously been demonstrated to 
inhibit contractility of rat aorta (Tang and Vanhoutte 2008) and a combination of 
Gap27/gap26 suppressed vasomotion in rat mesenteric small arteries (Matchkov et al. 
2006). In these cases, the effect was attributed to inhibition of gap junctions, either between 
SMCs, endothelial cells or as myoendothelial junctions. With the exposures time used here, 
Gap27 did not influence gap junctional coupling. The contraction experiments performed at 
room temperature/without endothelium were furthermore under conditions where 
endothelial and myoendothelial junctional coupling is grossly absent. Besides strongly 
different actions of L2 and Gap27 on gap junctions and hemichannels, another important 
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difference relates to their selectivity. Gap27 mimicks a sequence on the extracellular loop of 
the connexin protein that is well conserved between different connexins and therefore 
targets several connexins, including Cx37 and Cx43 present in mesenteric artery SMCs. By 
contrast, L2 peptide mimicks a sequence on the intracellular loop of Cx43 that is very 
different between different connexins. Its interaction partner is the C-terminal tail, that is 
also very different between different connexins. As a consequence, L2 peptide is expected to 
have better selectivity as compared to other connexin-mimetic peptides. Work with the L2-
derived gap19 peptide has confirmed this notion and demonstrated no effect on 
hemichannels composed of Cx40 or Panx1 (Wang et al. 2013).  
 
At 37 °C and intact endothelium, carbenoxolone and Gap27 had comparable effects on 
vessel contractility as recorded at room temperature/without endothelium. By contrast, 
TAT-L2 had a much stronger effect at 37 °C/intact endothelium. This may be related to a 
stronger cellular uptake of TAT-L2 at 37 °C or increased hemichannel activity with 
consequently larger effects upon inhibition. Alternatively, TAT-L2 promotion of gap 
junctional coupling may be stronger at 37 °C, thus favoring endothelial/myoendothelial 
Cx43-based junctional communication and promoting an endothelial vasodilatory influence.  
 
Hemichannel opening is associated with ATP release (Kang et al. 2008) and interfering with 
purinergic signaling inhibited SMC Ca2+ oscillations and blood vessel contractility. An 
association between purinergic signaling and Ca2+ oscillations has been reported in other cell 
types (Geyti et al. 2008, De Bock et al. 2012), while a linkage with blood vessel contractility 
has been reported by Billaud et al. in thoracodorsal arteries (Billaud et al. 2011). Suramin 
and PPADs had comparable and profound inhibitory effects on Ca2+ spiking while suramin 
more strongly suppressed contractility. The spectrum of purinergic receptors targeted by 
both compounds is wide but discrete differences exist that may form the basis of this 
differential activity. For example, PPADS has most pronounced effects on metabotropic P2Y1 
and P2Y6 while suramin does not influence P2Y4 receptors (von Kugelgen 2006). Vascular 
smooth muscle cells express several P2Y receptors, including P2Y1, P2Y2, P2Y4 and P2Y6 that 
link to Ca2+ signalling (Govindan et al. 2010). However, SMCs also express P2X ionotropic 
receptors, more specifically P2X1 receptors in SMCs of mesenteric blood vessels (Lamont et 
al. 2006), that facilitate Ca2+ entry upon activation (Lohman et al. 2012) and are inhibited by 
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suramin and PPADS (Lambrecht 2000). Thus, purinergic signaling may activate P2Y receptors 
leading to the generation of IP3 while activation of P2X1 receptors will facilitate Ca
2+ entry. As 
a consequence, block of hemichannels with L2 peptide will reduce hemichannel Ca2+ entry 
and ATP release, turning down P2Y-associated IP3 generation and shutting off P2X1-related 
Ca2+ entry. Such targeting of Ca2+ signalling from two sides, Ca2+ entry and Ca2+ release, is 
likely to result in blockage of Ca2+ oscillations as observed here. ATP actions may be 
autocrine or paracrine, as for example in pancreatic β-cells where paracrine ATP signaling 
helps to coordinate Ca2+ oscillations in multiple cells (Hellman et al. 2004, Grapengiesser et 
al. 2005). Because we did not observe any synchronization of spiking events between cells, 
autocrine signaling is the more probable mode.  
 
We did not find evidence for Panx1 in the presently used rat mesenteric artery SMCs, both at 
mRNA and protein level. By contrast, Billaud et al. (Billaud et al. 2011) have reported Panx1 
expression in mouse thoracodorsal resistance artery SMCs and have furthermore 
demonstrated that Panx1 is expressed in SMCs of a variety of small diameter resistance 
vessels (Lohman et al. 2012). Our results in rat mesenteric arteries differ from these 
observations, in terms of expression as well as function, as 10panx1 peptide did not influence 
the Ca2+ oscillations. Possibly, this is related to differences in vascular beds (mesenteric 
versus thoracodorsal) and species (rat versus mouse). Notwithstanding these differences, 
the results obtained here may well apply to the case of Panx1 channels present in other 
vascular beds.  
 
In conclusion, our results show that TAT-L2 peptide strongly inhibits norepinephrine-induced 
contraction of mesenteric arteries, indicating a role of Cx43 hemichannels and purinergic 
signaling in the control of vascular tone. Cx43 hemichannels thus come up as a novel target 
to interfere with vascular function, and TAT-L2 peptide adds as a new tool to modulate 
blood vessel function in the context of vascular disease. 
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Abstract  
Objectives: Cryopreserved blood vessels are being increasingly employed in vascular 
reconstruction procedures but freezing/thawing is associated with significant cell death that 
may lead to graft failure. Vascular cells express connexin proteins that form gap junction 
channels and hemichannels. Gap junction channels directly connect the cytoplasm of 
adjacent cells and may facilitate the passage of cell death messengers leading to bystander 
cell death. Two hemichannels form a gap junction channel but these channels are also 
present as free non-connected hemichannels. Hemichannels are normally closed but may 
open under stressful conditions and thereby promote cell death. We here investigated 
whether blocking gap junctions and hemichannels could prevent cell death after 
cryopreservation.  
Materials and Methods: Inclusion of Gap27, a connexin channel inhibitory peptide, during 
cryopreservation and thawing of human saphenous veins and femoral arteries was 
evaluated by TUNEL assays and histological examination. 
Results: We report that Gap27 significantly reduces cell death in human femoral arteries and 
saphenous veins when present during cryopreservation/thawing. In particular, smooth 
muscle cell death was reduced by 73% in arteries and 71% in veins, while endothelial cell 
death was reduced by 32% in arteries and 51% in veins. 
Conclusions: We conclude that inhibiting connexin channels during cryopreservation strongly 
promotes vascular cell viability. 
 
Key words: connexin, cryopreservation, cell death, blood vessel grafting 
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INTRODUCTION 
Vascular grafts have wide surgical applications but the preservation of those grafts has faced 
several problems. Grafts are preserved in cold storage at 4 °C as well as cryopreserved, but 
the procedure is still unsatisfactory and, after grafting, complications such as thrombosis and 
vasospasms occur which could lead to late graft failure (Callow 1996). The risk for 
thrombosis is enhanced by rejection, leading to loss of endothelial lining and function, and in 
a later phase, by immune related intimal hyperplasia and fibrosis (Vermassen et al. 1994). 
Even with the introduction of immunosuppressive treatment, the improvement of 
harvesting techniques and preservation fluids, and the use of anticoagulation therapy the 
patency of these allografts was not improved in most studies (Randon et al. 2010). 
The performance of cryopreserved vascular grafts is suboptimal, mainly because of 
spontaneous vessel wall fractures (Bujan et al. 2000) appearing at the time of thawing or 
grafting. Another important issue is that the current methods of vascular cryopreservation 
used in most vascular banks lead to a certain degree of loss of the intimal endothelial layer 
(Pascual et al. 2004). Before arterial or venous grafts are implanted to bypass occluded 
coronary arteries they undergo extensive apoptotic and necrotic cell death in the intimal and 
medial layers (Kouzi-Koliakos et al. 2007). Cell death plays an important role in vascular graft 
failure, and important for the present study, cell-cell communication may act to expand the 
cell death process to neighboring healthy cells, leading to bystander cell death during 
cryopreservation and thawing (Decrock et al. 2009).  
The most direct form of cell–cell communication is provided by gap junctions that consist of 
intercellular channels composed of connexin proteins, named according to their predicted 
molecular weight (Saez et al. 2003). Vascular cells abundantly express connexins, with Cx37, 
Cx40 and Cx43 as the most representative isoforms (Haefliger et al. 2004). Gap junction 
channels are formed by the interaction of two hemichannels, belonging to the membranes 
of adjacent cells and directly connect the cytoplasm of neighboring cells (Figure. 1). Gap 
junctions are able to pass cell death messengers leading to bystander cell death (Decrock et 
al. 2009). Recent work from our group has demonstrated that the physiological messenger 
IP3, which can pass through gap junction channels, becomes a crucial cell death-
communicating messenger under pro-apoptotic conditions (Decrock et al. 2012). 
Additionally, hemichannels, which are half gap junction channels, may by themselves 
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promote cell death. Unapposed hemichannels in the plasma membrane are typically closed 
and only open when they become incorporated into a gap junction. However, unapposed 
hemichannels not assembled into gap junctions may open under certain conditions like cell 
depolarization, decreased extracellular calcium, changes in intracellular calcium 
concentration, alterations in phosphorylation or redox status, mechanical strain, and 
ischemic and inflammatory conditions (Wang et al. 2012). Hemichannels are non-selective 
channels that allow, like gap junctions, the passage of up to 1.5 kDa molecules; as a 
consequence, uncontrolled hemichannel opening may lead to cell death, caused by 
excessive entry of sodium and calcium ion and loss of cellular ATP or other crucial metabolic 
molecules (Retamal et al. 2007, Decrock et al. 2009).  
Gap junction channels and hemichannels can be inhibited by connexin mimetic peptides 
such as Gap26 and Gap27 (de Wit and Griffith 2010, De Bock et al. 2011, Wang et al. 2012). 
These peptides mimic a sequence on the extracellular loops of the connexin protein and first 
inhibit unapposed hemichannels, that have their extracellular loops freely available for 
peptide interactions, followed by a somewhat delayed inhibition of gap junctions (Decrock et 
al. 2009, Evans et al. 2012, Wang et al. 2012). Previous work has demonstrated that 
connexin mimetic peptides prevent the propagation of cell death by inhibiting both gap 
junctions and (unapposed) hemichannels (Decrock et al. 2009). Recent work from others has 
furthermore shown that these peptides can significantly improve the outcome after 
experimental ischemia applied to heart or brain (Hawat et al. 2010, Davidson et al. 2012). 
Here, we used Gap27, which targets the two vascular connexins Cx37 and Cx43 (Haefliger et 
al. 2004), to investigate the hypothesis that the combined inhibition of gap junctions and 
hemichannels exerts a cell protective effect during the exposure of donor blood vessels to 
the stressful events of cryopreservation and thawing (Figure 1). Our results show that Gap27 
significantly reduces cell death in endothelial cells (ECs) and smooth muscle cells (SMCs) of 
cryopreserved human blood vessels. The strongest effects of Gap27 were found in SMCs of 
both vessel types and in the ECs in the veins. We further found that veins have a better 
conserved intimal layer compared to arteries and have less cell death in the ECs. 
          
 
  Chapter VII: Inhibiting Cx channels protects against cryopreservation-induced cell death in blood vessels 
 
130 
 
                      
Figure 1. Diagram of a bloodvessel illustrating the hypothesis investigated in this paper. Vascular cells express 
connexins that form gap junctions and hemichannels. Gap junctions connect the cytoplasm of smooth muscle 
cells (SMCs) and of endothelial cells (ECs); they also connect ECs with SMCs (Myo-endothelial gap junctions). 
Gap junctions can communicate cell death from dying to healthy neigboring cells, resulting in bystander cell 
death. Hemichannels are normally closed but may open in response to mechanical strain, ischemia, 
inflammation, low extracellular calcium, depolarization and altered phosphorylation or redox status. This can 
lead to the loss of essential metabolites and ionic shifts over the plasma membrane, thereby promoting cell 
death. Gap27 inhibits hemichannels within minutes and gap junctions with some delay; when present for 
several hours, both gap junctions and hemichannels will be inhibited. We investigated whether inclusion of 
Gap27 in the media used for cryopreservation and thawing could protect against vascular cell death. 
 
 
 
 
MATERIALS AND METHODS 
 
Tissue preparation 
Tissue samples of human femoral artery and saphenous vein were obtained from deceased 
donors (age: 45 + 1.7 years, n=13) according to a protocol that was approved by the ethical 
committee of the University Hospital Ghent. Blood vessels were selected and procured 
according to the Belgian law and guidelines of the Superior Health Council Belgium. 
Exclusion criteria were: presence of ulcers, calcific atheromas, rupture of intima or media 
and traction lesions due to prelevation in arteries; signs of phlebitis, atheromatosis, parietal 
abnormalities and lesions of intima in veins. Serologic testing for human immunodeficiency 
virus, hepatitis B and C and syphilis was also done and vessels were excluded in case of 
positivity. One centimeter long vessel samples were placed in HBSS-HEPES and prior to 
cryopreservation, DMSO was added to a final concentration of 15 %. DMSO is the most 
commonly used cell membrane-permeating freeze point lowering agent for cryopreservation 
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of blood vessels (Muller-Schweinitzer 2009) and concentrations up to 15% were shown to be 
safe for that purpose (Song et al. 1995). In Gap27 treated vessels, the peptide was added to 
the HBSS-HEPES-DMSO solution at a final concentration of 200 µM. Grafts were 
cryopreserved at a rate of 1 °C/min in a -80 °C freezer and after two weeks stored for at least 
another two weeks in a liquid nitrogen container (-196 °C).  
For vessel analysis and cell death studies, tissues were thawed in a 37 °C water bath and 
kept on ice before the next steps. DMSO was then progressively washed out by a stepwise 
reduction of the DMSO concentration in the HBSS-HEPES solution. To that purpose, the 
blood vessels remained for 4 min in HBSS-HEPES solution with respectively 10 %, 5 %, 2.5 % 
and 0 % DMSO. In Gap27 treated vessels, the peptide (200 µM) was present during DMSO 
washout. 
As shown in Figure 5A, we also performed experiments to verify the effect of Gap27 when 
included during cryopreservation/thawing only or during DMSO washout only.  
After DMSO washout, blood vessels were transferred to a neutral buffered 4 % formalin 
solution for fixation during 24 h and were then embedded in paraffin. Paraffin-embedded 
vessel specimens were cut into 5 µm serial sections along a transverse plane and were then 
stained with haematoxylin and eosin for microscopic analysis. Images were taken on a Nikon 
TE300 inverted microscope using a x10 or x20 objective and equipped with a Nikon DS-Ri1 
cooled color CCD camera (Nikon Belux, Brussel, Belgium).  
 
Immunostaining 
Paraffin slices were deparaffinized and subsequently incubated with an antigen retrieval 
solution (Vector, Lab Consult, Brussels, Belgium). Preincubation with a blocking buffer 
(Bovine serum albumin, 5 mg/ml; bovine skin gelatin, 0.1 %; Triton X-100, 0.25 % in 
phosphate-buffered saline (PBS)) was done for 30 min at room temperature. Sections were 
incubated overnight at 4 °C with primary antibody (anti-Cx43 polyclonal AB (1/250, Sigma, 
Belgium), anti-Cx37 polyclonal (1/100, Zymed, Life Techologies) or anti-Cx40 polyclonal 
(1/10, Thermo Fisher, Belgium) diluted in blocking solution. After washing, a secondary 
antibody conjugated to Alexa-594 (1/500, Molecular Probes, Life Technologies) was added. 
The sections were mounted with an antifade solution containing 4’,6-diamidino-2-
phenylindole (DAPI) (Vectashield, Lab Consult) for nuclear staining. Images were acquired on 
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a Nikon TE300 inverted epifluorescence microscope with a x20 objective and camera as 
referred to before. 
 
Apoptosis assay 
Embedded artery or vein sections were deparaffinized, rehydrated through graded alcohol, 
and permeabilized with 0.1 % Triton X-100 at room temperature (8 min incubation). Slides 
were rinsed twice in a phosphate-buffered saline (PBS). Apoptosis was detected through in 
situ terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP) 
nick end-labeling (TUNEL), using the In Situ Cell Death Detection Kit (Roche, Vilvoorde, 
Belgium). Slides were incubated with the TUNEL reaction mixture containing TdT and 
fluorescein-dUTP for 1 hr at 37 °C; thereafter, they were rinsed three times in PBS and 
mounted as described for immunostaining. Control experiments performed on C6 glioma 
cells stably transfected with Cx43 exposed to staurosporine (2 µM, 6 hours) induced massive 
TUNEL positivity while exposure to the DMSO vehicle had no effect. TUNEL-stained blood 
vessel tissue sections were examined by epifluorescence microscopy as described for 
immunostaining. Four areas from each slide were examined and 5 slides per blood vessel 
were analyzed. The number of TUNEL-positive cells is given as a percentage of the total 
number of cells quantified from DAPI positive counts.  
 
Pharmacological agents 
Gap27 (SRPTEKTIFII) and scrambled Gap27 (TFEPIRISITK) were synthesized by Thermo Fisher 
Scientific (Ulm, Germany) at >80% purity. HBSS-HEPES (Gibco, Merelbeke, Belgium) 
contained (in mM) CaCl2, 1.26; MgCl2-6H2O, 0.493; MgSO4-7H2O, 0.407; KCl, 5.33; KH2PO4, 
0.441; NaHCO3, 4.17; NaCl, 137.93; Na2HPO4, 0.338; D-Glucose (Dextrose), 5.56; Phenol Red, 
0.0266. PBS contained (in mM) NaCl, 137; KCl, 2.68; KH2PO4, 1.47; Na2HPO4.2H2O, 6.46; pH 
7.4. Staurosporine was obtained from Sigma (Bornem, Belgium). 
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Statistical Analysis 
All data are expressed as mean + SEM. Statistical analysis between groups was performed 
using Friedman Test with Dunn’s post-t-test. Proportions were compared using Pearson’s 
Chi-square test. Differences in cell death between control conditions of both blood vessels 
are analyzed by unpaired Student’s t-test. Correlations were assessed by Pearson’s 
Correlation tests. A value of P < 0.05 was considered as statistically significant. The symbol n 
represents the number of blood vessels. 
 
 
RESULTS 
Connexin expression in human femoral arteries and saphenous veins 
Immunostainings demonstrated the presence of the major vascular connexins, Cx37, Cx40 
and Cx43 in the intimal and medial layers of human cryopreserved blood vessels. Cx37 was 
mainly found in the intimal EC layer of saphenous veins, while it was present in intimal EC 
and medial SMC layers in femoral arteries (Figure 2A-D). Cx40 was found in both arteries and 
veins and was present in the intimal and medial layers (Figure 2E-H). Cx43 was most 
abundantly present and was mainly located in the medial layer of femoral arteries and in 
intimal and medial layers of saphenous veins (Figure 2I-L). 
 
 
 
 
 
 
 
Figure 2. Connexin expression in human saphenous veins and femoral arteries. A-D. Representative example 
images illustrating Cx37 immunostainings (red) overlayed on nuclear DAPI stainings (blue) in endothelial cells in 
the intimal and smooth muscle cells in the medial layer of femoral arteries (Artery) and saphenous veins (Vein). 
E-H. Example images illustrating Cx40 expression. I-L. Example images illustrating Cx43 expression. 
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Intimal layer detachment after cryopreservation is more important in femoral arteries 
than in saphenous veins 
Morphological analysis of haematoxylin-eosin stained blood vessel sections showed that 
femoral arteries had a pronounced detachment of the intimal lining compared to saphenous 
veins (Figure 3A-D). Quantification of the number of blood vessels with an intact intimal 
layer, less than 50 % intimal loss and more than 50 % loss, allowed us to construct a graph 
depicting the distribution pattern of loss of intimal integrity (Figure 3C-D). These data 
showed a significantly different distribution pattern between femoral arteries and 
saphenous veins, with a clearly better conserved intimal lining in the latter. When Gap27 
(200 µM) was included during cryopreservation, thawing and DMSO washout, the number of 
vessels with more than 50 % intimal loss was decreased but this visible difference did not 
attain statistical significance (Figure 3C-D). We verified whether intimal loss was correlated 
with the time between vessel procurement from the donor and the start of cryopreservation 
but found no significant correlation. 
 
                        
Figure 3. Intimal layer detachment in femoral arteries and saphenous veins. A-B. Example images illustrating an 
intact (A) and detached intimal layer (B) in two different femoral arteries. C-D. Summary data illustrating 
intimal loss distribution patterns of femoral arteries (C) and saphenous veins (D). The intimal layer was 
significantly better conserved in saphenous veins than in femoral arteries (** P <0.01). 
 
 
  Chapter VII: Inhibiting Cx channels protects against cryopreservation-induced cell death in blood vessels 
 
136 
 
Gap27 reduces apoptotic cell death in cryopreserved human blood vessels 
In order to quantify cell death in cryopreserved/thawed blood vessels, we performed TUNEL 
stainings to detect apoptotic cell death. As can be appreciated from Figure 4A&C, non-
treated blood vessels displayed clearly discernable TUNEL positivity in the intimal and medial 
layers. We verified whether the degree of TUNEL positivity varied with the duration of the 
time interval between vessel procurement and start of cryopreservation but found no 
significant correlation. Interestingly, we found that Gap27 (200 µM) visibly reduced TUNEL 
positivity counts when it was present during cryopreservation, thawing and DMSO washout. 
Average data of several such experiments are given in Figure 5. In femoral arteries, ~27 % of 
the ECs and ~5 % of the SMCs were TUNEL positive under control conditions. Gap27 
significantly reduced these cell death counts by more than 1/3 in the intimal layer and by 
more than 2/3 in the medial layer (Figure 5A&C). In saphenous veins, TUNEL positivity was 
~14 % in ECs and ~6 % in SMCs. Gap27 significantly reduced these counts by almost 1/2 in 
ECs and by more than 1/2 in SMCs (Figure 5B&D). Gap27 with a scrambled peptide sequence 
had no significant effects on cell death counts (Figure 5). Thus, Gap27 more than halved cell 
death in SMCs while cell death reduction was less than half in ECs.  
 
                  
Figure 4. Gap27 reduces apoptotic cell death in EC and SMC layers in cryopreserved human blood vessels. A-D. 
Example images of TUNEL (A-B, green) and DAPI (C-D, blue) stained sections of femoral arteries under control 
and after Gap27 treatment. The number of TUNEL positive cells was visibly reduced by Gap27 in ECs and SMCs 
from intimal and medial layers respectively. 
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Cell death in control (without Gap27) was much more prominent in ECs than in SMCs (ECs: 
27 and 14 % in arteries and veins respectively vs. SMCs: 5 and 6 %) and, as a consequence, 
the fraction of cells rescued by Gap27 may be more important in ECs as compared to SMCs. 
We therefore calculated the protective effect of Gap27 relative to the total number of cells 
(EC or SMC) as an alternative to calculations relative to the number of dead cells. Table 1 
summarizes these two measures of Gap27 protection and demonstrates that the cell mass 
rescued by Gap27 was larger in ECs than in SMCs. Note that the numbers given in Table 1 
were calculated from the combined data of figure 5 and figure 6 and therefore slightly differ 
from the relative effect size described above in relation to figure 5. 
Comparison of the control bars in panels A and B of figure 5 suggests that EC death is more 
prominent in arteries than in veins; panels H and I of figure 6 (presented below) indicate a 
similar difference. Table 2 summarizes average results in control conditions from the 
combined dataset of figure 5 and 6 with extra data from additional experiments, and shows 
that EC death was significantly lower in veins as compared to arteries. 
 
                  
Figure 5. Gap27 reduces apoptotic cell death in cryopreserved human blood vessels – average data. Apoptotic 
cell death in ECs (A, B) and SMCs (C, D) of femoral arteries (A, C) and saphenous veins (B, D). The number of 
TUNEL positive cells was significantly reduced by Gap27 in ECs and SMCs. Gap27 with a scrambled peptide 
sequence had no significant effects on cell death counts. The numbers of vessels are indicated in the bars. * P < 
0.05 
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In a next step, we determined in which phase Gap27 exerted most of its protective effects: 
during cryopreservation/thawing or during DMSO washout. Thus, we investigated cell death 
with Gap27 being included either during cryopreservation/thawing or during DMSO washout 
(Figure 6A). We found that inclusion of Gap27 during DMSO washout-only, slightly (but non-
significantly) reduced cell death in ECs and SMCs while inclusion during 
cryopreservation/thawing-only always gave larger and statistically significant protective 
effects in both femoral artery and saphenous vein. Figure 6B-G illustrates example images of 
TUNEL and DAPI stainings while average data are given in figure 6H-K. 
 
 
 
Table 1. Protective effect of Gap27 on cell death in ECs and SMCs. 
 Protection relative to total number of 
dead cells (%) 
Protection relative to total number of 
cells (%) 
 Arteries Veins Arteries Veins 
EC 32 ± 8 (n=11) 51 ± 8 (n=13) 11 + 4 (n=11) 12 ± 4 (n=13) 
SMC 73 ± 7 (n=11) 71 ± 6 (n=13)   6 + 3 (n=11)   6 ± 2 (n=13) 
Average values express inhibitory effect based on Gap27 treatment data of figure 5 and 6 (Figure 6 condition 
with Gap27 present during cryopreservation/thawing). 
 
 
Table 2. Vascular cell death in femoral arteries and saphenous veins. 
 Arteries Veins 
EC 30 ± 5 % (n=15) 17 ±3 % * (n=17) 
SMC  7 ± 3 % (n=15) 7 ± 2 % (n=17) 
Average values based on control condition data of figure 5, 6 and additional experiments. 
* significantly below value for arteries with P <0.05. 
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Figure 6. Gap27 exerts most of its protective effect when added during cryopreservation/thawing. A. Overview 
of the different treatment protocols used. ‘Cryopreservation’ refers to Cryopreservation/thawing and 
‘washout’ to DMSO washout. B-D. Example images of TUNEL stainings (green) in a saphenous vein. E-G. 
Corresponding example images of nuclear DAPI staining (blue) in the same preparation. Treatment was as 
indicated in the horizontal bars above each image (A). H-K. Average data of experiments as illustrated in A-G. 
Inclusion of Gap27 during DMSO washout-only, slightly (but non-significantly) reduced cell death in ECs and 
SMCs while inclusion during cryopreservation/thawing-only always gave larger and statistically significant 
protective effects in both femoral artery and saphenous vein preparations. Numbers of vessels are indicated in 
the bars. * P < 0.05 
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DISCUSSION 
This study demonstrates that inhibition of connexin channels (gap junctions and 
hemichannels) with the connexin mimetic peptide Gap27 that targets Cx37 and Cx43, 
significantly reduces cell death of SMCs and ECs in cryopreserved and subsequently thawed 
human femoral arteries and saphenous veins. Gap27 had slight but non-significant effects 
when it was present during DMSO washout only and most of its protective effect appeared 
to be related to its presence during cryopreservation/thawing.  
 
Cryopreserved vessels are being increasingly employed in vascular reconstruction 
procedures (Pascual et al. 2004). The considerable cell death provoked by cryopreservation 
is a major factor leading to the post-transplantation failure of vascular allografts (Pascual et 
al. 2004). In the present study, apoptotic cell death was more pronounced in the intimal 
layer than in the medial layer. Apoptosis in the ECs of vascular grafts has been extensively 
addressed in previous reports (Holzknecht et al. 2002, Pascual et al. 2004, Kanellaki-Kyparissi 
et al. 2005) and the influence of alternative procedures for prelevation, cryopreservation 
and thawing have been scrutinized (Bujan et al. 2000, Pascual et al. 2004). When compared 
to the application of a more gradual, automated thawing process yielding a 20 % reduction 
in EC death (Pascual et al. 2004), protection by Gap27 appears to be stronger. It remains to 
be determined whether the combination of these treatments, i.e. automated slow thawing 
plus inclusion of Gap27, yields an additive effect. Automated thawing is, however, not 
available as a standard procedure in all hospitals. Compromised endothelial preservation can 
lead to vasospasms, occlusive intimal hyperplasia and accelerated atherosclerosis (Steen 
2001). Other reports have indicated the occurrence of apoptosis and SMC loss in the tunica 
media (Hirsch et al. 1998, Kanellaki-Kyparissi et al. 2005) which, together with intimal 
proliferative lesions can lead to chronic rejection of the arterial allograft (Hirsch et al. 1998). 
 
Gap junctions form the most direct cell-cell communication pathway, connecting the 
cytoplasm of adjacent cells. They have a central role in vascular physiology, helping in 
coordinating the contraction of SMCs (Figueroa and Duling 2009), communicating electrical 
and Ca2+ signals in upstream direction via the endothelium (Dora 2010) and contributing to 
the fine tuning of EC-SMC communication via myo-endothelial gap junctions. Additionally, 
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gap junctions allow the passage of cell death messenger signals, thereby potentially 
contributing to the propagation of cell death known as bystander cell death (Decrock et al. 
2009). Work of our lab has recently demonstrated that the physiological messenger IP3 can 
turn into a crucial cell death messenger under pro-apoptotic conditions (Decrock et al. 
2012). While gap junctions may cause propagated bystander cell death, unapposed 
hemichannels may cause cell death by uncontrolled opening thereby contributing to the 
entry and escape from the cell of ions and small molecules below ~1.5 kDa (Decrock et al. 
2009). Work from our lab has demonstrated that this effect may additionally contribute to 
the propagation of cell death (Decrock et al. 2009). 
 
We here demonstrate the presence of vascular connexins Cx37, Cx40 and Cx43 in human 
femoral arteries and saphenous veins. Previous studies have reported that connexin 
expression varies with vessel type, species and even vessel diameter (Haefliger et al. 2004). 
These studies indicated Cx37 expression primarily in the intima, Cx40 in both intima and 
media and a prominent expression of Cx43 typically in the medial SMC layer. Our results 
grossly support this pattern with the exception that Cx37 was also found (although not 
prominently) in the media of human arteries and Cx43 in the intima of human veins (again 
much less prominent than in the media). We used Gap27 that mimics the second 
extracellular loop of both Cx37 and Cx43, to inhibit gap junctions and hemichannels (Decrock 
et al. 2009, de Wit and Griffith 2010, De Bock et al. 2011).  
 
Our results show a clear decrease of cell death in the intimal and medial layers of arteries 
and veins treated with Gap27. The smaller effect of Gap27 on EC death of arteries (Figure. 
5A and Table 1) may be related to a lower Cx43 expression in this layer. Interestingly, the 
gap junction and hemichannel inhibitors carbenoxolone and Gap26 were previously 
reported to reduce neointimal formation and this led to a reduced SMC deterioration and 
decreased risk for atherosclerosis and other complications (Song et al. 2009). In addition to 
this, it is important to realize that Gap27-reduced SMC death may be beneficial for ECs 
because the two cells are coupled via myo-endothelial gap junctions (Figure 1) that may pass 
cell death messengers from SMCs (the largest vascular cell population) to ECs. Conversely, a 
reduction by Gap27 of EC death may be beneficial at the functional level after 
transplantation given the important role of these junctions in endothelial control over SMC 
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function (Dora 2010). Previous work has demonstrated that cryopreservation of arterial 
specimens in low calcium solutions is associated with (unexpected) increased cell death 
(Bujan et al. 2000). Low extracellular calcium conditions are known to trigger hemichannel 
opening (Thimm et al. 2005) and it is tempting to speculate that this is one of the causes 
leading to increased vascular cell death. Thus, combining low extracellular calcium and 
Gap27 would be an interesting option to be explored in follow-up work. 
Gap27 exerted most of its protective effects during cryopreservation/thawing, while it was 
far less effective when only present during DMSO washout after thawing. Earlier reports 
have indicated that rapid thawing increases the fragility of the arterial vessel wall and leads 
to spontaneous macro- and microfractures in the vessel wall due to thermal stress created 
by temporal and spatial temperature gradients (Pegg et al. 1997, Bujan et al. 2000). It was 
earlier reported that the procedure of vascular cryopreservation used at most vascular banks 
provoke a certain loss of the endothelium, which is one of the main factors leading to graft 
failure (Pascual et al. 2004). Our work demonstrates that detachment of the endothelial 
layer was more often observed in arteries than in veins; also EC death was more pronounced 
in arteries than in veins. Previous reports have demonstrated that slow thawing is better 
suited for arterial grafts (Ruddle et al. 2000); thus, the prominent detachment of endothelial 
layer in arteries may be related to the less optimal thawing procedure used in our 
experiments. However, since slow thawing is not generally available in most hospitals, 
venous grafts, with a better preserved endothelium and therefore better antithrombotic 
potential, should be recommended for patients with severe vascular disease and with a 
higher risk for thrombosis. 
 
In conclusion, inhibition of the vascular connexins Cx37 and Cx43 with Gap27 peptide 
significantly protects human blood vessels against cell death that occurs in relation to the 
cryopreservation/thawing-procedure. Gap27 contains a sequence identical to an 
extracellular facing domain of Cx37 and Cx43 and will thus not act immunogenically when 
some residual peptide would be left over after thorough washing. Further studies including 
clinical application of the peptides will be needed to determine whether the protective 
potential of this treatment translates into a clinically better outcome after graft vessel 
transplantation in patients. 
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In this work we explored the modulation of blood vessel function by methanandamide, CGRP 
and CxHCs in small mesenteric rat arteries (Figure 1). Connexin channels (GJs and HCs) are 
important for the physiology of blood vessel function but may also contribute to cell death 
under pathological conditions. A specific form of pathological condition is the cell stress 
associated with cryopreservation and thawing. Thus in a next move, we investigated 
whether inhibiting GJs and HCs could improve the viability of cryopreserved human blood 
vessels (Figure 1). 
 
 
Figure 1. Overview of the topics we addressed in this doctoral thesis. We investigated the modulation of the 
blood vessel function by methanandamide and the perivascular nerves-releasing factor CGRP and CxHCs in 
small mesenteric rat arteries. Connexin channels may also contribute to cell death under pathological 
conditions such as cell stress associated with cryopreservation and thawing of human blood vessels. We 
investigated whether inhibiting GJs and HCs could improve the viability of these cryopreserved vascular grafts. 
 
Endocannabinoids, such as anandamide, have potent vasodilatory actions in a variety of 
vascular preparations. The mechanism of action of these endocannabinoids is complex and 
vary with species, vessel type, and even vessel size (Vanheel and Van de Voorde 2000, 
O'Sullivan et al. 2004). Several studies have found that anandamide or methanandamide 
stimulate TRPV1 (instead of the classical CB1 receptors) thereby releasing CGRP (Ralevic et 
al. 2000, Ahluwalia et al. 2003). The mechanism involved in vasorelaxation to CGRP seems to 
vary among species and vessel types. In some vessels, CGRP acts via an endothelium 
dependent mechanism, whereby CGRP interacts with endothelial receptors stimulating the 
release of endothelium derived relaxing factors (Gray and Marshall 1992, Wisskirchen et al. 
Chapter VIII: General discussion and perspectives 
 
148 
 
1998, Boussery et al. 2005). By contrast in other vessel types, such as small mesenteric rat 
arteries, CGRP acts directly on the smooth muscle cells by increasing the cAMP content 
(Ishikawa et al. 1993, Yoshimoto et al. 1998). The resultant activation of PKA has been 
shown to open K+ channels. KATP channels as well as BKCa channels were shown to be 
involved in this vasorelaxing effect of CGRP dependent on the vessel type and contractile 
condition.  
In chapter V we specifically addressed the question whether CGRP might activate BKCa 
currents in small mesenteric rat artery SMCs since previous studies in our lab showed that 
vasorelaxation to CGRP was partly sensitive to low concentration of TEA (Breyne et al. 2006). 
In contrast to previous studies, we used acutely isolated myocytes to investigate the direct 
effects of methanandamide and CGRP on these cells. Our findings showed that 
methanandamide failed to increase membrane K+ currents and failed to hyperpolarize the 
membrane potential of SMCs of small mesenteric arteries. Moreover, we found that CGRP is 
acting specifically and directly on these myocytes by increasing the BKCa channel activity via 
activation of the CGRP receptor and via cAMP- and PKA-dependent pathways. This suggests 
that methanandamide relaxes and hyperpolarizes intact rat mesenteric arteries by releasing 
CGRP from perivascular nerves. Methanandamide decreased the K+ currents and this was 
inhibited by the KV channel blocker 4-AP. This was in accordance with a previous study, 
showing a similar inhibition of K+ current in aortic SMCs (Van den Bossche and Vanheel 2000) 
and strongly argues against a direct hyperpolarizing influence of methanandamide on SMCs 
from small mesenteric arteries. Application of exogenous CGRP substantially increased 
mesenteric SMC K+ currents and hyperpolarized the membrane potential. The controversy in 
literature concerning the type of K+ channel activated by CGRP could be explained by the 
contractile tone of the artery. The activation of K+ channels by CGRP can be dependent on 
the choice of initial experimental conditions under which the vessel is placed. In 
precontracted rat coronary arteries, BKCa channel blockers attenuated the CGRP-induced 
reduction in both tension and [Ca2+]i. KATP channel blockers did not affect the CGRP-induced 
responses in these precontracted vessels. In resting arteries, only pretreatment with the 
combination of BKCa and KATP channel blockers attenuated the CGRP-induced decrease in 
[Ca2+]i and tension (Sheykhzade and Nyborg 2001). 
In conclusion, blood vessel tonus can be modulated by methanandamide via the release of 
CGRP from perivascular nerves leading to a hyperpolarization and vasorelaxation.  
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Next to electrical changes, vessel diameter and blood flow are also controlled by Ca2+ signals. 
Intracellular Ca2+ mediates a variety of vascular endothelial and smooth muscle cell 
functions. Smooth muscle cells respond to biological activators with oscillatory and 
propagating rises in [Ca2+]i that are highly organized in both time and space. GJs play a 
crucial role in the communication between vascular cells and in the synchronization of Ca2+ 
signals thereby tightly controlling the level of vasoconstriction. Before being incorporated 
into GJs, CxHCs reside in the plasma membrane in a closed state. Such unapposed non-
junctional HCs can be opened by various messengers and conditions, thereby forming a pore 
that allows the passage of ATP and ions. CxHC opening is regulated by [Ca2+]i and previously 
our lab showed that the opening of CxHCs crucially contributes to Ca2+ oscillations by 
providing Ca2+ entry that is necessary to sustain oscillatory activities (De Bock et al. 2011).  
In chapter VI we investigated the role of CxHCs on SMC [Ca2+]i responses and contractility of 
small mesenteric arteries. We suggest that HCs and ATP signaling are involved in controlling 
SMC contraction and blood vessel diameter by influencing the Ca2+ oscillations. The HC 
contribution appears to be essential as inhibition with connexin mimetic peptides stops the 
oscillations and inhibits SMC contraction. 
Ca2+ oscillations are influenced by HC opening and closure with increases in the [Ca2+]i, in a 
similar way as the dependency of IP3-receptor channel opening probability on [Ca
2+]i. CxHCs 
are activated by [Ca2+]i changes (de Vuyst et al. 2006, Ponsaerts et al. 2010) and are thus 
expected to open with each SMC Ca2+ spike and to release ATP in the extracellular space. 
ATP can bind to autocrine purinergic metabotropic receptors and the subsequent release of 
IP3 can contribute to the oscillations. Additionally, CxHC opening may favor Ca
2+ entry (Saez 
et al. 2010), which is necessary for sustained Ca2+ oscillations (Alonso et al. 1999). Thus, 
block of hemichannels with connexin mimetic peptides will reduce ATP-induced IP3 
generation and Ca2+ entry, thereby stopping the Ca2+ oscillations. In addition to autocrine 
actions of ATP, these actions may as well be paracrine. However, because no 
synchronization of oscillations was observed, paracrine signaling must be absent. In the 
tension measurements we saw in intact arteries sometimes vasomotion appear. In this 
circumstances, paracrine signaling of ATP could contribute to vasomotion. Furthermore, in 
those tension measurements, the effect of the connexin mimetic peptide Gap27 and the 
TAT-L2 peptide on the contractility was as inhibitory as in vessels without vasomotion, 
pointing to a role for CxHCs in vasomotion as well. This would mean that besides the very 
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well described role of GJs in vasomotion, CxHCs should be considered as additive players in 
this mechanism. Future studies should investigate thoroughly the role of CxHCs in 
vasomotion. Certainly since upregulation of vasomotion is considered to be protective in 
pathological conditions such as hypertension and ischemia. 
Gap27 and the TAT-L2 peptide inhibit the opening of CxHCs and this leads to a reduction of 
the norepinephrine-induced Ca2+ oscillations and contractility. The TAT-CT9 peptide inhibits 
the closure of CxHCs with high micromolar [Ca2+]i and the effect of this peptide is a 
persistent opening of the CxHC, and in this way the negative feedback loop is inactive and 
Ca2+ oscillations are inhibited. An additional effect of this prolonged opening of the HCs is 
the entrance of Ca2+ into the cytosol through these channels and this explains why the 
baseline Fluo-3 fluorescence increased in this condition and why the contractility in our 
blood vessels did not attenuate with the TAT-CT9 peptide. 
Changes in [Ca2+]i modulate vascular SMC tension (Ruehlmann et al. 2000). There is 
increasing evidence that pharmacological and/or pathophysiological factors modulate SMC 
responsiveness via alterations in the Ca2+ oscillations. NO, NO donors, β-adrenoceptor 
agonists, intravenous anesthetics, or benzodiazepines reduce the frequency of Ca2+ 
oscillations along with inducing relaxation (Savineau and Marthan 2000). Gap27 and the 
TAT-L2 peptide attenuated the norepinephrine-induced contractions in our isometric tension 
measurements. Cx mimetic peptides have been extensively used to investigate the role of 
GJs in vascular physiology (Dhein 2002) but our results support that the effect of these 
peptides on connexin channels should be reconsidered in the sense that these peptides also, 
and more rapidly, inhibit unapposed CxHCs. In addition to the well documented functions of 
GJs in controlling vascular contraction, our data bring up a possible contribution of CxHCs. 
These novel targets offer interesting opportunities for the development of new therapeutic 
approaches to vascular disease. Future experiments on hypertensive animal models are 
necessary to determine whether CxHCs are also involved in this particular disease state. It 
would be interesting to test the effects of the L2-peptide and Gap27 in spontaneous 
hypertensive rats (SHR rats) or in hypertensive animal models induced by angiotensin II or 
the nitric oxide synthase inhibitor L-NAME. In vivo studies of blood pressure in those animals 
treated with the connexin mimetic peptides would further elucidate the therapeutic 
potential of these substances. These peptides could be used as another target in the 
prevention of hypertension. 
Chapter VIII: General discussion and perspectives 
151 
 
GJs and CxHCs are important for vascular function, but connexin channels have also been 
described as contributors to the cell death process. GJs allow the passage of cell death 
messenger signals, thereby potentially contributing to the propagation of cell death known 
as bystander cell death or ‘kiss of death’ (Frank et al. 2005, Vinken et al. 2006, Decrock et al. 
2009, Feine et al. 2012). A positive correlation between GJIC and apoptosis was suggested 
since carbenoxolone and other GJ blockers prevented apoptosis (Frank et al. 2005, Peixoto 
et al. 2009). While GJs may cause propagated bystander cell death, unapposed HCs may 
cause cell death by uncontrolled opening thereby contributing to the entry and escape from 
the cell of ions and small molecules below ~1.5 kDa (Decrock et al. 2009). This may 
additionally contribute to the propagation of cell death (Decrock et al. 2009). 
Cryopreserved vessels, employed in vascular reconstruction procedures (Pascual et al. 2004), 
show massive cell death provoked by the methods of vascular cryopreservation. This is one 
of the main factors leading to the failure of grafting procedures performed using 
cryopreserved vascular allografts (Pascual et al. 2004).  
In Chapter VII we explored the possibilities of blocking connexin channels by Gap27 in the 
prevention of cryopreserved-induced cell death in vascular grafts. We showed a clear 
decrease of cell death in the intimal and medial layers of arteries and veins treated with 
Gap27. Song et al. stated earlier that carbenoxolone and Gap26 reduced neointimal 
formation and SMC deterioration and decreased risk for atherosclerosis and other 
complications (Song et al. 2009). Since SMCs are coupled with ECs via myo-endothelial GJs, 
cell death messengers from SMCs may transfer to ECs. In this way, Gap27-reduced SMC 
death may be beneficial for ECs. On the other hand, a reduction by Gap27 of EC death may 
be beneficial as well, since these myo-endothelial junctions play an important role in 
endothelial control over SMC function (Figueroa and Duling 2009, Dora 2010). Preservation 
of viable endothelial cells has the advantage of also preserving the antithrombogenic 
properties of the endothelium, which are important in the avoidance of early graft 
thrombosis, especially in low-flow situations (Randon et al. 2010). Partial absence of the 
endothelium means that the extracellular matrix makes contact with the circulating blood, 
which generally leads to thrombosis and/or restenosis (Pascual et al. 2004). On the other 
hand, preservation of viable endothelium has the disadvantage that the immunogenicity of 
the allografts is also preserved because vascular endothelial cells express ABO and major 
histocompatibility complex class I and II antigens. An immune response by activated T-
Chapter VIII: General discussion and perspectives 
 
152 
 
lymphocytes after implantation of an allograft due to ABO incompatibility was a significant 
risk factor for patency (Carpenter and Tomaszewski 1998). This immune reaction can be 
counteracted by matching the ABO and by administering a low dose of 
immunosuppressants.  
We used Gap27 that mimics the second extracellular loop of both Cx37 and Cx43, to inhibit 
GJs and HCs (Evans and Leybaert 2007, Decrock et al. 2009, de Wit and Griffith 2010, De 
Bock et al. 2011, Wang et al. 2012). In order to determine whether HCs or GJs are the main 
contributors to cell death in cryopreserved vascular grafts; application of Gap19, which has 
specificity for Cx43 and only inhibits HCs, could elucidate this question. Although the effects 
of the Gap19 peptide might be reduced due to blocking of Cx43 HCs, and not Cx37 HCs.  
In order to improve the preservation of vascular grafts, several cryopreservation solutions 
were tested over the years. Some authors tried cryopreservation of arterial specimens in low 
Ca2+ solutions but this was associated with increased cell death (Bujan et al. 2000). Low 
[Ca2+]e conditions are known to trigger HC opening (Quist et al. 2000, Thimm et al. 2005) and 
it is tempting to speculate that this is one of the causes leading to increased vascular cell 
death. The protective effects of Gap27 were more convincing during 
cryopreservation/thawing, while it was far less effective when only present during DMSO 
washout after thawing. Previous studies have shown that rapid thawing increases the 
fragility of the arterial vessel wall and macro- and microfractures in the vessel wall occur due 
to thermal stress (Pegg et al. 1997, Bujan et al. 2000). In this study, apoptotic cell death was 
more pronounced in the intimal layer than in the medial layer. Bad endothelial preservation 
can lead to vasospasm, occlusive intimal hyperplasia and accelerated atherosclerosis (Steen 
2001). Applying a more gradual, automated thawing process yields a 20 % reduction in EC 
death (Pascual et al. 2004) and a combination of gradually automated thawing (1 °C/min) 
and connexin mimetic peptides could be even more beneficial to reduce cell death in the 
endothelial layer. However, in most hospitals (in Belgium) automated thawing is not a 
standard procedure. 
In this study we demonstrated that detachment of the endothelial layer was more often 
observed in arteries than in veins; also EC death was more pronounced in arteries than in 
veins. Thus, veins have a better preserved endothelium after cryopreservation as compared 
to arteries and this property should be taken into account as one of the criteria in the 
decision which vascular graft to use for a particular patient. A possible explanation for the 
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worse preservation of the endothelium of arteries could be that both blood vessels are 
flushed prior to cryopreservation and since arteries have a more ‘robust’ structure compared 
to veins, flushing might be less carefully done (with higher pressure). Veins are more fragile 
and flushing happens here with more care to not damage the vein. Therefore a 
consideration of the flushing technique in arteries might improve endothelial cell survival.   
In this study, we focused on cell death studies and histological examination of cryopreserved 
vascular grafts after application with the connexin mimetic peptide. Future experiments are 
necessary to assess the more functional properties of the blood vessels via isometric tension 
measurements for example. The contractility induced by norepinephrine could be tested and 
the endothelium-dependent vasodilation could be investigated by acetylcholine. An 
evaluation by this method was already done by Rigol et al. in cryopreserved porcine femoral 
arteries, showing a 50 % reduction in norepinephrine-induced contractions and an equal 
dilation compared to control non-cryopreserved blood vessels (Rigol et al. 2000). It would be 
interesting to test our blood vessels cryopreserved with Gap27 and evaluate if the vascular 
functions were improved compared to standard cryopreserved grafts. 
Further studies including clinical application of the peptides will be needed to determine 
whether the protective potential of this treatment translates into a better clinical outcome 
after vessel transplantation. A first follow up study could be done by transplanting two blood 
vessels, one treated with Gap27 and one control, into pigs and procure the vessels after 
several weeks. A histological examination of the blood vessels would already indicate if 
certain adverse effects are developing. Major effects such as thrombosis, rejection, etc, are 
mostly seen after 6 months to 1 year of transplantation. Follow-up studies on patients would 
be a second step and here we could investigate the long-term effects of implanting 
cryopreserved Gap27-incubated grafts and see if adverse effects such as intimal hyperplasia, 
rejection of the graft or infection is reduced in this population.  
This newly proposed procedure, cryopreservation combined with application of connexin 
mimetic peptides, could be expanded to other tissues as well and for tissues that were 
vitrified (e.g. oocytes) The effects we found in blood vessels could be extrapolated to 
cryopreserved heart valves, bone tissues, keratinocytes, etcetera. Therefore additional 
studies testing the impact of blocking connexin or pannexin channels during 
cryopreservation/thawing of those tissues could improve the outcome after transplantation. 
Addition of connexin mimetic peptides could also be beneficial in preservation solutions for 
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non-cryopreserved tissues such as cornea, heart, liver,…. The cornea for example, is stored 
mostly at 2-8 °C in North America or in organ culture at 28-37 °C in Europe, leading to a 
prolonged preservation time. The successful outcome of the majority of corneal transplants 
depends on the presence of a viable corneal endothelium (Armitage 2011). Corneas express 
several connexin isoforms such as Cx43 (in endothelium and epithelium)(Williams and 
Watsky 2002) and Cx50 (in epithelium) (Gatzioufas et al. 2008), and blocking those connexins 
could reduce cell death and improve viability of the grafts. Bone fragments express Cx43 
abundantly and blocking this connexin by gap peptides could be important for preserving 
tissues such as ear bones (hammer or anvil) (Batra et al. 2012). Application of mimetic 
peptides could improve the preservation of organs and tissues and thereby contributing to a 
better outcome after transplantation. 
To conclude, in this doctoral thesis we elucidated the modulation of methanandamide, CGRP 
and CxHCs on the blood vessel function and we investigated the beneficial effect of connexin 
channel blockers on cryopreservation-induced cell death in vascular grafts (Figure 1). 
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Training 
Doctoral Training Programme Health Sciences and Medicine: 
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- From PhD to Job Market (2nd doctoral 
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- Knowledge for growth 2011 
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                 Collaborating (2011) 
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